Term | Genes involved | Match ratio | -log10 p-value |
---|---|---|---|
intracranial germ cell | 9 | 0.8181818 | 3.054593 |
angiosarcoma | 12 | 0.7500000 | 3.389041 |
thymus | 9 | 0.7500000 | 2.725992 |
soft tissue sarcomas | 14 | 0.5000000 | 2.132225 |
astrocytoma | 8 | 0.5000000 | 1.305324 |
bladder | 27 | 0.4029851 | 2.280247 |
breast | 31 | 0.3875000 | 2.280247 |
glioma | 28 | 0.3684211 | 1.877315 |
lymphoma | 52 | 0.3209877 | 1.901683 |
lung | 44 | 0.3076923 | 1.313824 |
ID | Term | Genes involved | Match ratio | -log10 p-value |
---|---|---|---|---|
DOID:1586 | rheumatic fever | 10 | 0.9090909 | 4.797592 |
DOID:11266 | hemorrhagic fever with renal syndrome | 10 | 0.8333333 | 4.209966 |
DOID:13359 | Ehlers-Danlos syndrome | 10 | 0.8333333 | 4.209966 |
DOID:3437 | laryngitis | 9 | 0.8181818 | 3.702061 |
DOID:786 | laryngeal disease | 9 | 0.8181818 | 3.702061 |
DOID:2214 | inherited blood coagulation disease | 21 | 0.8076923 | 8.219421 |
DOID:3737 | verrucous carcinoma | 8 | 0.8000000 | 3.215746 |
DOID:11247 | disseminated intravascular coagulation | 11 | 0.7857143 | 4.215514 |
DOID:12798 | mucopolysaccharidosis | 11 | 0.7857143 | 4.215514 |
DOID:12554 | hemolytic-uremic syndrome | 18 | 0.7826087 | 6.704788 |
DOID:9675 | pulmonary emphysema | 13 | 0.7647059 | 4.722775 |
DOID:2452 | thrombophilia | 18 | 0.7500000 | 6.261908 |
DOID:2256 | osteochondrodysplasia | 12 | 0.7500000 | 4.262468 |
DOID:200 | giant cell tumor | 13 | 0.7222222 | 4.336528 |
DOID:12689 | acoustic neuroma | 10 | 0.7142857 | 3.349986 |
DOID:13001 | carotid stenosis | 10 | 0.7142857 | 3.349986 |
DOID:10941 | intracranial aneurysm | 12 | 0.7058824 | 3.887553 |
DOID:3490 | Noonan syndrome | 12 | 0.7058824 | 3.887553 |
DOID:452 | pleomorphic adenoma | 14 | 0.7000000 | 4.407971 |
DOID:1080 | filariasis | 7 | 0.7000000 | 2.356767 |
DOID:2738 | pseudoxanthoma elasticum | 7 | 0.7000000 | 2.356767 |
DOID:3314 | angiomyolipoma | 7 | 0.7000000 | 2.356767 |
DOID:3493 | signet ring cell adenocarcinoma | 7 | 0.7000000 | 2.356767 |
DOID:4233 | clear cell sarcoma | 7 | 0.7000000 | 2.356767 |
DOID:13089 | intracranial arterial disease | 15 | 0.6818182 | 4.501470 |
DOID:3527 | cerebral arterial disease | 15 | 0.6818182 | 4.501470 |
DOID:235 | colonic benign neoplasm | 14 | 0.6666667 | 4.099843 |
DOID:3702 | cervical adenocarcinoma | 14 | 0.6666667 | 4.099843 |
DOID:1852 | intrahepatic cholestasis | 12 | 0.6666667 | 3.552487 |
DOID:3479 | uveal cancer | 12 | 0.6666667 | 3.552487 |
DOID:6039 | uveal melanoma | 12 | 0.6666667 | 3.552487 |
DOID:2870 | endometrial adenocarcinoma | 10 | 0.6666667 | 3.028698 |
DOID:4305 | bone giant cell tumor | 8 | 0.6666667 | 2.479297 |
DOID:8502 | bullous skin disease | 8 | 0.6666667 | 2.479297 |
DOID:962 | neurofibroma | 8 | 0.6666667 | 2.479297 |
DOID:8923 | skin melanoma | 11 | 0.6470588 | 3.145511 |
DOID:3149 | keratoacanthoma | 9 | 0.6428571 | 2.605015 |
DOID:9563 | bronchiectasis | 9 | 0.6428571 | 2.605015 |
DOID:203 | exostosis | 7 | 0.6363636 | 2.048341 |
DOID:2876 | laryngeal squamous cell carcinoma | 12 | 0.6315789 | 3.265637 |
DOID:4866 | salivary gland adenoid cystic carcinoma | 25 | 0.6250000 | 6.292779 |
DOID:4468 | clear cell adenocarcinoma | 15 | 0.6250000 | 3.922809 |
DOID:2615 | papilloma | 10 | 0.6250000 | 2.741626 |
DOID:0050624 | gastrointestinal system benign neoplasm | 31 | 0.6200000 | 7.637662 |
DOID:3086 | gingival overgrowth | 8 | 0.6153846 | 2.191809 |
DOID:2730 | epidermolysis bullosa | 11 | 0.6111111 | 2.881581 |
DOID:4248 | coronary stenosis | 11 | 0.6111111 | 2.881581 |
DOID:10126 | keratoconus | 14 | 0.6086957 | 3.526378 |
DOID:11723 | Duchenne muscular dystrophy | 14 | 0.6086957 | 3.526378 |
DOID:883 | parasitic helminthiasis infectious disease | 23 | 0.6052632 | 5.502882 |
DOID:3302 | chordoma | 12 | 0.6000000 | 3.022572 |
DOID:3303 | notochordal cancer | 12 | 0.6000000 | 3.022572 |
DOID:1395 | schistosomiasis | 9 | 0.6000000 | 2.342296 |
DOID:14268 | sclerosing cholangitis | 9 | 0.6000000 | 2.342296 |
DOID:0060050 | autoimmune disease of blood | 6 | 0.6000000 | 1.644875 |
DOID:0060099 | musculoskeletal system benign neoplasm | 6 | 0.6000000 | 1.644875 |
DOID:12185 | otosclerosis | 6 | 0.6000000 | 1.644875 |
DOID:13949 | interstitial cystitis | 6 | 0.6000000 | 1.644875 |
DOID:1498 | cholera | 6 | 0.6000000 | 1.644875 |
DOID:1678 | chronic interstitial cystitis | 6 | 0.6000000 | 1.644875 |
DOID:3179 | inverted papilloma | 6 | 0.6000000 | 1.644875 |
DOID:5200 | urinary tract obstruction | 6 | 0.6000000 | 1.644875 |
DOID:10487 | Hirschsprung’s disease | 10 | 0.5882353 | 2.483429 |
DOID:8850 | salivary gland cancer | 34 | 0.5862069 | 7.523249 |
DOID:3151 | skin squamous cell carcinoma | 14 | 0.5833333 | 3.286424 |
DOID:14499 | Fabry disease | 7 | 0.5833333 | 1.796666 |
DOID:1680 | chronic cystitis | 7 | 0.5833333 | 1.796666 |
DOID:3500 | gallbladder adenocarcinoma | 7 | 0.5833333 | 1.796666 |
DOID:5688 | Werner syndrome | 7 | 0.5833333 | 1.796666 |
DOID:7188 | autoimmune thyroiditis | 7 | 0.5833333 | 1.796666 |
DOID:4610 | intestinal benign neoplasm | 18 | 0.5806452 | 4.087798 |
DOID:0050904 | salivary gland carcinoma | 33 | 0.5789474 | 7.131912 |
DOID:2731 | vesiculobullous skin disease | 11 | 0.5789474 | 2.628136 |
DOID:3246 | embryonal rhabdomyosarcoma | 11 | 0.5789474 | 2.628136 |
DOID:3407 | carotid artery disease | 11 | 0.5789474 | 2.628136 |
DOID:205 | hyperostosis | 15 | 0.5769231 | 3.425429 |
DOID:2600 | laryngeal carcinoma | 15 | 0.5769231 | 3.425429 |
DOID:0060119 | pharynx cancer | 23 | 0.5750000 | 4.997425 |
DOID:8618 | oral cavity cancer | 35 | 0.5737705 | 7.423860 |
DOID:11077 | brucellosis | 24 | 0.5714286 | 5.147320 |
DOID:2596 | larynx cancer | 20 | 0.5714286 | 4.356451 |
DOID:13133 | HELLP syndrome | 12 | 0.5714286 | 2.780863 |
DOID:12206 | dengue hemorrhagic fever | 8 | 0.5714286 | 1.942981 |
DOID:12205 | dengue disease | 9 | 0.5625000 | 2.103290 |
DOID:1679 | cystitis | 9 | 0.5625000 | 2.103290 |
DOID:1993 | rectum cancer | 9 | 0.5625000 | 2.103290 |
DOID:3319 | lymphangioleiomyomatosis | 9 | 0.5625000 | 2.103290 |
DOID:2645 | benign mesothelioma | 32 | 0.5614035 | 6.514461 |
DOID:4531 | mucoepidermoid carcinoma | 14 | 0.5600000 | 3.074511 |
DOID:687 | hepatoblastoma | 14 | 0.5600000 | 3.074511 |
DOID:13378 | Kawasaki disease | 30 | 0.5555556 | 6.007844 |
DOID:9261 | nasopharynx carcinoma | 21 | 0.5526316 | 4.283452 |
DOID:1602 | lymphadenitis | 32 | 0.5517241 | 6.292779 |
DOID:9942 | lymph node disease | 32 | 0.5517241 | 6.292779 |
DOID:3193 | peripheral nerve sheath neoplasm | 16 | 0.5517241 | 3.351228 |
DOID:3111 | cystadenocarcinoma | 22 | 0.5500000 | 4.412240 |
DOID:3114 | serous cystadenocarcinoma | 22 | 0.5500000 | 4.412240 |
DOID:3355 | fibrosarcoma | 18 | 0.5454545 | 3.642637 |
DOID:3507 | dermatofibrosarcoma protuberans | 6 | 0.5454545 | 1.413548 |
DOID:3192 | neurilemmoma | 14 | 0.5384615 | 2.871784 |
DOID:9471 | meningitis | 14 | 0.5384615 | 2.871784 |
DOID:13608 | biliary atresia | 7 | 0.5384615 | 1.586845 |
DOID:2001 | neuroma | 15 | 0.5357143 | 3.022572 |
DOID:9446 | cholangitis | 15 | 0.5357143 | 3.022572 |
DOID:583 | hemolytic anemia | 32 | 0.5333333 | 5.886700 |
DOID:720 | normocytic anemia | 32 | 0.5333333 | 5.886700 |
DOID:1967 | leiomyosarcoma | 16 | 0.5333333 | 3.159208 |
DOID:4230 | smooth muscle cancer | 16 | 0.5333333 | 3.159208 |
DOID:11383 | cryptorchidism | 8 | 0.5333333 | 1.741171 |
DOID:4851 | pilocytic astrocytoma | 8 | 0.5333333 | 1.741171 |
DOID:0060033 | autoimmune disease of peripheral nervous system | 9 | 0.5294118 | 1.898168 |
DOID:10976 | membranous glomerulonephritis | 9 | 0.5294118 | 1.898168 |
DOID:12842 | Guillain-Barre syndrome | 9 | 0.5294118 | 1.898168 |
DOID:11372 | megacolon | 10 | 0.5263158 | 2.054603 |
DOID:214 | teeth hard tissue disease | 10 | 0.5263158 | 2.054603 |
DOID:2986 | IgA glomerulonephritis | 10 | 0.5263158 | 2.054603 |
DOID:0050339 | commensal bacterial infectious disease | 21 | 0.5250000 | 3.887553 |
DOID:3371 | chondrosarcoma | 33 | 0.5238095 | 5.841796 |
DOID:5940 | malignant peripheral nerve sheath tumor | 11 | 0.5238095 | 2.207793 |
DOID:1247 | blood coagulation disease | 94 | 0.5222222 | 15.926161 |
DOID:4914 | esophagus adenocarcinoma | 12 | 0.5217391 | 2.362354 |
DOID:1398 | parasitic infectious disease | 78 | 0.5200000 | 13.292418 |
DOID:14069 | cerebral malaria | 13 | 0.5200000 | 2.517579 |
DOID:854 | collagen disease | 104 | 0.5174129 | 17.102311 |
DOID:5100 | middle ear disease | 16 | 0.5161290 | 2.983822 |
DOID:9744 | type 1 diabetes mellitus | 16 | 0.5161290 | 2.983822 |
DOID:2228 | thrombocytosis | 17 | 0.5151515 | 3.123355 |
DOID:3443 | mammary Paget’s disease | 17 | 0.5151515 | 3.123355 |
DOID:1588 | thrombocytopenia | 35 | 0.5147059 | 5.944016 |
DOID:1116 | pertussis | 18 | 0.5142857 | 3.263445 |
DOID:2473 | opportunistic mycosis | 20 | 0.5128205 | 3.552487 |
DOID:0060095 | uterine benign neoplasm | 22 | 0.5116279 | 3.854296 |
DOID:13223 | uterine fibroid | 22 | 0.5116279 | 3.854296 |
DOID:7166 | thyroiditis | 27 | 0.5094340 | 4.567571 |
DOID:520 | aortic disease | 31 | 0.5081967 | 5.172561 |
DOID:12365 | malaria | 52 | 0.5048544 | 8.315805 |
DOID:4362 | cervical cancer | 53 | 0.5047619 | 8.459621 |
DOID:1575 | rheumatic disease | 94 | 0.5000000 | 14.499961 |
DOID:418 | systemic scleroderma | 94 | 0.5000000 | 14.499961 |
DOID:419 | scleroderma | 94 | 0.5000000 | 14.499961 |
DOID:2893 | cervix carcinoma | 52 | 0.5000000 | 8.148401 |
DOID:10124 | corneal disease | 31 | 0.5000000 | 4.991546 |
DOID:3627 | aortic aneurysm | 30 | 0.5000000 | 4.851886 |
DOID:350 | mastocytosis | 22 | 0.5000000 | 3.676322 |
DOID:3978 | extrinsic cardiomyopathy | 13 | 0.5000000 | 2.343631 |
DOID:820 | myocarditis | 13 | 0.5000000 | 2.343631 |
DOID:0060071 | pre-malignant neoplasm | 11 | 0.5000000 | 2.029012 |
DOID:9120 | amyloidosis | 10 | 0.5000000 | 1.875798 |
DOID:365 | bladder disease | 9 | 0.5000000 | 1.719678 |
DOID:8719 | in situ carcinoma | 9 | 0.5000000 | 1.719678 |
DOID:121 | vaginal disease | 7 | 0.5000000 | 1.404055 |
DOID:2170 | vaginitis | 7 | 0.5000000 | 1.404055 |
DOID:3385 | bacterial vaginosis | 7 | 0.5000000 | 1.404055 |
DOID:4231 | histiocytoma | 7 | 0.5000000 | 1.404055 |
DOID:5408 | Paget’s disease of bone | 7 | 0.5000000 | 1.404055 |
DOID:6204 | follicular adenoma | 7 | 0.5000000 | 1.404055 |
DOID:2789 | parasitic protozoa infectious disease | 63 | 0.4960630 | 9.671266 |
DOID:3744 | cervical squamous cell carcinoma | 36 | 0.4931507 | 5.570612 |
DOID:3326 | purpura | 35 | 0.4929577 | 5.431076 |
DOID:4948 | gallbladder carcinoma | 25 | 0.4901961 | 3.954023 |
DOID:2218 | blood platelet disease | 47 | 0.4895833 | 7.046789 |
DOID:0060086 | female reproductive organ benign neoplasm | 22 | 0.4888889 | 3.516384 |
DOID:3458 | breast adenocarcinoma | 22 | 0.4888889 | 3.516384 |
DOID:2916 | hypersensitivity reaction type IV disease | 43 | 0.4886364 | 6.437386 |
DOID:11335 | sarcoidosis | 41 | 0.4880952 | 6.141241 |
DOID:5157 | benign pleural mesothelioma | 20 | 0.4878049 | 3.221516 |
DOID:4989 | pancreatitis | 57 | 0.4871795 | 8.372408 |
DOID:255 | hemangioma | 18 | 0.4864865 | 2.942582 |
DOID:12716 | newborn respiratory distress syndrome | 17 | 0.4857143 | 2.781083 |
DOID:0060115 | nervous system benign neoplasm | 16 | 0.4848485 | 2.628136 |
DOID:4074 | pancreas adenocarcinoma | 78 | 0.4844720 | 11.297167 |
DOID:824 | periodontitis | 58 | 0.4833333 | 8.364691 |
DOID:0050735 | X-linked disease | 14 | 0.4827586 | 2.333862 |
DOID:3962 | follicular thyroid carcinoma | 27 | 0.4821429 | 4.095781 |
DOID:13129 | severe pre-eclampsia | 13 | 0.4814815 | 2.178033 |
DOID:299 | adenocarcinoma | 76 | 0.4810127 | 10.830209 |
DOID:3247 | rhabdomyosarcoma | 38 | 0.4810127 | 5.545062 |
DOID:3121 | gallbladder cancer | 25 | 0.4807692 | 3.797922 |
DOID:2213 | hemorrhagic disease | 73 | 0.4802632 | 10.362169 |
DOID:3376 | bone osteosarcoma | 24 | 0.4800000 | 3.646641 |
DOID:0060122 | integumentary system cancer | 47 | 0.4795918 | 6.706218 |
DOID:4159 | skin cancer | 47 | 0.4795918 | 6.706218 |
DOID:4045 | muscle cancer | 51 | 0.4766355 | 7.161164 |
DOID:0050136 | systemic mycosis | 20 | 0.4761905 | 3.074511 |
DOID:10923 | sickle cell anemia | 20 | 0.4761905 | 3.074511 |
DOID:349 | systemic mastocytosis | 18 | 0.4736842 | 2.780863 |
DOID:3713 | ovary adenocarcinoma | 18 | 0.4736842 | 2.780863 |
DOID:3095 | germ cell and embryonal cancer | 9 | 0.4736842 | 1.560925 |
DOID:8398 | osteoarthritis | 88 | 0.4705882 | 11.888871 |
DOID:1927 | sphingolipidosis | 16 | 0.4705882 | 2.479297 |
DOID:0050938 | breast lobular carcinoma | 8 | 0.4705882 | 1.404055 |
DOID:1273 | respiratory syncytial virus infectious disease | 8 | 0.4705882 | 1.404055 |
DOID:13564 | aspergillosis | 8 | 0.4705882 | 1.404055 |
DOID:3457 | invasive lobular carcinoma | 8 | 0.4705882 | 1.404055 |
DOID:7693 | abdominal aortic aneurysm | 23 | 0.4693878 | 3.351228 |
DOID:2797 | idiopathic interstitial pneumonia | 15 | 0.4687500 | 2.332153 |
DOID:974 | upper respiratory tract disease | 59 | 0.4682540 | 7.904842 |
DOID:0050622 | reproductive organ benign neoplasm | 22 | 0.4680851 | 3.212210 |
DOID:3388 | periodontal disease | 65 | 0.4676259 | 8.634735 |
DOID:75 | lymphatic system disease | 47 | 0.4653465 | 6.259987 |
DOID:4481 | allergic rhinitis | 46 | 0.4646465 | 6.108706 |
DOID:234 | colon adenocarcinoma | 13 | 0.4642857 | 2.020611 |
DOID:1024 | leprosy | 19 | 0.4634146 | 2.780863 |
DOID:1790 | malignant mesothelioma | 19 | 0.4634146 | 2.780863 |
DOID:1091 | tooth disease | 75 | 0.4629630 | 9.710508 |
DOID:552 | pneumonia | 50 | 0.4629630 | 6.546833 |
DOID:403 | mouth disease | 87 | 0.4627660 | 11.259706 |
DOID:0002116 | pterygium | 12 | 0.4615385 | 1.874008 |
DOID:10139 | conjunctival degeneration | 12 | 0.4615385 | 1.874008 |
DOID:10526 | conjunctival pterygium | 12 | 0.4615385 | 1.874008 |
DOID:104 | bacterial infectious disease | 125 | 0.4612546 | 15.855269 |
DOID:627 | severe combined immunodeficiency | 23 | 0.4600000 | 3.212437 |
DOID:9741 | biliary tract disease | 40 | 0.4597701 | 5.233588 |
DOID:5409 | lung small cell carcinoma | 33 | 0.4583333 | 4.362777 |
DOID:6543 | acne | 11 | 0.4583333 | 1.719678 |
DOID:9098 | sebaceous gland disease | 11 | 0.4583333 | 1.719678 |
DOID:4043 | skeletal muscle cancer | 38 | 0.4578313 | 4.953403 |
DOID:2921 | glomerulonephritis | 36 | 0.4556962 | 4.643978 |
DOID:2163 | nasal cavity disease | 46 | 0.4554455 | 5.838981 |
DOID:2825 | nose disease | 46 | 0.4554455 | 5.838981 |
DOID:4483 | rhinitis | 46 | 0.4554455 | 5.838981 |
DOID:0070004 | myeloma | 147 | 0.4551084 | 17.624085 |
DOID:289 | endometriosis | 40 | 0.4545455 | 5.091162 |
DOID:1227 | neutropenia | 15 | 0.4545455 | 2.183011 |
DOID:12987 | agranulocytosis | 15 | 0.4545455 | 2.183011 |
DOID:1483 | gingival disease | 15 | 0.4545455 | 2.183011 |
DOID:10754 | otitis media | 10 | 0.4545455 | 1.570019 |
DOID:640 | encephalomyelitis | 10 | 0.4545455 | 1.570019 |
DOID:4138 | bile duct disease | 39 | 0.4534884 | 4.954600 |
DOID:4960 | bone marrow cancer | 148 | 0.4512195 | 17.495466 |
DOID:3347 | osteosarcoma | 97 | 0.4511628 | 11.771864 |
DOID:8567 | Hodgkin’s lymphoma | 23 | 0.4509804 | 3.078970 |
DOID:9538 | multiple myeloma | 119 | 0.4507576 | 14.350121 |
DOID:12361 | Graves’ disease | 36 | 0.4500000 | 4.501470 |
DOID:10883 | herpangina | 9 | 0.4500000 | 1.407843 |
DOID:14067 | Plasmodium falciparum malaria | 9 | 0.4500000 | 1.407843 |
DOID:1532 | pleural disease | 9 | 0.4500000 | 1.407843 |
DOID:0050338 | primary bacterial infectious disease | 107 | 0.4495798 | 12.886499 |
DOID:184 | bone cancer | 109 | 0.4485597 | 13.015364 |
DOID:3829 | pituitary adenoma | 26 | 0.4482759 | 3.359858 |
DOID:3973 | thyroid medullary carcinoma | 17 | 0.4473684 | 2.343631 |
DOID:1520 | colon carcinoma | 75 | 0.4464286 | 8.830150 |
DOID:9500 | leukocyte disease | 41 | 0.4456522 | 4.965805 |
DOID:5517 | stomach carcinoma | 68 | 0.4444444 | 7.948954 |
DOID:9074 | systemic lupus erythematosus | 36 | 0.4444444 | 4.383526 |
DOID:715 | T-cell leukemia | 28 | 0.4444444 | 3.518318 |
DOID:0050621 | respiratory system benign neoplasm | 16 | 0.4444444 | 2.191809 |
DOID:5158 | pleural cancer | 16 | 0.4444444 | 2.191809 |
DOID:7474 | malignant pleural mesothelioma | 16 | 0.4444444 | 2.191809 |
DOID:1724 | duodenal ulcer | 12 | 0.4444444 | 1.731048 |
DOID:341 | peripheral vascular disease | 27 | 0.4426230 | 3.370812 |
DOID:2394 | ovarian cancer | 138 | 0.4423077 | 15.734760 |
DOID:628 | combined T cell and B cell immunodeficiency | 23 | 0.4423077 | 2.956912 |
DOID:10952 | nephritis | 65 | 0.4421769 | 7.514410 |
DOID:5672 | large intestine cancer | 127 | 0.4409722 | 14.389735 |
DOID:2151 | malignant ovarian surface epithelial-stromal neoplasm | 126 | 0.4405594 | 14.350121 |
DOID:2152 | ovary epithelial cancer | 126 | 0.4405594 | 14.350121 |
DOID:4001 | ovarian carcinoma | 126 | 0.4405594 | 14.350121 |
DOID:50 | thyroid gland disease | 70 | 0.4402516 | 7.956656 |
DOID:13515 | tuberous sclerosis | 11 | 0.4400000 | 1.586845 |
DOID:9256 | colorectal cancer | 126 | 0.4390244 | 14.224643 |
DOID:2871 | endometrial carcinoma | 36 | 0.4390244 | 4.261594 |
DOID:3498 | pancreatic ductal adenocarcinoma | 43 | 0.4387755 | 4.988116 |
DOID:0060049 | autoimmune disease of urogenital tract | 32 | 0.4383562 | 3.831292 |
DOID:12236 | primary biliary cirrhosis | 32 | 0.4383562 | 3.831292 |
DOID:13375 | temporal arteritis | 14 | 0.4375000 | 1.898168 |
DOID:2706 | synovium cancer | 14 | 0.4375000 | 1.898168 |
DOID:525 | central nervous system vasculitis | 14 | 0.4375000 | 1.898168 |
DOID:5485 | synovial sarcoma | 14 | 0.4375000 | 1.898168 |
DOID:0060005 | autoimmune disease of endocrine system | 38 | 0.4367816 | 4.403274 |
DOID:10155 | intestinal cancer | 131 | 0.4366667 | 14.433030 |
DOID:0080006 | bone development disease | 24 | 0.4363636 | 2.972142 |
DOID:219 | colon cancer | 123 | 0.4361702 | 13.608965 |
DOID:3717 | gastric adenocarcinoma | 41 | 0.4361702 | 4.699711 |
DOID:399 | tuberculosis | 68 | 0.4358974 | 7.549449 |
DOID:13580 | cholestasis | 27 | 0.4354839 | 3.252125 |
DOID:3480 | uveal disease | 20 | 0.4347826 | 2.515588 |
DOID:201 | connective tissue cancer | 160 | 0.4324324 | 17.041953 |
DOID:127 | leiomyoma | 41 | 0.4315789 | 4.567571 |
DOID:4079 | heart valve disease | 22 | 0.4313725 | 2.675020 |
DOID:4971 | myelofibrosis | 21 | 0.4285714 | 2.534379 |
DOID:10316 | pneumoconiosis | 15 | 0.4285714 | 1.912376 |
DOID:1272 | telangiectasis | 15 | 0.4285714 | 1.912376 |
DOID:13207 | proliferative diabetic retinopathy | 15 | 0.4285714 | 1.912376 |
DOID:3683 | lung benign neoplasm | 15 | 0.4285714 | 1.912376 |
DOID:13141 | uveitis | 12 | 0.4285714 | 1.607626 |
DOID:8552 | chronic myeloid leukemia | 12 | 0.4285714 | 1.607626 |
DOID:10286 | prostate carcinoma | 52 | 0.4262295 | 5.516550 |
DOID:1067 | open-angle glaucoma | 26 | 0.4262295 | 3.007713 |
DOID:0060100 | musculoskeletal system cancer | 187 | 0.4259681 | 18.716071 |
DOID:615 | leukopenia | 20 | 0.4255319 | 2.391784 |
DOID:8857 | lupus erythematosus | 37 | 0.4252874 | 4.038865 |
DOID:3277 | thymus cancer | 14 | 0.4242424 | 1.772047 |
DOID:6713 | cerebrovascular disease | 49 | 0.4224138 | 5.091162 |
DOID:3113 | papillary carcinoma | 19 | 0.4222222 | 2.251211 |
DOID:526 | Human immunodeficiency virus infectious disease | 73 | 0.4219653 | 7.404078 |
DOID:12894 | Sjogren’s syndrome | 29 | 0.4202899 | 3.176503 |
DOID:1070 | primary open angle glaucoma | 21 | 0.4200000 | 2.416369 |
DOID:3620 | central nervous system cancer | 52 | 0.4193548 | 5.279319 |
DOID:11394 | adult respiratory distress syndrome | 13 | 0.4193548 | 1.634616 |
DOID:2583 | agammaglobulinemia | 13 | 0.4193548 | 1.634616 |
DOID:620 | blood protein disease | 13 | 0.4193548 | 1.634616 |
DOID:4448 | macular degeneration | 31 | 0.4189189 | 3.329815 |
DOID:0080005 | bone remodeling disease | 59 | 0.4184397 | 5.891094 |
DOID:3083 | chronic obstructive pulmonary disease | 92 | 0.4181818 | 9.025866 |
DOID:5082 | liver cirrhosis | 92 | 0.4181818 | 9.025866 |
DOID:11162 | respiratory failure | 23 | 0.4181818 | 2.583609 |
DOID:438 | autoimmune disease of the nervous system | 23 | 0.4181818 | 2.583609 |
DOID:0060116 | sensory system cancer | 58 | 0.4172662 | 5.775186 |
DOID:2174 | ocular cancer | 58 | 0.4172662 | 5.775186 |
DOID:1793 | pancreatic cancer | 133 | 0.4169279 | 12.990357 |
DOID:11476 | osteoporosis | 40 | 0.4166667 | 4.101730 |
DOID:7998 | hyperthyroidism | 40 | 0.4166667 | 4.101730 |
DOID:10747 | lymphoid leukemia | 30 | 0.4166667 | 3.201231 |
DOID:10871 | age related macular degeneration | 30 | 0.4166667 | 3.201231 |
DOID:2007 | degeneration of macula and posterior pole | 30 | 0.4166667 | 3.201231 |
DOID:11260 | rabies | 25 | 0.4166667 | 2.746468 |
DOID:169 | neuroendocrine tumor | 10 | 0.4166667 | 1.307880 |
DOID:272 | hepatic vascular disease | 10 | 0.4166667 | 1.307880 |
DOID:3907 | lung squamous cell carcinoma | 10 | 0.4166667 | 1.307880 |
DOID:10534 | stomach cancer | 114 | 0.4160584 | 11.044348 |
DOID:0060085 | organ system benign neoplasm | 109 | 0.4160305 | 10.539500 |
DOID:8469 | influenza | 47 | 0.4159292 | 4.699711 |
DOID:4607 | biliary tract cancer | 74 | 0.4157303 | 7.176430 |
DOID:3565 | meningioma | 32 | 0.4155844 | 3.351228 |
DOID:26 | pancreas disease | 71 | 0.4152047 | 6.862103 |
DOID:3068 | glioblastoma multiforme | 29 | 0.4142857 | 3.071477 |
DOID:2462 | retinal vascular disease | 24 | 0.4137931 | 2.605015 |
DOID:3451 | skin carcinoma | 24 | 0.4137931 | 2.605015 |
DOID:8947 | diabetic retinopathy | 24 | 0.4137931 | 2.605015 |
DOID:12177 | common variable immunodeficiency | 12 | 0.4137931 | 1.484306 |
DOID:4798 | aggressive systemic mastocytosis | 12 | 0.4137931 | 1.484306 |
DOID:9834 | hyperopia | 12 | 0.4137931 | 1.484306 |
DOID:9408 | acute myocardial infarction | 38 | 0.4130435 | 3.831292 |
DOID:1686 | glaucoma | 45 | 0.4128440 | 4.419981 |
DOID:0080011 | bone resorption disease | 40 | 0.4123711 | 3.990853 |
DOID:1380 | endometrial cancer | 40 | 0.4123711 | 3.990853 |
DOID:576 | proteinuria | 28 | 0.4117647 | 2.942255 |
DOID:10223 | dermatomyositis | 14 | 0.4117647 | 1.652441 |
DOID:2043 | hepatitis B | 81 | 0.4111675 | 7.591224 |
DOID:0050589 | inflammatory bowel disease | 37 | 0.4111111 | 3.693260 |
DOID:363 | uterine cancer | 40 | 0.4081633 | 3.882496 |
DOID:3082 | interstitial lung disease | 69 | 0.4058824 | 6.261908 |
DOID:1319 | brain cancer | 17 | 0.4047619 | 1.859568 |
DOID:120 | female reproductive organ cancer | 184 | 0.4043956 | 16.224026 |
DOID:1036 | chronic leukemia | 90 | 0.4035874 | 7.948954 |
DOID:74 | hematopoietic system disease | 191 | 0.4029536 | 16.659419 |
DOID:6432 | pulmonary hypertension | 31 | 0.4025974 | 3.022572 |
DOID:2377 | multiple sclerosis | 68 | 0.4023669 | 6.020215 |
DOID:4905 | pancreatic carcinoma | 95 | 0.4008439 | 8.203973 |
DOID:3213 | demyelinating disease | 70 | 0.4000000 | 6.081838 |
DOID:4606 | bile duct cancer | 56 | 0.4000000 | 4.954600 |
DOID:4897 | bile duct carcinoma | 56 | 0.4000000 | 4.954600 |
DOID:8778 | Crohn’s disease | 20 | 0.4000000 | 2.054603 |
DOID:11830 | myopia | 18 | 0.4000000 | 1.888518 |
DOID:1115 | sarcoma | 77 | 0.3989637 | 6.590212 |
DOID:3910 | lung adenocarcinoma | 71 | 0.3988764 | 6.108706 |
DOID:3770 | pulmonary fibrosis | 49 | 0.3983740 | 4.338634 |
DOID:0060058 | lymphoma | 35 | 0.3977273 | 3.223797 |
DOID:6590 | spondylitis | 27 | 0.3970588 | 2.584609 |
DOID:5520 | head and neck squamous cell carcinoma | 69 | 0.3965517 | 5.847321 |
DOID:3070 | malignant glioma | 82 | 0.3961353 | 6.856168 |
DOID:13241 | Behcet’s disease | 34 | 0.3953488 | 3.101443 |
DOID:3963 | thyroid carcinoma | 79 | 0.3950000 | 6.555629 |
DOID:0060121 | integumentary system benign neoplasm | 13 | 0.3939394 | 1.407843 |
DOID:2115 | B cell deficiency | 13 | 0.3939394 | 1.407843 |
DOID:3165 | skin benign neoplasm | 13 | 0.3939394 | 1.407843 |
DOID:865 | vasculitis | 48 | 0.3934426 | 4.109251 |
DOID:3069 | astrocytoma | 44 | 0.3928571 | 3.797190 |
DOID:381 | arthropathy | 38 | 0.3917526 | 3.315902 |
DOID:0060180 | colitis | 27 | 0.3913043 | 2.483577 |
DOID:7147 | ankylosing spondylitis | 27 | 0.3913043 | 2.483577 |
DOID:8577 | ulcerative colitis | 27 | 0.3913043 | 2.483577 |
DOID:4896 | bile duct adenocarcinoma | 50 | 0.3906250 | 4.178660 |
DOID:4947 | cholangiocarcinoma | 50 | 0.3906250 | 4.178660 |
DOID:10283 | prostate cancer | 166 | 0.3905882 | 13.292418 |
DOID:1781 | thyroid cancer | 83 | 0.3896714 | 6.585249 |
DOID:2320 | obstructive lung disease | 119 | 0.3863636 | 9.104451 |
DOID:1459 | hypothyroidism | 17 | 0.3863636 | 1.650129 |
DOID:1555 | urticaria | 17 | 0.3863636 | 1.650129 |
DOID:3856 | male reproductive organ cancer | 168 | 0.3862069 | 12.986075 |
DOID:5041 | esophageal cancer | 56 | 0.3862069 | 4.442904 |
DOID:4450 | renal cell carcinoma | 132 | 0.3859649 | 10.106730 |
DOID:3908 | non-small cell lung carcinoma | 166 | 0.3851508 | 12.717954 |
DOID:10608 | celiac disease | 35 | 0.3846154 | 2.953533 |
DOID:4766 | embryoma | 135 | 0.3835227 | 10.111925 |
DOID:850 | lung disease | 191 | 0.3827655 | 14.350121 |
DOID:4251 | conjunctival disease | 13 | 0.3823529 | 1.307880 |
DOID:62 | aortic valve disease | 13 | 0.3823529 | 1.307880 |
DOID:1107 | esophageal carcinoma | 47 | 0.3821138 | 3.701126 |
DOID:1564 | fungal infectious disease | 29 | 0.3815789 | 2.461261 |
DOID:28 | endocrine system disease | 152 | 0.3809524 | 11.168597 |
DOID:3298 | vaccinia | 16 | 0.3809524 | 1.522903 |
DOID:18 | urinary system disease | 182 | 0.3807531 | 13.391176 |
DOID:2237 | hepatitis | 164 | 0.3805104 | 12.029591 |
DOID:9835 | refractive error | 27 | 0.3802817 | 2.298305 |
DOID:4451 | renal carcinoma | 144 | 0.3789474 | 10.362169 |
DOID:326 | ischemia | 77 | 0.3774510 | 5.549226 |
DOID:557 | kidney disease | 174 | 0.3774403 | 12.449641 |
DOID:5295 | intestinal disease | 59 | 0.3757962 | 4.294436 |
DOID:643 | progressive multifocal leukoencephalopathy | 24 | 0.3750000 | 2.000529 |
DOID:4645 | retinal cancer | 44 | 0.3728814 | 3.251961 |
DOID:768 | retinoblastoma | 43 | 0.3706897 | 3.137257 |
DOID:771 | retinal cell cancer | 43 | 0.3706897 | 3.137257 |
DOID:688 | embryonal cancer | 138 | 0.3699732 | 9.101917 |
DOID:161 | keratosis | 17 | 0.3695652 | 1.468922 |
DOID:2527 | nephrosis | 21 | 0.3684211 | 1.717198 |
DOID:2994 | germ cell cancer | 151 | 0.3682927 | 9.822377 |
DOID:4195 | hyperglycemia | 51 | 0.3669065 | 3.507214 |
DOID:635 | acquired immunodeficiency syndrome | 26 | 0.3661972 | 1.990959 |
DOID:437 | myasthenia gravis | 15 | 0.3658537 | 1.302351 |
DOID:2348 | arteriosclerotic cardiovascular disease | 126 | 0.3652174 | 7.948954 |
DOID:2349 | arteriosclerosis | 130 | 0.3651685 | 8.185000 |
DOID:1883 | hepatitis C | 85 | 0.3648069 | 5.431076 |
DOID:1123 | spondyloarthropathy | 28 | 0.3636364 | 2.068950 |
DOID:1184 | nephrotic syndrome | 20 | 0.3636364 | 1.594745 |
DOID:1936 | atherosclerosis | 125 | 0.3633721 | 7.741045 |
DOID:11934 | head and neck cancer | 86 | 0.3598326 | 5.222540 |
DOID:1074 | kidney failure | 56 | 0.3589744 | 3.528923 |
DOID:0060031 | autoimmune disease of gastrointestinal tract | 39 | 0.3577982 | 2.584608 |
DOID:1542 | head and neck carcinoma | 84 | 0.3574468 | 4.988116 |
DOID:0060084 | cell type benign neoplasm | 169 | 0.3557895 | 9.676543 |
DOID:1485 | cystic fibrosis | 49 | 0.3550725 | 3.053316 |
DOID:263 | kidney cancer | 155 | 0.3546911 | 8.735681 |
DOID:0060089 | endocrine organ benign neoplasm | 35 | 0.3535354 | 2.274082 |
DOID:10591 | pre-eclampsia | 98 | 0.3525180 | 5.476947 |
DOID:1205 | hypersensitivity reaction type I disease | 43 | 0.3524590 | 2.662393 |
DOID:229 | female reproductive system disease | 68 | 0.3523316 | 3.922809 |
DOID:8692 | myeloid leukemia | 50 | 0.3521127 | 3.022572 |
DOID:12449 | aplastic anemia | 26 | 0.3513514 | 1.756449 |
DOID:5844 | myocardial infarction | 98 | 0.3512545 | 5.404588 |
DOID:657 | adenoma | 119 | 0.3500000 | 6.385952 |
DOID:9119 | acute myeloid leukemia | 37 | 0.3457944 | 2.204137 |
DOID:633 | myositis | 28 | 0.3456790 | 1.766210 |
DOID:11612 | polycystic ovary syndrome | 57 | 0.3433735 | 3.078970 |
DOID:3969 | papillary thyroid carcinoma | 37 | 0.3425926 | 2.136064 |
DOID:3393 | coronary artery disease | 119 | 0.3419540 | 5.838981 |
DOID:612 | primary immunodeficiency disease | 67 | 0.3418367 | 3.468803 |
DOID:8466 | retinal degeneration | 89 | 0.3409962 | 4.403274 |
DOID:2355 | anemia | 83 | 0.3401639 | 4.102771 |
DOID:2742 | auditory system disease | 34 | 0.3400000 | 1.939098 |
DOID:1176 | bronchial disease | 52 | 0.3398693 | 2.748774 |
DOID:3996 | urinary system cancer | 169 | 0.3380000 | 7.835899 |
DOID:5683 | hereditary breast ovarian cancer | 75 | 0.3378378 | 3.651328 |
DOID:440 | neuromuscular disease | 28 | 0.3373494 | 1.634616 |
DOID:11054 | urinary bladder cancer | 36 | 0.3364486 | 1.954984 |
DOID:1040 | chronic lymphocytic leukemia | 74 | 0.3348416 | 3.491573 |
DOID:15 | reproductive system disease | 128 | 0.3316062 | 5.498683 |
DOID:9884 | muscular dystrophy | 34 | 0.3300971 | 1.750562 |
DOID:0050736 | autosomal dominant disease | 135 | 0.3300733 | 5.666527 |
DOID:1192 | peripheral nervous system neoplasm | 130 | 0.3282828 | 5.335443 |
DOID:9352 | type 2 diabetes mellitus | 70 | 0.3255814 | 2.987486 |
DOID:0050737 | autosomal recessive disease | 108 | 0.3233533 | 4.208392 |
DOID:37 | skin disease | 113 | 0.3228571 | 4.347404 |
DOID:2841 | asthma | 43 | 0.3208955 | 1.887609 |
DOID:2621 | autonomic nervous system neoplasm | 120 | 0.3200000 | 4.403274 |
DOID:769 | neuroblastoma | 120 | 0.3200000 | 4.403274 |
DOID:3459 | breast carcinoma | 122 | 0.3185379 | 4.378715 |
DOID:1037 | lymphoblastic leukemia | 141 | 0.3182844 | 4.988116 |
DOID:5223 | infertility | 65 | 0.3155340 | 2.451635 |
DOID:10652 | Alzheimer’s disease | 135 | 0.3139535 | 4.464213 |
DOID:680 | tauopathy | 136 | 0.3133641 | 4.454463 |
DOID:3211 | lysosomal storage disease | 47 | 0.3133333 | 1.832582 |
DOID:5679 | retinal disease | 110 | 0.3072626 | 3.353694 |
DOID:16 | integumentary system disease | 121 | 0.3071066 | 3.642637 |
DOID:0080000 | muscular disease | 124 | 0.3039216 | 3.526348 |
DOID:332 | amyotrophic lateral sclerosis | 47 | 0.3032258 | 1.590212 |
DOID:423 | myopathy | 120 | 0.3015075 | 3.286717 |
DOID:66 | muscle tissue disease | 120 | 0.3015075 | 3.286717 |
DOID:1307 | dementia | 45 | 0.3000000 | 1.461231 |
DOID:655 | inherited metabolic disorder | 94 | 0.2839879 | 1.906101 |
DOID:6000 | congestive heart failure | 64 | 0.2794760 | 1.302759 |
DOID:654 | overnutrition | 89 | 0.2763975 | 1.550232 |
DOID:374 | nutrition disease | 91 | 0.2692308 | 1.309329 |
ID | Term | Genes involved | Match ratio | -log10 p-value |
---|---|---|---|---|
umls:C0410538 | Pseudoachondroplasia | 17 | 0.9444444 | 11.098734 |
umls:C0027612 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 11 | 0.9166667 | 6.861067 |
umls:C0023067 | Laryngitis | 15 | 0.8823529 | 8.902791 |
umls:C0010324 | Crigler Najjar syndrome, type 1 | 13 | 0.8666667 | 7.525717 |
umls:C0265253 | Stickler syndrome (disorder) | 13 | 0.8666667 | 7.525717 |
umls:C1096903 | Sialic Acid Storage Disease, Finnish Type (disorder) | 11 | 0.8461538 | 6.181605 |
umls:C0019050 | Hemoglobinuria, Paroxysmal | 10 | 0.8333333 | 5.526101 |
umls:C0242594 | Residual Cancer | 10 | 0.8333333 | 5.526101 |
umls:C0206641 | Osteochondromatosis | 9 | 0.8181818 | 4.873490 |
umls:C1334928 | Necrotic changes (finding) | 9 | 0.8181818 | 4.873490 |
umls:C1834674 | Bethlem myopathy | 9 | 0.8181818 | 4.873490 |
umls:C0025294 | Meningococcal meningitis | 13 | 0.8125000 | 6.923563 |
umls:C0005129 | Bernard-Soulier Syndrome | 12 | 0.8000000 | 6.275926 |
umls:C0042025 | Urinary Stress Incontinence | 12 | 0.8000000 | 6.275926 |
umls:C0153687 | Secondary malignant neoplasm of skin | 8 | 0.8000000 | 4.230722 |
umls:C0205622 | Microinvasive tumor | 8 | 0.8000000 | 4.230722 |
umls:C0280630 | Uterine Carcinosarcoma | 8 | 0.8000000 | 4.230722 |
umls:C0342853 | Sialuria | 8 | 0.8000000 | 4.230722 |
umls:C0679408 | Lesion of stomach | 8 | 0.8000000 | 4.230722 |
umls:C0887976 | Chlamydophila Infections | 8 | 0.8000000 | 4.230722 |
umls:C1704376 | Uterine Corpus Carcinosarcoma | 8 | 0.8000000 | 4.230722 |
umls:C0265004 | Dilatation of aorta | 11 | 0.7857143 | 5.641376 |
umls:C0035288 | Reticuloendotheliosis, X-linked | 10 | 0.7692308 | 5.012055 |
umls:C0012359 | Pathological Dilatation | 13 | 0.7647059 | 6.408208 |
umls:C1568272 | Tendinopathy | 19 | 0.7600000 | 9.231506 |
umls:C0025297 | Viral meningitis | 9 | 0.7500000 | 4.390427 |
umls:C0079293 | Epidermolysis Bullosa Acquisita | 9 | 0.7500000 | 4.390427 |
umls:C0085119 | Foot Ulcer | 9 | 0.7500000 | 4.390427 |
umls:C0349534 | Carcinoma of anal margin | 9 | 0.7500000 | 4.390427 |
umls:C0410179 | Scleroatonic muscular dystrophy | 9 | 0.7500000 | 4.390427 |
umls:C2931187 | Nephropathic cystinosis | 9 | 0.7500000 | 4.390427 |
umls:C0409651 | Seropositive rheumatoid arthritis | 14 | 0.7368421 | 6.581864 |
umls:C1959632 | Plasma Cell Neoplasm | 14 | 0.7368421 | 6.581864 |
umls:C3840085 | Disorder of Achilles tendon | 14 | 0.7368421 | 6.581864 |
umls:C0311370 | Lupus anticoagulant disorder | 19 | 0.7307692 | 8.785549 |
umls:C0014761 | Erythroblastosis, Fetal | 8 | 0.7272727 | 3.793957 |
umls:C0333297 | Chronic ulcer | 8 | 0.7272727 | 3.793957 |
umls:C0684256 | Bacterial sepsis | 8 | 0.7272727 | 3.793957 |
umls:C1260325 | Dendritic Cell Sarcoma, Follicular | 8 | 0.7272727 | 3.793957 |
umls:C3532222 | Inflammatory cardiomyopathy | 8 | 0.7272727 | 3.793957 |
umls:C0030848 | Peyronie Disease | 10 | 0.7142857 | 4.582696 |
umls:C0033822 | Pseudomyxoma Peritonei | 10 | 0.7142857 | 4.582696 |
umls:C0206769 | Nevi and Melanomas | 10 | 0.7142857 | 4.582696 |
umls:C0206699 | Cystadenocarcinoma, Mucinous | 12 | 0.7058824 | 5.383986 |
umls:C0473583 | Nevus elasticus | 19 | 0.7037037 | 8.364878 |
umls:C0020725 | Type II Mucolipidosis | 7 | 0.7000000 | 3.201464 |
umls:C0030186 | Paget Disease Extramammary | 7 | 0.7000000 | 3.201464 |
umls:C0162529 | Colitis, Ischemic | 7 | 0.7000000 | 3.201464 |
umls:C0280317 | Squamous cell carcinoma of tonsil | 7 | 0.7000000 | 3.201464 |
umls:C0346040 | Stage 0 Skin Melanoma | 7 | 0.7000000 | 3.201464 |
umls:C0700345 | Candidiasis, Vulvovaginal | 7 | 0.7000000 | 3.201464 |
umls:C0751689 | Peripheral Nerve Sheath Neoplasm | 7 | 0.7000000 | 3.201464 |
umls:C0862878 | Dedifferentiated chondrosarcoma | 7 | 0.7000000 | 3.201464 |
umls:C1264039 | von Willebrand Disease, Type 1 | 7 | 0.7000000 | 3.201464 |
umls:C1282359 | Ocular Cicatricial Pemphigoid | 7 | 0.7000000 | 3.201464 |
umls:C0079740 | High Grade Lymphoma (neoplasm) | 16 | 0.6956522 | 6.960581 |
umls:C0877015 | Pelvic Organ Prolapse | 16 | 0.6956522 | 6.960581 |
umls:C0030804 | Pemphigoid, Benign Mucous Membrane | 9 | 0.6923077 | 3.992706 |
umls:C0085253 | Adult-Onset Still Disease | 9 | 0.6923077 | 3.992706 |
umls:C0221775 | Lumbar disc disease | 9 | 0.6923077 | 3.992706 |
umls:C0263314 | Pemphigus and fogo selvagem | 9 | 0.6923077 | 3.992706 |
umls:C1306557 | Chronic venous insufficiency | 9 | 0.6923077 | 3.992706 |
umls:C0175704 | LEOPARD Syndrome | 22 | 0.6875000 | 9.351418 |
umls:C0205645 | Adenocarcinoma, Tubular | 11 | 0.6875000 | 4.790212 |
umls:C0280856 | Squamous cell carcinoma of vulva | 11 | 0.6875000 | 4.790212 |
umls:C0948954 | Alveolar echinococcosis | 11 | 0.6875000 | 4.790212 |
umls:C1266005 | Basaloid squamous cell carcinoma | 11 | 0.6875000 | 4.790212 |
umls:C0497550 | Benign neurologic neoplasms | 13 | 0.6842105 | 5.586798 |
umls:C0018128 | Graft Occlusion, Vascular | 15 | 0.6818182 | 6.372405 |
umls:C0878675 | Erdheim-Chester Disease | 15 | 0.6818182 | 6.372405 |
umls:C0025295 | Meningitis, Pneumococcal | 23 | 0.6764706 | 9.546776 |
umls:C0587248 | Costello syndrome (disorder) | 25 | 0.6756757 | 10.350139 |
umls:C0282577 | Congenital Disorders of Glycosylation | 35 | 0.6730769 | 14.354024 |
umls:C0020097 | HTLV-I Infections | 24 | 0.6666667 | 9.760232 |
umls:C0553692 | Brain hemorrhage | 16 | 0.6666667 | 6.592515 |
umls:C1861171 | THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | 16 | 0.6666667 | 6.592515 |
umls:C0265221 | Walker-Warburg congenital muscular dystrophy | 14 | 0.6666667 | 5.803603 |
umls:C0431391 | Hemimegalencephaly | 14 | 0.6666667 | 5.803603 |
umls:C0013291 | Duodenal Neoplasms | 10 | 0.6666667 | 4.213967 |
umls:C0019623 | Malignant histiocytosis | 10 | 0.6666667 | 4.213967 |
umls:C0206171 | Community-Acquired Infections | 10 | 0.6666667 | 4.213967 |
umls:C0263874 | Degeneration of lumbar intervertebral disc | 10 | 0.6666667 | 4.213967 |
umls:C0003537 | Aphasia | 8 | 0.6666667 | 3.428611 |
umls:C0007772 | Intracranial Arteriovenous Malformation | 8 | 0.6666667 | 3.428611 |
umls:C0022346 | Icterus | 8 | 0.6666667 | 3.428611 |
umls:C0027706 | Hereditary nephritis | 8 | 0.6666667 | 3.428611 |
umls:C0085426 | Gram-Positive Bacterial Infections | 8 | 0.6666667 | 3.428611 |
umls:C0398368 | Lymphatic Abnormalities | 8 | 0.6666667 | 3.428611 |
umls:C1704327 | Bone Sarcoma | 8 | 0.6666667 | 3.428611 |
umls:C2348820 | Triple-Negative Breast Carcinoma | 8 | 0.6666667 | 3.428611 |
umls:C2720434 | Macroencephaly | 8 | 0.6666667 | 3.428611 |
umls:C2828150 | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | 8 | 0.6666667 | 3.428611 |
umls:C0474853 | Plasma cell tumor, malignant | 13 | 0.6500000 | 5.240303 |
umls:C0877430 | Asthma chronic | 13 | 0.6500000 | 5.240303 |
umls:C0948201 | Alloimmunisation | 13 | 0.6500000 | 5.240303 |
umls:C0021818 | Intervertebral Disk Displacement | 24 | 0.6486486 | 9.421782 |
umls:C0002690 | Amputation Stumps | 11 | 0.6470588 | 4.439922 |
umls:C0085167 | Granular cell tumor | 11 | 0.6470588 | 4.439922 |
umls:C1275081 | Cardio-facio-cutaneous syndrome | 11 | 0.6470588 | 4.439922 |
umls:C1314694 | Astrocytoma, low grade | 18 | 0.6428571 | 7.038395 |
umls:C0034902 | Pure Red-Cell Aplasia | 9 | 0.6428571 | 3.662117 |
umls:C0035326 | Retinal vascular occlusion | 9 | 0.6428571 | 3.662117 |
umls:C0206683 | Papillary and follicular adenocarcinoma | 9 | 0.6428571 | 3.662117 |
umls:C0268362 | Osteogenesis imperfecta type III (disorder) | 9 | 0.6428571 | 3.662117 |
umls:C0272401 | Virchow’s node (disorder) | 9 | 0.6428571 | 3.662117 |
umls:C0302358 | Disease caused by Shigella dysenteriae | 9 | 0.6428571 | 3.662117 |
umls:C0751560 | Malignant neoplasm tonsil | 9 | 0.6428571 | 3.662117 |
umls:C2239120 | eyelids (symptom) | 9 | 0.6428571 | 3.662117 |
umls:C2697932 | Loeys-Dietz Syndrome | 9 | 0.6428571 | 3.662117 |
umls:C0345893 | Juvenile polyposis syndrome | 21 | 0.6363636 | 8.070942 |
umls:C0029423 | Cartilaginous exostosis | 14 | 0.6363636 | 5.470772 |
umls:C0149630 | Bicuspid aortic valve | 14 | 0.6363636 | 5.470772 |
umls:C0002438 | Amebiasis | 7 | 0.6363636 | 2.869940 |
umls:C0018965 | Hematuria | 7 | 0.6363636 | 2.869940 |
umls:C0035312 | Retinal Drusen | 7 | 0.6363636 | 2.869940 |
umls:C0079770 | Lymphoma, Small Noncleaved-Cell | 7 | 0.6363636 | 2.869940 |
umls:C0206627 | Mixed Tumor, Mullerian | 7 | 0.6363636 | 2.869940 |
umls:C0221239 | Rapidly progressive glomerulonephritis | 7 | 0.6363636 | 2.869940 |
umls:C0349658 | Trichoepithelioma | 7 | 0.6363636 | 2.869940 |
umls:C1260903 | Dysfibrinogenemia | 7 | 0.6363636 | 2.869940 |
umls:C1262117 | Fungal keratitis | 7 | 0.6363636 | 2.869940 |
umls:C1567742 | Alport Syndrome, X-Linked | 7 | 0.6363636 | 2.869940 |
umls:C2584778 | Thrombotic thrombocytopenic purpura, acquired | 7 | 0.6363636 | 2.869940 |
umls:C2985290 | Fetal Alcohol Spectrum Disorders | 7 | 0.6363636 | 2.869940 |
umls:C0409818 | Chronic Infantile Neurological, Cutaneous, and Articular Syndrome | 12 | 0.6315789 | 4.680505 |
umls:C0085437 | Meningitis, Bacterial | 25 | 0.6250000 | 9.325266 |
umls:C0343751 | Asymptomatic human immunodeficiency virus infection | 15 | 0.6250000 | 5.704700 |
umls:C0156181 | Peritoneal adhesion | 10 | 0.6250000 | 3.898671 |
umls:C0206702 | Klatskin Tumor | 10 | 0.6250000 | 3.898671 |
umls:C0334424 | Nodular melanoma | 10 | 0.6250000 | 3.898671 |
umls:C0862506 | Borderline ovarian tumour | 10 | 0.6250000 | 3.898671 |
umls:C0206696 | Carcinoma, Signet Ring Cell | 18 | 0.6206897 | 6.723018 |
umls:C0346109 | Malignant Mesothelioma of Peritoneum | 13 | 0.6190476 | 4.919803 |
umls:C1531608 | Smoldering myeloma | 13 | 0.6190476 | 4.919803 |
umls:C0001420 | Papillary adenocarcinoma | 16 | 0.6153846 | 5.943541 |
umls:C0240903 | Rheumatoid Vasculitis | 8 | 0.6153846 | 3.117904 |
umls:C0268393 | Familial Cerebral Amyloid Angiopathy | 8 | 0.6153846 | 3.117904 |
umls:C0742133 | cervical cancer squamous cell | 8 | 0.6153846 | 3.117904 |
umls:C3150911 | GASTRIC CANCER, INTESTINAL | 8 | 0.6153846 | 3.117904 |
umls:C0278803 | Adenocarcinoma of small intestine | 11 | 0.6111111 | 4.136133 |
umls:C0868908 | Pancolitis | 11 | 0.6111111 | 4.136133 |
umls:C0878555 | Diffuse panbronchiolitis | 11 | 0.6111111 | 4.136133 |
umls:C1704356 | Enchondroma | 11 | 0.6111111 | 4.136133 |
umls:C0018824 | Heart valve disease | 25 | 0.6097561 | 9.022806 |
umls:C1519678 | Tumor Expansion | 14 | 0.6086957 | 5.164075 |
umls:C0206114 | Periodontal Attachment Loss | 17 | 0.6071429 | 6.181605 |
umls:C0079474 | Hallopeau-Siemens Disease | 20 | 0.6060606 | 7.203147 |
umls:C0030805 | Bullous pemphigoid | 43 | 0.6056338 | 15.181918 |
umls:C0038395 | Streptococcal Infections | 26 | 0.6046512 | 9.256779 |
umls:C0242666 | Protein S Deficiency | 18 | 0.6000000 | 6.419962 |
umls:C0014848 | Esophageal Achalasia | 12 | 0.6000000 | 4.383674 |
umls:C0276680 | Infection by Candida albicans | 12 | 0.6000000 | 4.383674 |
umls:C0024897 | Mastocytoma | 9 | 0.6000000 | 3.367692 |
umls:C0026760 | Multiple Epiphyseal Dysplasia | 9 | 0.6000000 | 3.367692 |
umls:C0038579 | Substance Abuse, Intravenous | 9 | 0.6000000 | 3.367692 |
umls:C0155773 | Portal vein thrombosis | 9 | 0.6000000 | 3.367692 |
umls:C0334664 | Mast Cell Neoplasm | 9 | 0.6000000 | 3.367692 |
umls:C0558355 | Tonsillar Carcinoma | 9 | 0.6000000 | 3.367692 |
umls:C0853105 | Penis carcinoma | 9 | 0.6000000 | 3.367692 |
umls:C2242987 | Benign Mastocytoma | 9 | 0.6000000 | 3.367692 |
umls:C0003869 | Arthritis, Infectious | 6 | 0.6000000 | 2.334383 |
umls:C0009763 | Conjunctivitis | 6 | 0.6000000 | 2.334383 |
umls:C0020102 | HTLV-II Infections | 6 | 0.6000000 | 2.334383 |
umls:C0023518 | Leukocytosis | 6 | 0.6000000 | 2.334383 |
umls:C0036329 | Schistosomiasis japonica | 6 | 0.6000000 | 2.334383 |
umls:C0040560 | Toxoplasmosis, Congenital | 6 | 0.6000000 | 2.334383 |
umls:C0041374 | Tumor Virus Infections | 6 | 0.6000000 | 2.334383 |
umls:C0042880 | Vitamin K Deficiency | 6 | 0.6000000 | 2.334383 |
umls:C0085694 | Chronic cholecystitis | 6 | 0.6000000 | 2.334383 |
umls:C0151785 | Disease of mucous membrane | 6 | 0.6000000 | 2.334383 |
umls:C0266159 | Pyloric Atresia | 6 | 0.6000000 | 2.334383 |
umls:C0334277 | Adenocarcinoma, metastatic | 6 | 0.6000000 | 2.334383 |
umls:C0340803 | Capillary malformation (disorder) | 6 | 0.6000000 | 2.334383 |
umls:C0342731 | Deficiency of mevalonate kinase | 6 | 0.6000000 | 2.334383 |
umls:C0345050 | Congenital aneurysm of ascending aorta | 6 | 0.6000000 | 2.334383 |
umls:C1332166 | Adenocarcinoma of the gastroesophageal junction | 6 | 0.6000000 | 2.334383 |
umls:C1516061 | Astler-Coller B1 Rectal Carcinoma | 6 | 0.6000000 | 2.334383 |
umls:C2987191 | Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type | 6 | 0.6000000 | 2.334383 |
umls:C3276706 | Small Fiber Neuropathy | 6 | 0.6000000 | 2.334383 |
umls:C3472608 | Micropapillary carcinoma | 6 | 0.6000000 | 2.334383 |
umls:C0002448 | Ameloblastoma | 38 | 0.5937500 | 13.082479 |
umls:C0029118 | Opportunistic Infections | 19 | 0.5937500 | 6.667491 |
umls:C0019087 | Hemorrhagic Disorders | 16 | 0.5925926 | 5.653660 |
umls:C0403396 | Steroid-sensitive nephrotic syndrome | 16 | 0.5925926 | 5.653660 |
umls:C0029422 | Osteochondrodysplasias | 23 | 0.5897436 | 7.949218 |
umls:C0017662 | Glomerulonephritis, Membranoproliferative | 20 | 0.5882353 | 6.919927 |
umls:C0029464 | Osteosclerosis | 10 | 0.5882353 | 3.619043 |
umls:C0079301 | Junctional Epidermolysis Bullosa | 10 | 0.5882353 | 3.619043 |
umls:C0206735 | Melanoma, Amelanotic | 10 | 0.5882353 | 3.619043 |
umls:C1301194 | Salivary duct carcinoma | 10 | 0.5882353 | 3.619043 |
umls:C1390474 | Increased susceptibility to fractures | 10 | 0.5882353 | 3.619043 |
umls:C0017639 | Gliosis | 17 | 0.5862069 | 5.904597 |
umls:C0242583 | Bare Lymphocyte Syndrome | 17 | 0.5862069 | 5.904597 |
umls:C2931418 | Bare lymphocyte syndrome 2 | 17 | 0.5862069 | 5.904597 |
umls:C0003838 | Arterial Occlusive Diseases | 24 | 0.5853659 | 8.196444 |
umls:C0024796 | Marfan Syndrome | 28 | 0.5833333 | 9.458113 |
umls:C0022821 | Kyphosis deformity of spine | 7 | 0.5833333 | 2.585618 |
umls:C0040115 | Thymus Hyperplasia | 7 | 0.5833333 | 2.585618 |
umls:C0265268 | Adams Oliver syndrome | 7 | 0.5833333 | 2.585618 |
umls:C0272285 | Heparin-induced thrombocytopenia | 7 | 0.5833333 | 2.585618 |
umls:C0543698 | Hypersensitive syndrome | 7 | 0.5833333 | 2.585618 |
umls:C0860594 | Malignant melanoma, metastatic | 7 | 0.5833333 | 2.585618 |
umls:C0877009 | Muscle fibrosis | 7 | 0.5833333 | 2.585618 |
umls:C1292777 | Aggressive natural killer-cell leukemia | 7 | 0.5833333 | 2.585618 |
umls:C1319860 | Sendai virus infection | 7 | 0.5833333 | 2.585618 |
umls:C2936331 | Sarcoglycanopathies | 7 | 0.5833333 | 2.585618 |
umls:C0032965 | Pregnancy Complications, Infectious | 18 | 0.5806452 | 6.150246 |
umls:C2931788 | Atypical Hemolytic Uremic Syndrome | 18 | 0.5806452 | 6.150246 |
umls:C0085078 | Lysosomal Storage Diseases | 44 | 0.5789474 | 14.559578 |
umls:C0035854 | Rosacea | 11 | 0.5789474 | 3.871258 |
umls:C0086647 | Mucopolysaccharidosis Type IIIA | 11 | 0.5789474 | 3.871258 |
umls:C0272322 | Severe hereditary factor VIII deficiency disease | 11 | 0.5789474 | 3.871258 |
umls:C0281479 | Primary Systemic Amyloidosis | 11 | 0.5789474 | 3.871258 |
umls:C0699889 | Malignant Female Reproductive System Neoplasm | 11 | 0.5789474 | 3.871258 |
umls:C1334011 | High Grade Cervical Intraepithelial Neoplasia | 11 | 0.5789474 | 3.871258 |
umls:C0549523 | Oropharynx (excludes nasopharynx) | 15 | 0.5769231 | 5.136067 |
umls:C1540912 | Hypereosinophilic syndrome | 15 | 0.5769231 | 5.136067 |
umls:C0699743 | Congenital muscular dystrophy (disorder) | 23 | 0.5750000 | 7.672173 |
umls:C0206727 | Nerve Sheath Tumors | 31 | 0.5740741 | 10.197342 |
umls:C0950124 | Papillomavirus Infections | 28 | 0.5714286 | 9.191821 |
umls:C0600433 | Activated Protein C Resistance | 20 | 0.5714286 | 6.644421 |
umls:C0025269 | Multiple Endocrine Neoplasia Type 2b | 16 | 0.5714286 | 5.390064 |
umls:C0206245 | Amyloid Neuropathies, Familial | 12 | 0.5714286 | 4.115495 |
umls:C0399440 | Hereditary gingival fibromatosis | 12 | 0.5714286 | 4.115495 |
umls:C1266158 | Nonseminomatous germ cell tumor | 12 | 0.5714286 | 4.115495 |
umls:C0079747 | Low Grade Lymphoma (neoplasm) | 8 | 0.5714286 | 2.849156 |
umls:C0151544 | Gastrointestinal carcinoma | 8 | 0.5714286 | 2.849156 |
umls:C0158683 | Polycystic liver disease | 8 | 0.5714286 | 2.849156 |
umls:C0162526 | AIDS-Related Opportunistic Infections | 8 | 0.5714286 | 2.849156 |
umls:C2930826 | Acute malaria | 8 | 0.5714286 | 2.849156 |
umls:C0026703 | Mucopolysaccharidoses | 17 | 0.5666667 | 5.636444 |
umls:C0043395 | Yellow Fever | 13 | 0.5652174 | 4.370180 |
umls:C1261287 | Stenosis | 18 | 0.5625000 | 5.892811 |
umls:C0017551 | Gilbert Disease (disorder) | 9 | 0.5625000 | 3.107617 |
umls:C0457133 | Muscle eye brain disease | 9 | 0.5625000 | 3.107617 |
umls:C0524702 | Pulmonary Thromboembolisms | 9 | 0.5625000 | 3.107617 |
umls:C0153567 | Uterine Cancer | 28 | 0.5600000 | 8.943645 |
umls:C0022603 | Seborrheic keratosis | 14 | 0.5600000 | 4.623061 |
umls:C0221052 | Chronic berylliosis | 14 | 0.5600000 | 4.623061 |
umls:C0278689 | Ovarian epithelial cancer recurrent | 14 | 0.5600000 | 4.623061 |
umls:C0006272 | Bronchiolitis Obliterans | 34 | 0.5573770 | 10.706312 |
umls:C0033847 | Pseudoxanthoma Elasticum | 25 | 0.5555556 | 7.918617 |
umls:C0155765 | Disease of capillaries | 20 | 0.5555556 | 6.386275 |
umls:C1384494 | Metastatic Carcinoma | 20 | 0.5555556 | 6.386275 |
umls:C0042131 | Uterine Diseases | 10 | 0.5555556 | 3.367343 |
umls:C0206721 | Inverted Papilloma | 10 | 0.5555556 | 3.367343 |
umls:C0268380 | Systemic amyloidosis | 10 | 0.5555556 | 3.367343 |
umls:C0268390 | Muckle-Wells Syndrome | 10 | 0.5555556 | 3.367343 |
umls:C0349532 | Gastric lymphoma | 10 | 0.5555556 | 3.367343 |
umls:C1719495 | Aggressive periodontitis, generalized | 21 | 0.5526316 | 6.643289 |
umls:C0008373 | Cholesteatoma | 22 | 0.5500000 | 6.903048 |
umls:C0009917 | Contracture | 22 | 0.5500000 | 6.903048 |
umls:C0022672 | Acute Kidney Tubular Necrosis | 11 | 0.5500000 | 3.620436 |
umls:C0034150 | Purpura | 11 | 0.5500000 | 3.620436 |
umls:C0279637 | Anal carcinoma | 11 | 0.5500000 | 3.620436 |
umls:C0345958 | Large cell carcinoma of lung | 11 | 0.5500000 | 3.620436 |
umls:C0027830 | neurofibroma | 28 | 0.5490196 | 8.694956 |
umls:C0019061 | Hemolytic-Uremic Syndrome | 34 | 0.5483871 | 10.452251 |
umls:C0035436 | Rheumatic Fever | 17 | 0.5483871 | 5.392270 |
umls:C1402294 | Primary Lesion | 18 | 0.5454545 | 5.641846 |
umls:C1167791 | Skin toxicity | 12 | 0.5454545 | 3.876233 |
umls:C1266025 | Traditional Serrated Adenoma | 12 | 0.5454545 | 3.876233 |
umls:C1956089 | Osteophyte | 12 | 0.5454545 | 3.876233 |
umls:C0000735 | Abdominal Neoplasms | 6 | 0.5454545 | 2.092222 |
umls:C0002994 | Angioedema | 6 | 0.5454545 | 2.092222 |
umls:C0004093 | Asthenia | 6 | 0.5454545 | 2.092222 |
umls:C0006285 | Bronchopneumonia | 6 | 0.5454545 | 2.092222 |
umls:C0010043 | Corneal Ulcer | 6 | 0.5454545 | 2.092222 |
umls:C0011057 | Hearing Loss, Sudden | 6 | 0.5454545 | 2.092222 |
umls:C0017926 | Glycogen Storage Disease Type VII | 6 | 0.5454545 | 2.092222 |
umls:C0020492 | Hyperostosis | 6 | 0.5454545 | 2.092222 |
umls:C0023234 | Legg-Calve-Perthes Disease | 6 | 0.5454545 | 2.092222 |
umls:C0085423 | Gram-Negative Bacterial Infections | 6 | 0.5454545 | 2.092222 |
umls:C0155305 | Optic Neuropathy, Ischemic | 6 | 0.5454545 | 2.092222 |
umls:C0158447 | Idiopathic osteoporosis | 6 | 0.5454545 | 2.092222 |
umls:C0221391 | Melanosis coli | 6 | 0.5454545 | 2.092222 |
umls:C0235896 | Lung infiltration | 6 | 0.5454545 | 2.092222 |
umls:C0729531 | Viral respiratory infection | 6 | 0.5454545 | 2.092222 |
umls:C0751422 | Hereditary Autoinflammatory Diseases | 6 | 0.5454545 | 2.092222 |
umls:C1334603 | Malignant Mixed Mesodermal (Mullerian) Tumor | 6 | 0.5454545 | 2.092222 |
umls:C1510489 | Cerebral Amyloid Angiopathy, Hereditary | 6 | 0.5454545 | 2.092222 |
umls:C1704231 | Metastatic Malignant Neoplasm to the Leptomeninges | 6 | 0.5454545 | 2.092222 |
umls:C1842372 | ASPIRIN RESISTANCE | 6 | 0.5454545 | 2.092222 |
umls:C1850808 | Miyoshi myopathy | 6 | 0.5454545 | 2.092222 |
umls:C1864205 | Macular Degeneration, Age-Related, 1 | 6 | 0.5454545 | 2.092222 |
umls:C2745959 | Spondyloepiphyseal dysplasia, congenita | 6 | 0.5454545 | 2.092222 |
umls:C0011608 | Dermatitis Herpetiformis | 19 | 0.5428571 | 5.901767 |
umls:C0340643 | Dissection of aorta | 19 | 0.5428571 | 5.901767 |
umls:C0009405 | Hereditary Nonpolyposis Colorectal Neoplasms | 13 | 0.5416667 | 4.125691 |
umls:C0263662 | Disseminated eosinophilic collagen disease | 13 | 0.5416667 | 4.125691 |
umls:C0745091 | Hypereosinophilia | 13 | 0.5416667 | 4.125691 |
umls:C0002382 | Alveolar Bone Loss | 20 | 0.5405405 | 6.150683 |
umls:C3669246 | Mammary adenocarcinoma | 20 | 0.5405405 | 6.150683 |
umls:C0034155 | Purpura, Thrombotic Thrombocytopenic | 21 | 0.5384615 | 6.398946 |
umls:C0019101 | Hemorrhagic Fever with Renal Syndrome | 14 | 0.5384615 | 4.383674 |
umls:C0041466 | Typhoid Fever | 14 | 0.5384615 | 4.383674 |
umls:C0027613 | Neonatal hepatitis | 7 | 0.5384615 | 2.348868 |
umls:C0027660 | Neoplasms, Glandular and Epithelial | 7 | 0.5384615 | 2.348868 |
umls:C0042065 | Genitourinary Neoplasms | 7 | 0.5384615 | 2.348868 |
umls:C0151436 | Vasculitis, Leukocytoclastic, Cutaneous | 7 | 0.5384615 | 2.348868 |
umls:C0153446 | Malignant neoplasm of anus | 7 | 0.5384615 | 2.348868 |
umls:C0153467 | Malignant tumor of peritoneum | 7 | 0.5384615 | 2.348868 |
umls:C0158252 | Intervertebral disc disorder | 7 | 0.5384615 | 2.348868 |
umls:C0268363 | Osteogenesis imperfecta type IV (disorder) | 7 | 0.5384615 | 2.348868 |
umls:C0752143 | Intracranial Thrombosis | 7 | 0.5384615 | 2.348868 |
umls:C1333280 | Desmoplastic melanoma | 7 | 0.5384615 | 2.348868 |
umls:C1456246 | Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site | 7 | 0.5384615 | 2.348868 |
umls:C0042487 | Venous Thrombosis | 50 | 0.5376344 | 14.806867 |
umls:C0029883 | Otitis Media with Effusion | 15 | 0.5357143 | 4.640150 |
umls:C0242381 | Lyme Arthritis | 16 | 0.5333333 | 4.895745 |
umls:C0007384 | Cataplexy | 8 | 0.5333333 | 2.607532 |
umls:C0025306 | Meningococcemia | 8 | 0.5333333 | 2.607532 |
umls:C0035112 | Reoviridae Infections | 8 | 0.5333333 | 2.607532 |
umls:C0155880 | Intrinsic asthma | 8 | 0.5333333 | 2.607532 |
umls:C0268351 | Cutis Laxa, Autosomal Recessive, Type I | 8 | 0.5333333 | 2.607532 |
umls:C0311361 | Adenomatous goiter | 8 | 0.5333333 | 2.607532 |
umls:C0456861 | Low grade B-cell lymphoma | 8 | 0.5333333 | 2.607532 |
umls:C0740340 | Amyloidosis, Familial | 8 | 0.5333333 | 2.607532 |
umls:C0917804 | Arteriovenous Malformations, Cerebral | 8 | 0.5333333 | 2.607532 |
umls:C1257806 | Chromosomal Instability | 8 | 0.5333333 | 2.607532 |
umls:C1568363 | Tendinosis | 8 | 0.5333333 | 2.607532 |
umls:C1881254 | Inverted Squamous Cell Papilloma | 8 | 0.5333333 | 2.607532 |
umls:C2732618 | Sessile Serrated Adenoma/Polyp | 8 | 0.5333333 | 2.607532 |
umls:C0025303 | Meningococcal Infections | 33 | 0.5322581 | 9.705136 |
umls:C0006309 | Brucellosis | 25 | 0.5319149 | 7.429901 |
umls:C0015302 | External exotoses | 17 | 0.5312500 | 5.157026 |
umls:C0034040 | Puerperal Disorders | 17 | 0.5312500 | 5.157026 |
umls:C0003855 | Arteriovenous fistula | 18 | 0.5294118 | 5.413802 |
umls:C0022572 | keratoacanthoma | 18 | 0.5294118 | 5.413802 |
umls:C0851887 | Adenoviral infections | 18 | 0.5294118 | 5.413802 |
umls:C0004031 | Aspergillosis, Allergic Bronchopulmonary | 9 | 0.5294118 | 2.871688 |
umls:C0151281 | Genital ulceration | 9 | 0.5294118 | 2.871688 |
umls:C0852077 | Blood Coagulation Disorders, Inherited | 9 | 0.5294118 | 2.871688 |
umls:C1368404 | Hypopharyngeal Carcinoma | 9 | 0.5294118 | 2.871688 |
umls:C3714534 | dowling-degos disease | 9 | 0.5294118 | 2.871688 |
umls:C0004626 | Pneumonia, Bacterial | 20 | 0.5263158 | 5.923417 |
umls:C0016085 | Filariasis | 10 | 0.5263158 | 3.136785 |
umls:C0036330 | Schistosomiasis mansoni | 10 | 0.5263158 | 3.136785 |
umls:C1336905 | Endometrial Endometrioid Adenocarcinoma | 10 | 0.5263158 | 3.136785 |
umls:C3472614 | Plasmablastic lymphoma | 10 | 0.5263158 | 3.136785 |
umls:C0040053 | Thrombosis | 72 | 0.5255474 | 20.427790 |
umls:C0206651 | Sarcoma, Clear Cell | 21 | 0.5250000 | 6.176202 |
umls:C0242966 | Systemic Inflammatory Response Syndrome | 33 | 0.5238095 | 9.479843 |
umls:C0018023 | Nodular Goiter | 11 | 0.5238095 | 3.394278 |
umls:C0039445 | Hereditary hemorrhagic telangiectasia | 11 | 0.5238095 | 3.394278 |
umls:C0349631 | Richter’s syndrome | 11 | 0.5238095 | 3.394278 |
umls:C1739363 | Prostatic Hypertrophy | 11 | 0.5238095 | 3.394278 |
umls:C2936380 | Neointima | 11 | 0.5238095 | 3.394278 |
umls:C0349458 | Cervical intraepithelial neoplasia grade 1 | 23 | 0.5227273 | 6.686125 |
umls:C0029899 | Otosclerosis | 12 | 0.5217391 | 3.652519 |
umls:C0023223 | Leg Ulcer | 13 | 0.5200000 | 3.906538 |
umls:C0263661 | Disorder of skeletal system | 13 | 0.5200000 | 3.906538 |
umls:C0854135 | Pseudomonas aeruginosa infection | 13 | 0.5200000 | 3.906538 |
umls:C1332347 | Atypical Ductal Breast Hyperplasia | 13 | 0.5200000 | 3.906538 |
umls:C2745963 | Kashin-Beck Disease | 13 | 0.5200000 | 3.906538 |
umls:C0085109 | Corneal Neovascularization | 14 | 0.5185185 | 4.157936 |
umls:C0279651 | Gallbladder adenocarcinoma | 14 | 0.5185185 | 4.157936 |
umls:C0393576 | Chorea Acanthocytosis Syndrome | 14 | 0.5185185 | 4.157936 |
umls:C1852502 | CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT | 14 | 0.5185185 | 4.157936 |
umls:C0920646 | Renal ischaemia | 43 | 0.5180723 | 12.054875 |
umls:C0028326 | Noonan Syndrome | 30 | 0.5172414 | 8.506449 |
umls:C3542024 | AORTIC VALVE DISEASE 2 | 30 | 0.5172414 | 8.506449 |
umls:C0003493 | Aortic Diseases | 15 | 0.5172414 | 4.413734 |
umls:C0014121 | Bacterial Endocarditis | 15 | 0.5172414 | 4.413734 |
umls:C0346976 | Secondary malignant neoplasm of pancreas | 15 | 0.5172414 | 4.413734 |
umls:C0398625 | Protein C Deficiency | 16 | 0.5161290 | 4.675506 |
umls:C0677936 | Refractory cancer | 33 | 0.5156250 | 9.262202 |
umls:C0031094 | Periodontal Pocket | 17 | 0.5151515 | 4.930859 |
umls:C0521173 | Granulomatosis | 17 | 0.5151515 | 4.930859 |
umls:C0085083 | Ovarian Hyperstimulation Syndrome | 19 | 0.5135135 | 5.449389 |
umls:C0010051 | Coronary Aneurysm | 20 | 0.5128205 | 5.704700 |
umls:C0010072 | Coronary Thrombosis | 20 | 0.5128205 | 5.704700 |
umls:C0014518 | Toxic Epidermal Necrolysis | 20 | 0.5128205 | 5.704700 |
umls:C0267941 | Pancreatitis, Acute Necrotizing | 20 | 0.5128205 | 5.704700 |
umls:C0027873 | Neuromyelitis Optica | 21 | 0.5121951 | 5.960664 |
umls:C0403416 | Idiopathic crescentic glomerulonephritis | 21 | 0.5121951 | 5.960664 |
umls:C0030807 | Pemphigus | 26 | 0.5098039 | 7.243384 |
umls:C0013720 | Ehlers-Danlos Syndrome | 29 | 0.5087719 | 8.023447 |
umls:C0025289 | Meningitis | 30 | 0.5084746 | 8.283716 |
umls:C0019100 | Severe Dengue | 37 | 0.5068493 | 10.069672 |
umls:C0008149 | Chlamydia Infections | 42 | 0.5060241 | 11.361524 |
umls:C0015944 | Fetal Membranes, Premature Rupture | 98 | 0.5051546 | 25.993327 |
umls:C2919032 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | 94 | 0.5026738 | 24.738750 |
umls:C0022408 | Arthropathy | 59 | 0.5000000 | 15.573558 |
umls:C0027439 | Nasopharyngeal Neoplasms | 37 | 0.5000000 | 9.858052 |
umls:C0039263 | Takayasu Arteritis | 23 | 0.5000000 | 6.263946 |
umls:C0037199 | Sinusitis | 21 | 0.5000000 | 5.752128 |
umls:C1518171 | Malignant Conversion | 21 | 0.5000000 | 5.752128 |
umls:C2717961 | Thrombotic Microangiopathies | 21 | 0.5000000 | 5.752128 |
umls:C0855095 | Small Lymphocytic Lymphoma | 20 | 0.5000000 | 5.497423 |
umls:C0242172 | Pelvic Inflammatory Disease | 18 | 0.5000000 | 4.981902 |
umls:C0155862 | Streptococcal pneumonia | 17 | 0.5000000 | 4.726511 |
umls:C0340629 | Aortic aneurysm without mention of rupture NOS | 17 | 0.5000000 | 4.726511 |
umls:C2986536 | Bisphosphonate-associated osteonecrosis | 17 | 0.5000000 | 4.726511 |
umls:C0149978 | Adenocarcinoma of rectum | 16 | 0.5000000 | 4.463136 |
umls:C0334533 | Arteriovenous hemangioma | 16 | 0.5000000 | 4.463136 |
umls:C0002390 | Extrinsic allergic alveolitis | 15 | 0.5000000 | 4.209671 |
umls:C0032273 | Pneumoconiosis | 15 | 0.5000000 | 4.209671 |
umls:C0036420 | Localized scleroderma | 15 | 0.5000000 | 4.209671 |
umls:C0016629 | Fowlpox | 14 | 0.5000000 | 3.952078 |
umls:C0205824 | Liposarcoma, Dedifferentiated | 14 | 0.5000000 | 3.952078 |
umls:C0206141 | Idiopathic Hypereosinophilic Syndrome | 14 | 0.5000000 | 3.952078 |
umls:C0278493 | Breast cancer recurrent | 14 | 0.5000000 | 3.952078 |
umls:C0375071 | Malignant neoplasm of vulva | 14 | 0.5000000 | 3.952078 |
umls:C1961121 | Congenital vascular anomaly | 14 | 0.5000000 | 3.952078 |
umls:C0032300 | Lobar Pneumonia | 13 | 0.5000000 | 3.698170 |
umls:C0206733 | Strawberry nevus of skin | 13 | 0.5000000 | 3.698170 |
umls:C0751362 | Narcolepsy-Cataplexy Syndrome | 13 | 0.5000000 | 3.698170 |
umls:C0021775 | Intermittent Claudication | 12 | 0.5000000 | 3.443428 |
umls:C0026916 | Mycobacterium avium-intracellulare Infection | 12 | 0.5000000 | 3.443428 |
umls:C0206706 | Verrucous carcinoma | 12 | 0.5000000 | 3.443428 |
umls:C2363973 | Chronic thromboembolic pulmonary hypertension | 12 | 0.5000000 | 3.443428 |
umls:C2931161 | Immunoglobulin a deficiency 1 | 12 | 0.5000000 | 3.443428 |
umls:C3809250 | ESTROGEN RESISTANCE | 12 | 0.5000000 | 3.443428 |
umls:C0005138 | Berylliosis | 11 | 0.5000000 | 3.186671 |
umls:C0010418 | Cryptosporidiosis | 11 | 0.5000000 | 3.186671 |
umls:C0031039 | Pericardial effusion | 11 | 0.5000000 | 3.186671 |
umls:C0276199 | Canarypox (disorder) | 11 | 0.5000000 | 3.186671 |
umls:C0000832 | Abruptio Placentae | 10 | 0.5000000 | 2.923497 |
umls:C0003165 | Anthracosis | 10 | 0.5000000 | 2.923497 |
umls:C0031350 | Pharyngitis | 10 | 0.5000000 | 2.923497 |
umls:C0259785 | Malignant Meningioma | 10 | 0.5000000 | 2.923497 |
umls:C0280631 | Leiomyosarcoma of uterus | 10 | 0.5000000 | 2.923497 |
umls:C0399447 | Early onset periodontitis | 10 | 0.5000000 | 2.923497 |
umls:C0740903 | allergic symptom | 10 | 0.5000000 | 2.923497 |
umls:C1266119 | Solitary fibrous tumor | 10 | 0.5000000 | 2.923497 |
umls:C1857941 | Brooke-Spiegler syndrome | 10 | 0.5000000 | 2.923497 |
umls:C0019104 | Hemorrhagic Fevers, Viral | 9 | 0.5000000 | 2.660527 |
umls:C0026707 | Mucopolysaccharidosis IV | 9 | 0.5000000 | 2.660527 |
umls:C0409980 | Primary antiphospholipid syndrome | 9 | 0.5000000 | 2.660527 |
umls:C0559470 | Allergy to peanuts | 9 | 0.5000000 | 2.660527 |
umls:C1844383 | Recurrent bacterial infection | 9 | 0.5000000 | 2.660527 |
umls:C0031030 | Periapical Periodontitis | 8 | 0.5000000 | 2.402136 |
umls:C0154778 | Myopia, Degenerative | 8 | 0.5000000 | 2.402136 |
umls:C0221273 | Juvenile polyp | 8 | 0.5000000 | 2.402136 |
umls:C0343752 | Acute HIV infection | 8 | 0.5000000 | 2.402136 |
umls:C0555971 | Oral infection | 8 | 0.5000000 | 2.402136 |
umls:C0877445 | Candidemia | 8 | 0.5000000 | 2.402136 |
umls:C1444680 | Posterior capsule opacification | 8 | 0.5000000 | 2.402136 |
umls:C1519214 | Secondary Glioblastoma | 8 | 0.5000000 | 2.402136 |
umls:C0023461 | Leukemia, Mast-Cell | 7 | 0.5000000 | 2.142971 |
umls:C0024054 | Lown-Ganong-Levine Syndrome | 7 | 0.5000000 | 2.142971 |
umls:C0026998 | Acute Myeloid Leukemia, M1 | 7 | 0.5000000 | 2.142971 |
umls:C0205825 | Liposarcoma, Pleomorphic | 7 | 0.5000000 | 2.142971 |
umls:C0238348 | Squamous cell carcinoma of penis | 7 | 0.5000000 | 2.142971 |
umls:C0264936 | Secondary pulmonary hypertension | 7 | 0.5000000 | 2.142971 |
umls:C0267834 | Liver cyst | 7 | 0.5000000 | 2.142971 |
umls:C0344460 | Carcinoma ex pleomorphic adenoma | 7 | 0.5000000 | 2.142971 |
umls:C0543822 | Atherosclerotic occlusive disease | 7 | 0.5000000 | 2.142971 |
umls:C1318500 | Non-toxic nodular goiter | 7 | 0.5000000 | 2.142971 |
umls:C1368354 | Mixed Neoplasm | 7 | 0.5000000 | 2.142971 |
umls:C1396243 | Intolerance to protein | 7 | 0.5000000 | 2.142971 |
umls:C1854365 | BREAST CANCER 3 | 7 | 0.5000000 | 2.142971 |
umls:C2733158 | Cerebral Small Vessel Diseases | 7 | 0.5000000 | 2.142971 |
umls:C2921106 | Recurrent pregnancy loss | 7 | 0.5000000 | 2.142971 |
umls:C0003499 | Supravalvular aortic stenosis | 6 | 0.5000000 | 1.881518 |
umls:C0004659 | Bacteriuria | 6 | 0.5000000 | 1.881518 |
umls:C0006079 | Bowen’s Disease | 6 | 0.5000000 | 1.881518 |
umls:C0011351 | Dental Enamel Hypoplasia | 6 | 0.5000000 | 1.881518 |
umls:C0014236 | Endophthalmitis | 6 | 0.5000000 | 1.881518 |
umls:C0016522 | Foramen Ovale, Patent | 6 | 0.5000000 | 1.881518 |
umls:C0022577 | Keratoconjunctivitis, Vernal | 6 | 0.5000000 | 1.881518 |
umls:C0042024 | Urinary Incontinence | 6 | 0.5000000 | 1.881518 |
umls:C0238019 | Carcinoma of extrahepatic bile duct | 6 | 0.5000000 | 1.881518 |
umls:C0267952 | Fibrosis of pancreas | 6 | 0.5000000 | 1.881518 |
umls:C0271844 | Parathyroid hyperplasia | 6 | 0.5000000 | 1.881518 |
umls:C0278619 | Extramedullary Plasmacytoma | 6 | 0.5000000 | 1.881518 |
umls:C0280788 | Anaplastic Ependymoma | 6 | 0.5000000 | 1.881518 |
umls:C0457334 | Acute monoblastic leukemia | 6 | 0.5000000 | 1.881518 |
umls:C0878649 | Gastric hyperplastic polyp | 6 | 0.5000000 | 1.881518 |
umls:C1619692 | Nephrogenic Fibrosing Dermopathy | 6 | 0.5000000 | 1.881518 |
umls:C1833662 | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 6 | 0.5000000 | 1.881518 |
umls:C1861355 | Syndactyly, Type IV | 6 | 0.5000000 | 1.881518 |
umls:C0007684 | Central Nervous System Infection | 5 | 0.5000000 | 1.616183 |
umls:C0011989 | Camurati-Engelmann Syndrome | 5 | 0.5000000 | 1.616183 |
umls:C0016048 | Fibromatosis | 5 | 0.5000000 | 1.616183 |
umls:C0017565 | Gingival Hemorrhage | 5 | 0.5000000 | 1.616183 |
umls:C0018991 | Hemiplegia | 5 | 0.5000000 | 1.616183 |
umls:C0038015 | Spondyloepiphyseal Dysplasia | 5 | 0.5000000 | 1.616183 |
umls:C0039373 | Tay-Sachs Disease | 5 | 0.5000000 | 1.616183 |
umls:C0043154 | Dental White Spot | 5 | 0.5000000 | 1.616183 |
umls:C0079294 | Epidermolysis Bullosa Dystrophica | 5 | 0.5000000 | 1.616183 |
umls:C0154841 | Central retinal vein occlusion | 5 | 0.5000000 | 1.616183 |
umls:C0220654 | Meningeal Carcinomatosis | 5 | 0.5000000 | 1.616183 |
umls:C0236848 | Age-related cognitive decline | 5 | 0.5000000 | 1.616183 |
umls:C0262380 | Asymptomatic bacteriuria | 5 | 0.5000000 | 1.616183 |
umls:C0278802 | Recurrent Endometrial Cancer | 5 | 0.5000000 | 1.616183 |
umls:C0278828 | Stage IV Bladder Cancer AJCC v6 | 5 | 0.5000000 | 1.616183 |
umls:C0403440 | Thin basement membrane disease | 5 | 0.5000000 | 1.616183 |
umls:C0409702 | Undifferentiated inflammatory oligoarthritis | 5 | 0.5000000 | 1.616183 |
umls:C0496836 | Malignant tumor of eye | 5 | 0.5000000 | 1.616183 |
umls:C0524801 | Retinal Neoplasms | 5 | 0.5000000 | 1.616183 |
umls:C0694571 | extranodal lymphoma | 5 | 0.5000000 | 1.616183 |
umls:C1260403 | prothrombin gene mutation | 5 | 0.5000000 | 1.616183 |
umls:C1266029 | Enterochromaffin-like cell carcinoid | 5 | 0.5000000 | 1.616183 |
umls:C1290344 | Nonspecific interstitial pneumonia | 5 | 0.5000000 | 1.616183 |
umls:C1318533 | Secondary polycythemia | 5 | 0.5000000 | 1.616183 |
umls:C1335473 | Conventional Chondrosarcoma | 5 | 0.5000000 | 1.616183 |
umls:C1861185 | THROMBOCYTOPENIA 2 (disorder) | 5 | 0.5000000 | 1.616183 |
umls:C1865343 | OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE | 5 | 0.5000000 | 1.616183 |
umls:C2350350 | Ventilator-Induced Lung Injury | 5 | 0.5000000 | 1.616183 |
umls:C3542021 | Duchenne and Becker Muscular Dystrophy | 5 | 0.5000000 | 1.616183 |
umls:C3665596 | Warts | 5 | 0.5000000 | 1.616183 |
umls:C1511789 | Desmoplastic | 37 | 0.4933333 | 9.653328 |
umls:C0008495 | Chorioamnionitis | 96 | 0.4923077 | 24.448264 |
umls:C0031154 | Peritonitis | 52 | 0.4905660 | 13.357993 |
umls:C0027662 | Multiple Endocrine Neoplasia | 26 | 0.4905660 | 6.834986 |
umls:C0006663 | Calcinosis | 48 | 0.4897959 | 12.306436 |
umls:C0035439 | Rheumatic Heart Disease | 24 | 0.4897959 | 6.316245 |
umls:C0751674 | Lymphangioleiomyomatosis | 24 | 0.4897959 | 6.316245 |
umls:C0006267 | Bronchiectasis | 23 | 0.4893617 | 6.068165 |
umls:C0600518 | Choroidal Neovascularization | 23 | 0.4893617 | 6.068165 |
umls:C0031106 | Periodontitis, Juvenile | 44 | 0.4888889 | 11.266180 |
umls:C0026654 | Moyamoya Disease | 22 | 0.4888889 | 5.808959 |
umls:C0023484 | Leukemia, Plasma Cell | 21 | 0.4883721 | 5.553172 |
umls:C0340708 | Deep vein thrombosis of lower limb | 21 | 0.4883721 | 5.553172 |
umls:C0085390 | Li-Fraumeni Syndrome | 20 | 0.4878049 | 5.301994 |
umls:C0013295 | Duodenal Ulcer | 37 | 0.4868421 | 9.458608 |
umls:C0003175 | Anthrax disease | 18 | 0.4864865 | 4.786625 |
umls:C0016037 | Fibrodysplasia Ossificans Progressiva | 18 | 0.4864865 | 4.786625 |
umls:C0029443 | Osteomyelitis | 18 | 0.4864865 | 4.786625 |
umls:C0276623 | Chronic viral hepatitis | 18 | 0.4864865 | 4.786625 |
umls:C0477474 | Dermatitis and eczema | 18 | 0.4864865 | 4.786625 |
umls:C1292754 | Mediastinal (Thymic) Large B-Cell Lymphoma | 18 | 0.4864865 | 4.786625 |
umls:C0040034 | Thrombocytopenia | 33 | 0.4852941 | 8.448781 |
umls:C0001824 | Agranulocytosis | 16 | 0.4848485 | 4.266990 |
umls:C0302810 | Uremia syndrome | 16 | 0.4848485 | 4.266990 |
umls:C0340293 | Anterior myocardial infarction | 16 | 0.4848485 | 4.266990 |
umls:C0240035 | Interstitial fibrosis | 47 | 0.4845361 | 11.836850 |
umls:C0010495 | Cutis Laxa | 15 | 0.4838710 | 4.013339 |
umls:C0259779 | Fibrous Dysplasia | 15 | 0.4838710 | 4.013339 |
umls:C0029410 | Osteoarthritis of hip | 29 | 0.4833333 | 7.404974 |
umls:C0022876 | Premature Obstetric Labor | 98 | 0.4827586 | 24.224459 |
umls:C0584960 | Factor V Leiden mutation | 27 | 0.4821429 | 6.895794 |
umls:C0016169 | pathologic fistula | 26 | 0.4814815 | 6.633985 |
umls:C0334633 | Malignant lymphoma - lymphoplasmacytic | 13 | 0.4814815 | 3.508703 |
umls:C1136085 | Monoclonal Gammapathies | 13 | 0.4814815 | 3.508703 |
umls:C1260954 | Morphologically altered structure | 13 | 0.4814815 | 3.508703 |
umls:C1541923 | Infective endocarditis | 13 | 0.4814815 | 3.508703 |
umls:C1708565 | Invasive Skin Melanoma | 13 | 0.4814815 | 3.508703 |
umls:C1402315 | Vascular lesions | 24 | 0.4800000 | 6.128192 |
umls:C0008311 | Cholangitis | 12 | 0.4800000 | 3.251508 |
umls:C0015306 | Hereditary Multiple Exostoses | 12 | 0.4800000 | 3.251508 |
umls:C0162323 | Polyarthritis | 12 | 0.4800000 | 3.251508 |
umls:C0206728 | Plexiform Neurofibroma | 12 | 0.4800000 | 3.251508 |
umls:C0494261 | Combined immunodeficiency | 12 | 0.4800000 | 3.251508 |
umls:C1883018 | Severe Aplastic Anemia | 12 | 0.4800000 | 3.251508 |
umls:C3714524 | Fibromyxosarcoma | 12 | 0.4800000 | 3.251508 |
umls:C1955869 | Malformations of Cortical Development | 22 | 0.4782609 | 5.617963 |
umls:C0278512 | Metastatic osteosarcoma | 11 | 0.4782609 | 2.993839 |
umls:C0162810 | Cicatrix, Hypertrophic | 32 | 0.4776119 | 7.991762 |
umls:C0151950 | Deep thrombophlebitis | 21 | 0.4772727 | 5.368505 |
umls:C0343284 | Chondrodysplasia | 21 | 0.4772727 | 5.368505 |
umls:C1959635 | Parvovirus B19 (disease) | 21 | 0.4772727 | 5.368505 |
umls:C0751690 | Malignant Peripheral Nerve Sheath Tumor | 72 | 0.4768212 | 17.564372 |
umls:C0027859 | Acoustic Neuroma | 41 | 0.4767442 | 10.094802 |
umls:C0010276 | Craniopharyngioma | 10 | 0.4761905 | 2.733240 |
umls:C0018843 | Heat Stroke | 10 | 0.4761905 | 2.733240 |
umls:C0032045 | Placenta Disorders | 10 | 0.4761905 | 2.733240 |
umls:C0265385 | Autosomal dominant hereditary disorder | 10 | 0.4761905 | 2.733240 |
umls:C0272375 | Antithrombin III Deficiency | 10 | 0.4761905 | 2.733240 |
umls:C1266050 | Poorly Differentiated Thyroid Carcinoma | 10 | 0.4761905 | 2.733240 |
umls:C2931038 | Pancreatic carcinoma, familial | 10 | 0.4761905 | 2.733240 |
umls:C0162678 | Neurofibromatoses | 19 | 0.4750000 | 4.849625 |
umls:C1569637 | Adenocarcinoma, Endometrioid | 28 | 0.4745763 | 6.958271 |
umls:C0000809 | Abortion, Habitual | 37 | 0.4743590 | 9.083030 |
umls:C0879615 | Stromal Neoplasm | 36 | 0.4736842 | 8.837728 |
umls:C0013312 | Dupuytren Contracture | 9 | 0.4736842 | 2.474782 |
umls:C0346210 | Vulval intraepithelial neoplasia | 9 | 0.4736842 | 2.474782 |
umls:C1301363 | Blastic plasmacytoid dendritic cell neoplasm | 9 | 0.4736842 | 2.474782 |
umls:C1562585 | Leprosy, Multibacillary | 9 | 0.4736842 | 2.474782 |
umls:C1511291 | Breast Cancer Model | 35 | 0.4729730 | 8.583044 |
umls:C0011226 | Hepatitis D Infection | 26 | 0.4727273 | 6.443456 |
umls:C0851140 | Carcinoma in situ of uterine cervix | 25 | 0.4716981 | 6.190854 |
umls:C0334299 | Carcinoid tumor no ICD-O subtype | 41 | 0.4712644 | 9.907732 |
umls:C0010701 | Phyllodes Tumor | 24 | 0.4705882 | 5.943406 |
umls:C0007867 | Cervix Diseases | 16 | 0.4705882 | 4.085907 |
umls:C0014070 | Encephalomyelitis | 16 | 0.4705882 | 4.085907 |
umls:C0278838 | Prostate cancer recurrent | 16 | 0.4705882 | 4.085907 |
umls:C0431380 | Cortical Dysplasia | 16 | 0.4705882 | 4.085907 |
umls:C0677944 | Sentinel node (disorder) | 16 | 0.4705882 | 4.085907 |
umls:C0023860 | Listeriosis | 8 | 0.4705882 | 2.221825 |
umls:C0043020 | Wallerian Degeneration | 8 | 0.4705882 | 2.221825 |
umls:C0205768 | Subependymal Giant Cell Astrocytoma | 8 | 0.4705882 | 2.221825 |
umls:C0265110 | Cerebral Vasospasm | 8 | 0.4705882 | 2.221825 |
umls:C0265216 | X-linked hydrocephalus syndrome | 8 | 0.4705882 | 2.221825 |
umls:C0268615 | 5,10-Methylenetetrahydrofolate reductase deficiency | 8 | 0.4705882 | 2.221825 |
umls:C0752351 | Embryo Loss | 8 | 0.4705882 | 2.221825 |
umls:C0796033 | MARDEN-WALKER SYNDROME | 8 | 0.4705882 | 2.221825 |
umls:C1566590 | Delayed Graft Function | 8 | 0.4705882 | 2.221825 |
umls:C2348101 | Destructive Arthritis | 8 | 0.4705882 | 2.221825 |
umls:C0403529 | Anti-Glomerular Basement Membrane Disease | 23 | 0.4693878 | 5.688962 |
umls:C0033999 | Pterygium | 30 | 0.4687500 | 7.287731 |
umls:C0028880 | Odontogenic Tumors | 15 | 0.4687500 | 3.838781 |
umls:C1536085 | Geographic Atrophy | 15 | 0.4687500 | 3.838781 |
umls:C0038358 | Gastric ulcer | 52 | 0.4684685 | 12.372814 |
umls:C0278601 | Inflammatory Breast Carcinoma | 44 | 0.4680851 | 10.499483 |
umls:C0278678 | Metastatic Renal Cell Cancer | 22 | 0.4680851 | 5.436141 |
umls:C0205696 | Anaplastic carcinoma | 29 | 0.4677419 | 7.027476 |
umls:C0948192 | Primary infection NOS | 29 | 0.4677419 | 7.027476 |
umls:C0029134 | Optic Neuritis | 21 | 0.4666667 | 5.180775 |
umls:C1257930 | Mammary Carcinoma, Human | 21 | 0.4666667 | 5.180775 |
umls:C0004030 | Aspergillosis | 14 | 0.4666667 | 3.587179 |
umls:C0014527 | Epidermolysis Bullosa | 14 | 0.4666667 | 3.587179 |
umls:C0038160 | Staphylococcal Infections | 14 | 0.4666667 | 3.587179 |
umls:C0521607 | Peritoneal Fibrosis | 14 | 0.4666667 | 3.587179 |
umls:C0016470 | Food Allergy | 7 | 0.4666667 | 1.963273 |
umls:C0019555 | Hip Dislocation, Congenital | 7 | 0.4666667 | 1.963273 |
umls:C0206709 | Cystadenoma, Serous | 7 | 0.4666667 | 1.963273 |
umls:C0268381 | Primary amyloidosis | 7 | 0.4666667 | 1.963273 |
umls:C0334287 | Fibrolamellar hepatocellular carcinoma | 7 | 0.4666667 | 1.963273 |
umls:C0334294 | Multiple adenomatous polyps | 7 | 0.4666667 | 1.963273 |
umls:C0342751 | Generalized glycogen storage disease of infants | 7 | 0.4666667 | 1.963273 |
umls:C1112160 | Gastrooesophageal cancer | 7 | 0.4666667 | 1.963273 |
umls:C1609433 | Congenital absence of kidneys syndrome | 7 | 0.4666667 | 1.963273 |
umls:C1708604 | Keratocystic Odontogenic Tumor | 7 | 0.4666667 | 1.963273 |
umls:C2931784 | Amyloid angiopathy | 7 | 0.4666667 | 1.963273 |
umls:C3149841 | POLYCYSTIC KIDNEY DISEASE 1 | 7 | 0.4666667 | 1.963273 |
umls:C3272841 | MUTYH-Associate Polyposis | 7 | 0.4666667 | 1.963273 |
umls:C1519689 | Tumor Promotion | 41 | 0.4659091 | 9.720585 |
umls:C0036983 | Septic Shock | 27 | 0.4655172 | 6.520008 |
umls:C0007130 | Mucinous Adenocarcinoma | 40 | 0.4651163 | 9.472482 |
umls:C0206693 | Medullary carcinoma | 26 | 0.4642857 | 6.268647 |
umls:C0341858 | Endometriosis of uterus | 26 | 0.4642857 | 6.268647 |
umls:C0349530 | Early gastric cancer | 13 | 0.4642857 | 3.330892 |
umls:C2316212 | Cryopyrin-Associated Periodic Syndromes | 13 | 0.4642857 | 3.330892 |
umls:C0038325 | Stevens-Johnson Syndrome | 32 | 0.4637681 | 7.622226 |
umls:C0158266 | Intervertebral Disc Degeneration | 38 | 0.4634146 | 8.981208 |
umls:C0012739 | Disseminated Intravascular Coagulation | 19 | 0.4634146 | 4.672886 |
umls:C1258104 | Diffuse Scleroderma | 19 | 0.4634146 | 4.672886 |
umls:C0014522 | Epidermodysplasia Verruciformis | 25 | 0.4629630 | 6.019387 |
umls:C0852949 | Arteriopathic disease | 25 | 0.4629630 | 6.019387 |
umls:C0018923 | Hemangiosarcoma | 31 | 0.4626866 | 7.359692 |
umls:C0151942 | Arterial thrombosis | 31 | 0.4626866 | 7.359692 |
umls:C0162871 | Aortic Aneurysm, Abdominal | 86 | 0.4623656 | 19.826350 |
umls:C0019069 | Hemophilia A | 43 | 0.4623656 | 10.056582 |
umls:C0027697 | Nephritis | 67 | 0.4620690 | 15.521198 |
umls:C0008479 | Chondrosarcoma | 103 | 0.4618834 | 23.686279 |
umls:C1960397 | Philadelphia chromosome-positive acute lymphoblastic leukemia | 24 | 0.4615385 | 5.760514 |
umls:C3665419 | Intracranial glioma | 18 | 0.4615385 | 4.412826 |
umls:C0018188 | Granuloma | 12 | 0.4615385 | 3.075127 |
umls:C0018418 | Gynecomastia | 12 | 0.4615385 | 3.075127 |
umls:C0079746 | Immunoblastic Large-Cell Lymphoma | 12 | 0.4615385 | 3.075127 |
umls:C0162869 | Aneurysm, Ruptured | 12 | 0.4615385 | 3.075127 |
umls:C0266470 | Cerebellar Hypoplasia | 12 | 0.4615385 | 3.075127 |
umls:C0010635 | Cystadenoma, Mucinous | 6 | 0.4615385 | 1.700124 |
umls:C0012813 | Diverticulitis | 6 | 0.4615385 | 1.700124 |
umls:C0016663 | Pathological fracture | 6 | 0.4615385 | 1.700124 |
umls:C0020302 | Hydrophthalmos | 6 | 0.4615385 | 1.700124 |
umls:C0021847 | Intestinal Pseudo-Obstruction | 6 | 0.4615385 | 1.700124 |
umls:C0025209 | Melanosis | 6 | 0.4615385 | 1.700124 |
umls:C0035021 | Relapsing Fever | 6 | 0.4615385 | 1.700124 |
umls:C0039743 | Thanatophoric Dysplasia | 6 | 0.4615385 | 1.700124 |
umls:C0085315 | Toxoplasmosis, Cerebral | 6 | 0.4615385 | 1.700124 |
umls:C0206717 | Olfactory Neuroblastoma | 6 | 0.4615385 | 1.700124 |
umls:C0281899 | Prolapsed lumbar disc | 6 | 0.4615385 | 1.700124 |
umls:C0282201 | Phosphate Diabetes | 6 | 0.4615385 | 1.700124 |
umls:C0342158 | Hypothyroidism, Autoimmune | 6 | 0.4615385 | 1.700124 |
umls:C0346388 | Malignant melanoma of choroid | 6 | 0.4615385 | 1.700124 |
umls:C0349579 | Atypical Endometrial Hyperplasia | 6 | 0.4615385 | 1.700124 |
umls:C0585274 | Periodic syndrome | 6 | 0.4615385 | 1.700124 |
umls:C0742468 | Central nervous system lesion | 6 | 0.4615385 | 1.700124 |
umls:C0742472 | Central nervous system lymphoma | 6 | 0.4615385 | 1.700124 |
umls:C0747256 | Parasitic infection | 6 | 0.4615385 | 1.700124 |
umls:C0810032 | Pancreatic disorders (not diabetes) | 6 | 0.4615385 | 1.700124 |
umls:C0857305 | Thrombocytopenic purpura | 6 | 0.4615385 | 1.700124 |
umls:C1282952 | Enthesitis | 6 | 0.4615385 | 1.700124 |
umls:C1377913 | Pleural Mesothelioma | 6 | 0.4615385 | 1.700124 |
umls:C1868678 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | 6 | 0.4615385 | 1.700124 |
umls:C3161650 | Primary immunoglobulin A nephropathy (disorder) | 6 | 0.4615385 | 1.700124 |
umls:C0019080 | Hemorrhage | 29 | 0.4603175 | 6.855723 |
umls:C0040411 | Tongue Neoplasms | 17 | 0.4594595 | 4.158978 |
umls:C0085278 | Antiphospholipid Syndrome | 28 | 0.4590164 | 6.595691 |
umls:C0002793 | Anaplasia | 106 | 0.4588745 | 24.075996 |
umls:C0004610 | Bacteremia | 44 | 0.4583333 | 10.127976 |
umls:C0027533 | Neck Neoplasms | 22 | 0.4583333 | 5.260415 |
umls:C0006023 | Borna Disease | 11 | 0.4583333 | 2.819107 |
umls:C0034362 | Q Fever | 11 | 0.4583333 | 2.819107 |
umls:C0334359 | Papillary serous cystadenocarcinoma | 11 | 0.4583333 | 2.819107 |
umls:C0334663 | Histiocytic sarcoma | 11 | 0.4583333 | 2.819107 |
umls:C1136084 | Plasma cell dyscrasia | 11 | 0.4583333 | 2.819107 |
umls:C0398623 | Thrombophilia | 49 | 0.4579439 | 11.238933 |
umls:C0005940 | Bone Diseases | 75 | 0.4573171 | 17.028516 |
umls:C0854917 | Rhabdoid Tumor of the Kidney | 48 | 0.4571429 | 10.997148 |
umls:C0026766 | Multiple Organ Failure | 16 | 0.4571429 | 3.912341 |
umls:C0040015 | Thrombasthenia | 16 | 0.4571429 | 3.912341 |
umls:C0346421 | Chronic eosinophilic leukemia | 16 | 0.4571429 | 3.912341 |
umls:C0018021 | Goiter | 37 | 0.4567901 | 8.550621 |
umls:C0013238 | Dry Eye Syndromes | 21 | 0.4565217 | 5.003172 |
umls:C0019621 | Histiocytosis, Langerhans-Cell | 31 | 0.4558824 | 7.183952 |
umls:C0002171 | Alopecia Areata | 30 | 0.4545455 | 6.932244 |
umls:C0029434 | Osteogenesis Imperfecta | 20 | 0.4545455 | 4.752871 |
umls:C1335475 | Primary Carcinoma | 20 | 0.4545455 | 4.752871 |
umls:C0027707 | Nephritis, Interstitial | 15 | 0.4545455 | 3.662117 |
umls:C0027814 | Neuritis, Autoimmune, Experimental | 15 | 0.4545455 | 3.662117 |
umls:C0162538 | Immunoglobulin A deficiency (disorder) | 15 | 0.4545455 | 3.662117 |
umls:C0474808 | Follicular neoplasm | 15 | 0.4545455 | 3.662117 |
umls:C1332225 | Aggressive Non-Hodgkin Lymphoma | 15 | 0.4545455 | 3.662117 |
umls:C1527408 | Rectal Tumors | 15 | 0.4545455 | 3.662117 |
umls:C0153601 | Malignant neoplasm of penis | 10 | 0.4545455 | 2.562872 |
umls:C0206684 | Sebaceous Adenocarcinoma | 10 | 0.4545455 | 2.562872 |
umls:C0432487 | Post-transplant lymphoproliferative disorder | 10 | 0.4545455 | 2.562872 |
umls:C0854988 | Adenocarcinoma of lung, stage IV | 10 | 0.4545455 | 2.562872 |
umls:C1334455 | Pulmonary Sclerosing Hemangioma | 10 | 0.4545455 | 2.562872 |
umls:C1370419 | Granulosa cell tumor of the ovary | 10 | 0.4545455 | 2.562872 |
umls:C0007302 | Cartilage Diseases | 5 | 0.4545455 | 1.438517 |
umls:C0023801 | Lipomatosis | 5 | 0.4545455 | 1.438517 |
umls:C0025205 | Melanoma, Experimental | 5 | 0.4545455 | 1.438517 |
umls:C0026265 | Diseases of mitral valve | 5 | 0.4545455 | 1.438517 |
umls:C0034089 | Pulmonary Valve Stenosis | 5 | 0.4545455 | 1.438517 |
umls:C0038505 | Sturge-Weber Syndrome | 5 | 0.4545455 | 1.438517 |
umls:C0041227 | Trypanosomiasis | 5 | 0.4545455 | 1.438517 |
umls:C0085663 | Plasmacytosis | 5 | 0.4545455 | 1.438517 |
umls:C0085758 | Aganglionosis, Colonic | 5 | 0.4545455 | 1.438517 |
umls:C0206750 | Coronavirus Infections | 5 | 0.4545455 | 1.438517 |
umls:C0238124 | Necrotizing fasciitis | 5 | 0.4545455 | 1.438517 |
umls:C0265808 | Cyanotic congenital heart disease | 5 | 0.4545455 | 1.438517 |
umls:C0342513 | Idiopathic hirsutism | 5 | 0.4545455 | 1.438517 |
umls:C0458219 | Complex Regional Pain Syndromes | 5 | 0.4545455 | 1.438517 |
umls:C0555278 | Cerebral metastasis | 5 | 0.4545455 | 1.438517 |
umls:C0920028 | Leukaemia recurrent | 5 | 0.4545455 | 1.438517 |
umls:C1304140 | Familial psoriasis | 5 | 0.4545455 | 1.438517 |
umls:C1336538 | Supratentorial Primitive Neuroectodermal Tumor | 5 | 0.4545455 | 1.438517 |
umls:C1368910 | Mature Teratoma | 5 | 0.4545455 | 1.438517 |
umls:C1706004 | Anhydrotic Ectodermal Dysplasias | 5 | 0.4545455 | 1.438517 |
umls:C1865868 | ALZHEIMER DISEASE 5 | 5 | 0.4545455 | 1.438517 |
umls:C1876165 | Copper-Overload Cirrhosis | 5 | 0.4545455 | 1.438517 |
umls:C2931642 | Benign symmetrical lipomatosis | 5 | 0.4545455 | 1.438517 |
umls:C2931687 | Dysferlinopathy | 5 | 0.4545455 | 1.438517 |
umls:C0566602 | Primary sclerosing cholangitis | 49 | 0.4537037 | 11.067964 |
umls:C0030286 | Pancreatic Diseases | 24 | 0.4528302 | 5.591253 |
umls:C0151468 | Thyroid Gland Follicular Adenoma | 38 | 0.4523810 | 8.631938 |
umls:C0011644 | Scleroderma | 75 | 0.4518072 | 16.684649 |
umls:C0220726 | Diastrophic dysplasia | 14 | 0.4516129 | 3.411921 |
umls:C0037116 | Silicosis | 23 | 0.4509804 | 5.344414 |
umls:C0001768 | Agammaglobulinemia | 9 | 0.4500000 | 2.310906 |
umls:C0014511 | Epithelial cyst | 9 | 0.4500000 | 2.310906 |
umls:C0014742 | Erythema Multiforme | 9 | 0.4500000 | 2.310906 |
umls:C0037933 | Spinal Diseases | 9 | 0.4500000 | 2.310906 |
umls:C0238013 | invasive aspergillosis | 9 | 0.4500000 | 2.310906 |
umls:C0796154 | SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 | 9 | 0.4500000 | 2.310906 |
umls:C1280433 | Lipoatrophy | 9 | 0.4500000 | 2.310906 |
umls:C1370889 | Liposarcoma, well differentiated | 9 | 0.4500000 | 2.310906 |
umls:C1518693 | Ovarian Clear Cell Adenocarcinoma | 9 | 0.4500000 | 2.310906 |
umls:C2609129 | Autoimmune pancreatitis | 9 | 0.4500000 | 2.310906 |
umls:C1262091 | Lymphocytic infiltration | 22 | 0.4489796 | 5.087218 |
umls:C0027672 | Neoplastic Syndromes, Hereditary | 26 | 0.4482759 | 5.925767 |
umls:C0005694 | Bladder neck obstruction | 13 | 0.4482759 | 3.160011 |
umls:C0238301 | Cancer of Nasopharynx | 43 | 0.4479167 | 9.531759 |
umls:C0017205 | Gaucher Disease | 30 | 0.4477612 | 6.762168 |
umls:C0746102 | Chronic lung disease | 25 | 0.4464286 | 5.674984 |
umls:C0027686 | Pathologic Neovascularization | 33 | 0.4459459 | 7.350983 |
umls:C0034065 | Pulmonary Embolism | 33 | 0.4459459 | 7.350983 |
umls:C0206139 | Lichen Planus, Oral | 37 | 0.4457831 | 8.199668 |
umls:C0600452 | Hepatopulmonary Syndrome | 44 | 0.4444444 | 9.615858 |
umls:C1302773 | Low Grade Squamous Intraepithelial Neoplasia | 24 | 0.4444444 | 5.426143 |
umls:C0042345 | Varicosity | 20 | 0.4444444 | 4.582696 |
umls:C0152096 | Complete trisomy 18 syndrome | 16 | 0.4444444 | 3.748066 |
umls:C0001080 | Achondroplasia | 12 | 0.4444444 | 2.905416 |
umls:C0007868 | Cervical dysplasia | 12 | 0.4444444 | 2.905416 |
umls:C0039128 | Syphilis | 12 | 0.4444444 | 2.905416 |
umls:C0392784 | Dermatofibrosarcoma Protuberans | 12 | 0.4444444 | 2.905416 |
umls:C0746883 | Febrile Neutropenia | 12 | 0.4444444 | 2.905416 |
umls:C3536714 | Renal dysplasia | 12 | 0.4444444 | 2.905416 |
umls:C3536715 | AA amyloidosis | 12 | 0.4444444 | 2.905416 |
umls:C0011848 | Diabetes Insipidus | 8 | 0.4444444 | 2.056052 |
umls:C0030499 | Parasitic Diseases | 8 | 0.4444444 | 2.056052 |
umls:C0040997 | Trigeminal Neuralgia | 8 | 0.4444444 | 2.056052 |
umls:C0221269 | Pseudolymphoma | 8 | 0.4444444 | 2.056052 |
umls:C0856761 | Budd-Chiari Syndrome | 8 | 0.4444444 | 2.056052 |
umls:C1266044 | Collecting Duct Carcinoma of the Kidney | 8 | 0.4444444 | 2.056052 |
umls:C0085409 | Polyendocrinopathies, Autoimmune | 42 | 0.4421053 | 9.128014 |
umls:C0035243 | Respiratory Tract Infections | 34 | 0.4415584 | 7.437159 |
umls:C0036323 | Schistosomiasis | 30 | 0.4411765 | 6.595691 |
umls:C0206638 | Giant Cell Tumor of Bone | 30 | 0.4411765 | 6.595691 |
umls:C0206685 | Acinar Cell Carcinoma | 15 | 0.4411765 | 3.501298 |
umls:C0221228 | Comedone | 15 | 0.4411765 | 3.501298 |
umls:C2931384 | Moyamoya disease 1 | 15 | 0.4411765 | 3.501298 |
umls:C2931785 | Juvenile dermatomyositis | 15 | 0.4411765 | 3.501298 |
umls:C0029172 | Oral Submucous Fibrosis | 26 | 0.4406780 | 5.760287 |
umls:C0079218 | Fibromatosis, Aggressive | 26 | 0.4406780 | 5.760287 |
umls:C0024232 | Lymphatic Metastasis | 74 | 0.4404762 | 15.733108 |
umls:C0005411 | Biliary Atresia | 37 | 0.4404762 | 8.035680 |
umls:C0007766 | Intracranial Aneurysm | 48 | 0.4403670 | 10.301255 |
umls:C0003857 | Congenital arteriovenous malformation | 22 | 0.4400000 | 4.921780 |
umls:C0085435 | Arthritis, Reactive | 22 | 0.4400000 | 4.921780 |
umls:C0035450 | Rheumatoid Nodule | 11 | 0.4400000 | 2.648709 |
umls:C0036472 | Scrub Typhus | 11 | 0.4400000 | 2.648709 |
umls:C0162566 | Porphyria Cutanea Tarda | 11 | 0.4400000 | 2.648709 |
umls:C0268575 | Isovaleryl-CoA dehydrogenase deficiency | 11 | 0.4400000 | 2.648709 |
umls:C0016059 | Fibrosis | 84 | 0.4397906 | 17.826338 |
umls:C0153690 | Secondary malignant neoplasm of bone | 126 | 0.4390244 | 26.277583 |
umls:C0018081 | Gonorrhea | 18 | 0.4390244 | 4.084988 |
umls:C1336527 | Carcinoma of urinary bladder, superficial | 18 | 0.4390244 | 4.084988 |
umls:C0018916 | Hemangioma | 32 | 0.4383562 | 6.936113 |
umls:C0334579 | Anaplastic astrocytoma | 60 | 0.4379562 | 12.683813 |
umls:C0206682 | Follicular thyroid carcinoma | 74 | 0.4378698 | 15.578694 |
umls:C0040038 | Thromboembolism | 49 | 0.4375000 | 10.393992 |
umls:C0024419 | Waldenstrom Macroglobulinemia | 42 | 0.4375000 | 8.976145 |
umls:C0012546 | Diphtheria | 35 | 0.4375000 | 7.527687 |
umls:C0042974 | von Willebrand Disease | 21 | 0.4375000 | 4.674319 |
umls:C1367654 | Marginal Zone B-Cell Lymphoma | 21 | 0.4375000 | 4.674319 |
umls:C0276496 | Familial Alzheimer Disease (FAD) | 14 | 0.4375000 | 3.250369 |
umls:C0003868 | Arthritis, Gouty | 7 | 0.4375000 | 1.799127 |
umls:C0011119 | Decompression Sickness | 7 | 0.4375000 | 1.799127 |
umls:C0023241 | Legionnaires’ Disease | 7 | 0.4375000 | 1.799127 |
umls:C0033117 | Priapism | 7 | 0.4375000 | 1.799127 |
umls:C0037278 | Skin Diseases, Infectious | 7 | 0.4375000 | 1.799127 |
umls:C0242526 | Gonadal Dysgenesis, 45,X | 7 | 0.4375000 | 1.799127 |
umls:C0271829 | Pendred’s syndrome | 7 | 0.4375000 | 1.799127 |
umls:C0278480 | Stage III Colon Cancer | 7 | 0.4375000 | 1.799127 |
umls:C0346163 | Endometrioid carcinoma ovary | 7 | 0.4375000 | 1.799127 |
umls:C0521989 | Associated symptom | 7 | 0.4375000 | 1.799127 |
umls:C0745287 | infertility tubal factor | 7 | 0.4375000 | 1.799127 |
umls:C1300127 | Perivascular Epithelioid Cell Neoplasms | 7 | 0.4375000 | 1.799127 |
umls:C1318973 | Staphylococcus aureus infection | 7 | 0.4375000 | 1.799127 |
umls:C1955861 | T-Cell Large Granular Lymphocyte Leukemia | 7 | 0.4375000 | 1.799127 |
umls:C3146254 | Stage III Colon Cancer AJCC v7 | 7 | 0.4375000 | 1.799127 |
umls:C1519346 | Skin Carcinogenesis | 48 | 0.4363636 | 10.128429 |
umls:C0238033 | Carcinoma of Male Breast | 24 | 0.4363636 | 5.266430 |
umls:C0029458 | Osteoporosis, Postmenopausal | 41 | 0.4361702 | 8.726788 |
umls:C0205647 | Follicular adenoma | 41 | 0.4361702 | 8.726788 |
umls:C0035869 | Rotavirus Infections | 17 | 0.4358974 | 3.841867 |
umls:C0349637 | Common acute lymphoblastic leukemia | 17 | 0.4358974 | 3.841867 |
umls:C0278883 | Metastatic melanoma | 145 | 0.4354354 | 29.752017 |
umls:C0021361 | Female infertility | 30 | 0.4347826 | 6.430944 |
umls:C0266292 | Congenital anomaly of the kidney | 10 | 0.4347826 | 2.401623 |
umls:C0276226 | Herpes encephalitis | 10 | 0.4347826 | 2.401623 |
umls:C0282606 | Myomatous neoplasm | 10 | 0.4347826 | 2.401623 |
umls:C0333293 | Healing ulcer | 10 | 0.4347826 | 2.401623 |
umls:C0598798 | Lymphoid neoplasm | 10 | 0.4347826 | 2.401623 |
umls:C1322286 | Thymoma, type C | 10 | 0.4347826 | 2.401623 |
umls:C0221026 | X-linked agammaglobulinemia | 23 | 0.4339623 | 5.012757 |
umls:C3665444 | Neutrophilia (disorder) | 23 | 0.4339623 | 5.012757 |
umls:C0003486 | Aortic Aneurysm | 91 | 0.4333333 | 18.772721 |
umls:C0392707 | Atopy | 26 | 0.4333333 | 5.604197 |
umls:C0151650 | Renal fibrosis | 68 | 0.4331210 | 14.078977 |
umls:C0856742 | Post MI | 16 | 0.4324324 | 3.594870 |
umls:C0033687 | Proteinuria | 35 | 0.4320988 | 7.364686 |
umls:C0041956 | Ureteral obstruction | 57 | 0.4318182 | 11.758643 |
umls:C0034885 | Rectal Neoplasms | 38 | 0.4318182 | 7.966804 |
umls:C0598894 | Monocytic leukemia | 19 | 0.4318182 | 4.172870 |
umls:C0017658 | Glomerulonephritis | 88 | 0.4313725 | 18.024214 |
umls:C0002893 | Refractory anemias | 22 | 0.4313725 | 4.767622 |
umls:C0027809 | Neurilemmoma | 56 | 0.4307692 | 11.507899 |
umls:C1510885 | Angiogenic Switch | 28 | 0.4307692 | 5.943541 |
umls:C0034067 | Pulmonary Emphysema | 77 | 0.4301676 | 15.692961 |
umls:C0971858 | Arthritis, Collagen-Induced | 70 | 0.4294479 | 14.260262 |
umls:C1334274 | Invasive Carcinoma | 66 | 0.4285714 | 13.415862 |
umls:C1333064 | Classical Hodgkin’s Lymphoma | 54 | 0.4285714 | 11.019397 |
umls:C0005967 | Bone neoplasms | 39 | 0.4285714 | 8.060018 |
umls:C0008313 | Cholangitis, Sclerosing | 36 | 0.4285714 | 7.461163 |
umls:C1264606 | Persistent infection | 27 | 0.4285714 | 5.696993 |
umls:C0334463 | Malignant Fibrous Histiocytoma | 24 | 0.4285714 | 5.108722 |
umls:C0086942 | Rous Sarcoma | 21 | 0.4285714 | 4.513640 |
umls:C0549463 | X-Linked Lymphoproliferative Disorder | 21 | 0.4285714 | 4.513640 |
umls:C0007140 | Carcinosarcoma | 18 | 0.4285714 | 3.928959 |
umls:C0272138 | Erythroblastosis | 18 | 0.4285714 | 3.928959 |
umls:C0701807 | Acute anterior uveitis | 18 | 0.4285714 | 3.928959 |
umls:C0014335 | Enteritis | 15 | 0.4285714 | 3.349305 |
umls:C0280321 | Squamous cell carcinoma of the hypopharynx | 12 | 0.4285714 | 2.747112 |
umls:C0002949 | Aneurysm, Dissecting | 9 | 0.4285714 | 2.148919 |
umls:C0039446 | Telangiectasis | 9 | 0.4285714 | 2.148919 |
umls:C0205697 | Carcinoma, Spindle-Cell | 9 | 0.4285714 | 2.148919 |
umls:C0854985 | Adenocarcinoma of lung, stage I | 9 | 0.4285714 | 2.148919 |
umls:C2608079 | WARFARIN SENSITIVITY (disorder) | 9 | 0.4285714 | 2.148919 |
umls:C0003128 | Anovulation | 6 | 0.4285714 | 1.546414 |
umls:C0003615 | Appendicitis | 6 | 0.4285714 | 1.546414 |
umls:C0008513 | Chorioretinitis | 6 | 0.4285714 | 1.546414 |
umls:C0019154 | Hepatic Vein Thrombosis | 6 | 0.4285714 | 1.546414 |
umls:C0023351 | Tuberculoid leprosy | 6 | 0.4285714 | 1.546414 |
umls:C0028064 | Niemann-Pick Diseases | 6 | 0.4285714 | 1.546414 |
umls:C0036161 | Sandhoff Disease | 6 | 0.4285714 | 1.546414 |
umls:C0039106 | Pigmented villonodular synovitis | 6 | 0.4285714 | 1.546414 |
umls:C0040425 | Tonsillitis | 6 | 0.4285714 | 1.546414 |
umls:C0085280 | Alagille Syndrome | 6 | 0.4285714 | 1.546414 |
umls:C0151945 | Thrombosis of cerebral veins | 6 | 0.4285714 | 1.546414 |
umls:C0238122 | Fallopian Tube Carcinoma | 6 | 0.4285714 | 1.546414 |
umls:C0345907 | Angiosarcoma of liver | 6 | 0.4285714 | 1.546414 |
umls:C0375019 | Human T-cell lymphotrophic virus, type I [HTLV-I] | 6 | 0.4285714 | 1.546414 |
umls:C0376620 | Pouchitis | 6 | 0.4285714 | 1.546414 |
umls:C0475801 | Leukemia, Prolymphocytic, B-Cell | 6 | 0.4285714 | 1.546414 |
umls:C0553681 | Hypofibrinogenemia | 6 | 0.4285714 | 1.546414 |
umls:C0796563 | Localized Malignant Neoplasm | 6 | 0.4285714 | 1.546414 |
umls:C0855146 | Precursor B-lymphoblastic lymphoma | 6 | 0.4285714 | 1.546414 |
umls:C0948750 | Salivary gland carcinoma | 6 | 0.4285714 | 1.546414 |
umls:C1096458 | Vascular occlusion | 6 | 0.4285714 | 1.546414 |
umls:C1701940 | Pneumonia, Ventilator-Associated | 6 | 0.4285714 | 1.546414 |
umls:C1708349 | Hereditary Diffuse Gastric Cancer | 6 | 0.4285714 | 1.546414 |
umls:C1846707 | SPINOCEREBELLAR ATAXIA 17 | 6 | 0.4285714 | 1.546414 |
umls:C2752147 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | 6 | 0.4285714 | 1.546414 |
umls:C3714753 | RETINOSCHISIS 1, X-LINKED, JUVENILE | 6 | 0.4285714 | 1.546414 |
umls:C0035435 | Rheumatism | 44 | 0.4271845 | 8.999053 |
umls:C0153392 | Malignant neoplasm of nasopharynx | 29 | 0.4264706 | 6.040201 |
umls:C0023283 | Leishmaniasis, Cutaneous | 23 | 0.4259259 | 4.858573 |
umls:C0002962 | Angina Pectoris | 20 | 0.4255319 | 4.266990 |
umls:C0017574 | Gingivitis | 20 | 0.4255319 | 4.266990 |
umls:C3665593 | Melanocytic nevus of skin | 20 | 0.4255319 | 4.266990 |
umls:C0333307 | Superficial ulcer | 57 | 0.4253731 | 11.443869 |
umls:C0011269 | Dementia, Vascular | 34 | 0.4250000 | 6.960680 |
umls:C1456781 | Benign melanocytic nevus | 34 | 0.4250000 | 6.960680 |
umls:C0149939 | Obstructive nephropathy | 17 | 0.4250000 | 3.686469 |
umls:C0206633 | Angiomyolipoma | 17 | 0.4250000 | 3.686469 |
umls:C0276447 | Rhinovirus infection | 17 | 0.4250000 | 3.686469 |
umls:C0314719 | Dryness of eye | 17 | 0.4250000 | 3.686469 |
umls:C0149516 | Chronic sinusitis | 31 | 0.4246575 | 6.372405 |
umls:C0022548 | Keloid | 73 | 0.4244186 | 14.534581 |
umls:C0040147 | Thyroiditis | 42 | 0.4242424 | 8.506449 |
umls:C0007930 | Chagas Cardiomyopathy | 14 | 0.4242424 | 3.100490 |
umls:C0042165 | Anterior uveitis | 14 | 0.4242424 | 3.100490 |
umls:C0263666 | Dermatomyositis, Childhood Type | 14 | 0.4242424 | 3.100490 |
umls:C0678213 | Complete hydatidiform mole | 14 | 0.4242424 | 3.100490 |
umls:C0027059 | Myocarditis | 47 | 0.4234234 | 9.425127 |
umls:C0032914 | Pre-Eclampsia | 154 | 0.4230769 | 29.752017 |
umls:C0014836 | Escherichia coli Infections | 11 | 0.4230769 | 2.499315 |
umls:C0025229 | Melioidosis | 11 | 0.4230769 | 2.499315 |
umls:C0029442 | Osteomalacia | 11 | 0.4230769 | 2.499315 |
umls:C0036974 | Shock | 11 | 0.4230769 | 2.499315 |
umls:C0038363 | Aphthous Stomatitis | 11 | 0.4230769 | 2.499315 |
umls:C0152276 | Granulocytic Sarcoma | 11 | 0.4230769 | 2.499315 |
umls:C0221357 | Brachydactyly | 11 | 0.4230769 | 2.499315 |
umls:C0266464 | Polymicrogyria | 11 | 0.4230769 | 2.499315 |
umls:C0677932 | Progressive Neoplastic Disease | 68 | 0.4223602 | 13.452817 |
umls:C3539781 | Progressive cGVHD | 68 | 0.4223602 | 13.452817 |
umls:C0040021 | Thromboangiitis Obliterans | 19 | 0.4222222 | 4.024384 |
umls:C0042344 | Varicose Ulcer | 19 | 0.4222222 | 4.024384 |
umls:C0242706 | Hyperoxia | 19 | 0.4222222 | 4.024384 |
umls:C0398650 | Immune thrombocytopenic purpura | 46 | 0.4220183 | 9.184467 |
umls:C1658953 | tumor vasculature | 46 | 0.4220183 | 9.184467 |
umls:C0040592 | Trachoma | 27 | 0.4218750 | 5.545721 |
umls:C0162770 | Right Ventricular Hypertrophy | 27 | 0.4218750 | 5.545721 |
umls:C0018206 | granulosa cell tumor | 35 | 0.4216867 | 7.057015 |
umls:C0205698 | Undifferentiated carcinoma | 35 | 0.4216867 | 7.057015 |
umls:C0024534 | Malaria, Cerebral | 40 | 0.4210526 | 8.001545 |
umls:C0001486 | Adenovirus Infections | 32 | 0.4210526 | 6.466896 |
umls:C0278498 | Malignant neoplasm of stomach stage IV | 16 | 0.4210526 | 3.442637 |
umls:C0002991 | Cutaneous Fibrous Histiocytoma | 8 | 0.4210526 | 1.901966 |
umls:C0005396 | Bile Duct Neoplasms | 8 | 0.4210526 | 1.901966 |
umls:C0013370 | Amebic colitis | 8 | 0.4210526 | 1.901966 |
umls:C0041582 | Ulcer | 8 | 0.4210526 | 1.901966 |
umls:C0085693 | Acute appendicitis NOS (disorder) | 8 | 0.4210526 | 1.901966 |
umls:C0235831 | Renal Cell Dysplasia | 8 | 0.4210526 | 1.901966 |
umls:C1306889 | Peripheral arterial occlusive disease | 8 | 0.4210526 | 1.901966 |
umls:C1561921 | Non-ST elevation (NSTEMI) myocardial infarction | 8 | 0.4210526 | 1.901966 |
umls:C0751967 | Multiple Sclerosis, Relapsing-Remitting | 37 | 0.4204545 | 7.403971 |
umls:C0030521 | Parathyroid Neoplasms | 21 | 0.4200000 | 4.370180 |
umls:C0032269 | Pneumococcal Infections | 21 | 0.4200000 | 4.370180 |
umls:C0017665 | Membranous glomerulonephritis | 34 | 0.4197531 | 6.817451 |
umls:C0020507 | Hyperplasia | 60 | 0.4195804 | 11.737972 |
umls:C0948380 | Colorectal cancer metastatic | 78 | 0.4193548 | 15.179566 |
umls:C0029927 | Ovarian Cysts | 26 | 0.4193548 | 5.304102 |
umls:C0021359 | Infertility | 13 | 0.4193548 | 2.851354 |
umls:C0221014 | Reactive systemic amyloidosis | 13 | 0.4193548 | 2.851354 |
umls:C0409952 | Idiopathic osteoarthritis | 13 | 0.4193548 | 2.851354 |
umls:C0041234 | Chagas Disease | 70 | 0.4191617 | 13.654203 |
umls:C0030809 | Pemphigus Vulgaris | 31 | 0.4189189 | 6.225981 |
umls:C0031069 | Familial Mediterranean Fever | 36 | 0.4186047 | 7.159798 |
umls:C0206656 | Rhabdomyosarcoma, Embryonal | 36 | 0.4186047 | 7.159798 |
umls:C0242787 | Malignant neoplasm of male breast | 18 | 0.4186047 | 3.787698 |
umls:C0238339 | Hereditary pancreatitis | 46 | 0.4181818 | 9.035351 |
umls:C0206695 | Carcinoma, Neuroendocrine | 23 | 0.4181818 | 4.713024 |
umls:C0085096 | Peripheral Vascular Diseases | 48 | 0.4173913 | 9.374707 |
umls:C0004623 | Bacterial Infections | 103 | 0.4170040 | 19.741304 |
umls:C0042384 | Vasculitis | 60 | 0.4166667 | 11.589797 |
umls:C0014743 | Erythema Nodosum | 20 | 0.4166667 | 4.123702 |
umls:C1328840 | Autoimmune Lymphoproliferative Syndrome | 20 | 0.4166667 | 4.123702 |
umls:C0036982 | Shock, Hemorrhagic | 15 | 0.4166667 | 3.198448 |
umls:C0220656 | Malignant ascites | 15 | 0.4166667 | 3.198448 |
umls:C0004277 | Tooth Attrition | 10 | 0.4166667 | 2.254707 |
umls:C0376154 | Skin callus | 10 | 0.4166667 | 2.254707 |
umls:C1336745 | Thymic Lymphoma | 10 | 0.4166667 | 2.254707 |
umls:C0002940 | Aneurysm | 57 | 0.4160584 | 11.011929 |
umls:C0002726 | Amyloidosis | 52 | 0.4160000 | 10.056582 |
umls:C0022578 | Keratoconus | 32 | 0.4155844 | 6.321766 |
umls:C0949691 | Spondylarthropathies | 32 | 0.4155844 | 6.321766 |
umls:C0005941 | Bone Diseases, Developmental | 22 | 0.4150943 | 4.463136 |
umls:C0279672 | Cervical Adenocarcinoma | 22 | 0.4150943 | 4.463136 |
umls:C1096063 | Drug Resistant Epilepsy | 22 | 0.4150943 | 4.463136 |
umls:C0085786 | Hamman-Rich syndrome | 17 | 0.4146341 | 3.544411 |
umls:C0016057 | Fibrosarcoma | 104 | 0.4143426 | 19.703886 |
umls:C0017525 | Giant Cell Tumors | 29 | 0.4142857 | 5.740868 |
umls:C0030481 | Tropical Spastic Paraparesis | 24 | 0.4137931 | 4.810325 |
umls:C0155668 | Old myocardial infarction | 12 | 0.4137931 | 2.599755 |
umls:C0030305 | Pancreatitis | 86 | 0.4134615 | 16.289877 |
umls:C0035455 | Rhinitis | 43 | 0.4134615 | 8.300991 |
umls:C0039103 | Synovitis | 43 | 0.4134615 | 8.300991 |
umls:C0266929 | Chronic Periodontitis | 74 | 0.4134078 | 14.056516 |
umls:C0342257 | Complications of Diabetes Mellitus | 31 | 0.4133333 | 6.082967 |
umls:C0687675 | Pregnancy loss | 31 | 0.4133333 | 6.082967 |
umls:C0008533 | Hemophilia B | 19 | 0.4130435 | 3.885916 |
umls:C0013575 | Ectodermal Dysplasia | 19 | 0.4130435 | 3.885916 |
umls:C0016978 | gallbladder neoplasm | 19 | 0.4130435 | 3.885916 |
umls:C0021367 | Mammary Ductal Carcinoma | 19 | 0.4130435 | 3.885916 |
umls:C0034186 | Pyelonephritis | 19 | 0.4130435 | 3.885916 |
umls:C0162872 | Aortic Aneurysm, Thoracic | 47 | 0.4122807 | 8.994967 |
umls:C0334121 | Inflammatory Myofibroblastic Tumor | 14 | 0.4117647 | 2.949811 |
umls:C1839259 | Bulbo-Spinal Atrophy, X-Linked | 14 | 0.4117647 | 2.949811 |
umls:C0013902 | Elliptocytosis, Hereditary | 7 | 0.4117647 | 1.652179 |
umls:C0023481 | Chronic Neutrophilic Leukemia | 7 | 0.4117647 | 1.652179 |
umls:C0024116 | Lung Diseases, Fungal | 7 | 0.4117647 | 1.652179 |
umls:C0029182 | orbit (eye disorders) | 7 | 0.4117647 | 1.652179 |
umls:C0206178 | Cytomegalovirus Retinitis | 7 | 0.4117647 | 1.652179 |
umls:C0206666 | Trophoblastic Tumor, Placental Site | 7 | 0.4117647 | 1.652179 |
umls:C0262401 | Carcinoma of ampulla of Vater | 7 | 0.4117647 | 1.652179 |
umls:C0302180 | Condyloma | 7 | 0.4117647 | 1.652179 |
umls:C0545074 | Myxoid/Round Cell Liposarcoma | 7 | 0.4117647 | 1.652179 |
umls:C0549379 | Recurrent Carcinoma | 7 | 0.4117647 | 1.652179 |
umls:C0683381 | inflammatory joint disease | 7 | 0.4117647 | 1.652179 |
umls:C0151526 | Premature Birth | 120 | 0.4109589 | 22.334431 |
umls:C0024790 | Paroxysmal nocturnal hemoglobinuria | 30 | 0.4109589 | 5.843508 |
umls:C0410528 | Skeletal dysplasia | 30 | 0.4109589 | 5.843508 |
umls:C0271183 | Severe myopia | 32 | 0.4102564 | 6.181605 |
umls:C0280785 | Diffuse Astrocytoma | 16 | 0.4102564 | 3.300849 |
umls:C0149678 | Epstein-Barr Virus Infections | 89 | 0.4101382 | 16.597814 |
umls:C1333600 | Hereditary Malignant Neoplasm | 25 | 0.4098361 | 4.911758 |
umls:C0007873 | Uterine Cervical Neoplasm | 68 | 0.4096386 | 12.692813 |
umls:C0027831 | Neurofibromatosis 1 | 61 | 0.4093960 | 11.396340 |
umls:C0349639 | Juvenile Myelomonocytic Leukemia | 45 | 0.4090909 | 8.506449 |
umls:C0024282 | Lymphocytosis | 27 | 0.4090909 | 5.260415 |
umls:C0010633 | Cystadenoma | 18 | 0.4090909 | 3.645787 |
umls:C0002880 | Autoimmune hemolytic anemia | 9 | 0.4090909 | 2.010123 |
umls:C0008525 | Choroideremia | 9 | 0.4090909 | 2.010123 |
umls:C0206731 | Angiofibroma | 9 | 0.4090909 | 2.010123 |
umls:C0268151 | Classical galactosemia | 9 | 0.4090909 | 2.010123 |
umls:C0750929 | Arnold-Chiari Malformation, Type I | 9 | 0.4090909 | 2.010123 |
umls:C0026896 | Myasthenia Gravis | 74 | 0.4088398 | 13.770068 |
umls:C0007282 | Carotid Stenosis | 47 | 0.4086957 | 8.853573 |
umls:C0006271 | Bronchiolitis | 20 | 0.4081633 | 3.981141 |
umls:C1842937 | AURAL ATRESIA, CONGENITAL | 20 | 0.4081633 | 3.981141 |
umls:C0079487 | Helicobacter Infections | 44 | 0.4074074 | 8.258140 |
umls:C1840264 | IMMUNE SUPPRESSION | 33 | 0.4074074 | 6.281833 |
umls:C0041318 | Tuberculosis, Meningeal | 11 | 0.4074074 | 2.357401 |
umls:C0162359 | Christ-Siemens-Touraine syndrome | 11 | 0.4074074 | 2.357401 |
umls:C0856825 | Acute GVH disease | 57 | 0.4071429 | 10.567659 |
umls:C0036202 | Sarcoidosis | 103 | 0.4071146 | 18.868512 |
umls:C1719672 | Severe Sepsis | 35 | 0.4069767 | 6.624197 |
umls:C0021841 | Intestinal Neoplasms | 59 | 0.4068966 | 10.922907 |
umls:C0920420 | cancer recurrence | 24 | 0.4067797 | 4.672886 |
umls:C0005818 | Blood Platelet Disorders | 13 | 0.4062500 | 2.705476 |
umls:C0017919 | Glycogen Storage Disease | 13 | 0.4062500 | 2.705476 |
umls:C0019270 | Hernia | 13 | 0.4062500 | 2.705476 |
umls:C1275126 | TNF receptor-associated periodic fever syndrome (TRAPS) | 13 | 0.4062500 | 2.705476 |
umls:C0220650 | Metastatic malignant neoplasm to brain | 54 | 0.4060150 | 9.970005 |
umls:C0694549 | Community acquired pneumonia | 15 | 0.4054054 | 3.059279 |
umls:C0085413 | Polycystic Kidney, Autosomal Dominant | 64 | 0.4050633 | 11.710508 |
umls:C0026936 | Mycoplasma Infections | 32 | 0.4050633 | 6.047724 |
umls:C0242231 | Coronary Stenosis | 32 | 0.4050633 | 6.047724 |
umls:C0013264 | Muscular Dystrophy, Duchenne | 49 | 0.4049587 | 9.047066 |
umls:C0014057 | Japanese Encephalitis | 17 | 0.4047619 | 3.404630 |
umls:C0037299 | Skin Ulcer | 17 | 0.4047619 | 3.404630 |
umls:C0011616 | Contact Dermatitis | 36 | 0.4044944 | 6.728719 |
umls:C0020433 | Hyperbilirubinemia | 19 | 0.4042553 | 3.746571 |
umls:C0023462 | Acute Megakaryocytic Leukemias | 42 | 0.4038462 | 7.770884 |
umls:C0149871 | Deep Vein Thrombosis | 42 | 0.4038462 | 7.770884 |
umls:C0026277 | Mixed Salivary Gland Tumor | 44 | 0.4036697 | 8.113623 |
umls:C0345905 | Intrahepatic Cholangiocarcinoma | 44 | 0.4036697 | 8.113623 |
umls:C0007133 | Carcinoma, Papillary | 94 | 0.4034335 | 16.969737 |
umls:C0206694 | Mucoepidermoid Carcinoma | 25 | 0.4032258 | 4.776499 |
umls:C0011065 | Cessation of life | 52 | 0.4031008 | 9.483267 |
umls:C1337013 | Differentiated Thyroid Gland Carcinoma | 54 | 0.4029851 | 9.827778 |
umls:C0206677 | Adenomatous Polyps | 29 | 0.4027778 | 5.464674 |
umls:C0340288 | Stable angina | 33 | 0.4024390 | 6.148841 |
umls:C0034069 | Pulmonary Fibrosis | 143 | 0.4016854 | 25.400474 |
umls:C0346957 | Disseminated Malignant Neoplasm | 65 | 0.4012346 | 11.675728 |
umls:C0026691 | Mucocutaneous Lymph Node Syndrome | 79 | 0.4010152 | 14.135464 |
umls:C0002895 | Anemia, Sickle Cell | 93 | 0.4008621 | 16.597814 |
umls:C0023443 | Hairy Cell Leukemia | 44 | 0.4000000 | 7.980640 |
umls:C1519680 | Tumor Immunity | 42 | 0.4000000 | 7.632469 |
umls:C0877373 | Advanced cancer | 40 | 0.4000000 | 7.284159 |
umls:C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 32 | 0.4000000 | 5.909680 |
umls:C0080032 | Pleural Effusion, Malignant | 30 | 0.4000000 | 5.565454 |
umls:C0036439 | Scoliosis, unspecified | 28 | 0.4000000 | 5.226047 |
umls:C0040137 | Thyroid Nodule | 26 | 0.4000000 | 4.875885 |
umls:C0036205 | Sarcoidosis, Pulmonary | 24 | 0.4000000 | 4.531103 |
umls:C0553694 | Oropharyngeal disorders | 18 | 0.4000000 | 3.508703 |
umls:C0085220 | Cerebral Amyloid Angiopathy | 16 | 0.4000000 | 3.165339 |
umls:C0155094 | Corneal pannus | 16 | 0.4000000 | 3.165339 |
umls:C0014378 | Enterovirus Infections | 14 | 0.4000000 | 2.819107 |
umls:C0156344 | Endometriosis of ovary | 14 | 0.4000000 | 2.819107 |
umls:C0700208 | Acquired scoliosis | 14 | 0.4000000 | 2.819107 |
umls:C0752125 | Spinocerebellar Ataxia Type 7 | 14 | 0.4000000 | 2.819107 |
umls:C0006277 | Bronchitis | 12 | 0.4000000 | 2.467466 |
umls:C0205969 | Thymic Carcinoma | 12 | 0.4000000 | 2.467466 |
umls:C0342208 | Multinodular goiter | 12 | 0.4000000 | 2.467466 |
umls:C0751587 | CADASIL Syndrome | 12 | 0.4000000 | 2.467466 |
umls:C1384584 | Generalized osteoarthritis | 12 | 0.4000000 | 2.467466 |
umls:C1567741 | Alport Syndrome | 12 | 0.4000000 | 2.467466 |
umls:C0003949 | Asbestosis | 10 | 0.4000000 | 2.119665 |
umls:C0011609 | Drug Eruptions | 10 | 0.4000000 | 2.119665 |
umls:C0206061 | Pneumonia, Interstitial | 10 | 0.4000000 | 2.119665 |
umls:C1562908 | Leprosy, Paucibacillary | 10 | 0.4000000 | 2.119665 |
umls:C0003496 | Aortic Rupture | 8 | 0.4000000 | 1.766054 |
umls:C0009766 | Allergic Conjunctivitis | 8 | 0.4000000 | 1.766054 |
umls:C0015644 | Muscular fasciculation | 8 | 0.4000000 | 1.766054 |
umls:C0017921 | Glycogen storage disease type II | 8 | 0.4000000 | 1.766054 |
umls:C0027086 | Myoma | 8 | 0.4000000 | 1.766054 |
umls:C0156259 | Hypertrophy of kidney | 8 | 0.4000000 | 1.766054 |
umls:C0272187 | Congenital leukocyte adherence deficiency | 8 | 0.4000000 | 1.766054 |
umls:C0349636 | Pre B-cell acute lymphoblastic leukemia | 8 | 0.4000000 | 1.766054 |
umls:C1334015 | High Grade Intraepithelial Neoplasia | 8 | 0.4000000 | 1.766054 |
umls:C0002938 | Aneuploidy | 6 | 0.4000000 | 1.411416 |
umls:C0007762 | Cerebellar Neoplasms | 6 | 0.4000000 | 1.411416 |
umls:C0009812 | Constitutional Symptom | 6 | 0.4000000 | 1.411416 |
umls:C0010691 | Cystinuria | 6 | 0.4000000 | 1.411416 |
umls:C0011436 | Dentinogenesis Imperfecta | 6 | 0.4000000 | 1.411416 |
umls:C0011649 | Dermoid Cyst | 6 | 0.4000000 | 1.411416 |
umls:C0022354 | Jaundice, Obstructive | 6 | 0.4000000 | 1.411416 |
umls:C0031036 | Polyarteritis Nodosa | 6 | 0.4000000 | 1.411416 |
umls:C0032768 | Postherpetic neuralgia | 6 | 0.4000000 | 1.411416 |
umls:C0086025 | Codependency | 6 | 0.4000000 | 1.411416 |
umls:C0149826 | Gastric adenoma | 6 | 0.4000000 | 1.411416 |
umls:C0178238 | Intestinal infectious disease (disorder) | 6 | 0.4000000 | 1.411416 |
umls:C0206674 | Adenoma, Villous | 6 | 0.4000000 | 1.411416 |
umls:C0266483 | Pachygyria | 6 | 0.4000000 | 1.411416 |
umls:C0278076 | Behavioral tic | 6 | 0.4000000 | 1.411416 |
umls:C0280253 | stage, gastric cancer | 6 | 0.4000000 | 1.411416 |
umls:C0349217 | Depressive episode, unspecified | 6 | 0.4000000 | 1.411416 |
umls:C0394006 | Dysequilibrium syndrome | 6 | 0.4000000 | 1.411416 |
umls:C0595995 | Idiopathic scoliosis | 6 | 0.4000000 | 1.411416 |
umls:C0699753 | Cancer Relapse | 6 | 0.4000000 | 1.411416 |
umls:C0740345 | Germ Cell Cancer | 6 | 0.4000000 | 1.411416 |
umls:C1335729 | Refractory Neoplasm | 6 | 0.4000000 | 1.411416 |
umls:C1956391 | Temporal Arteritis | 6 | 0.4000000 | 1.411416 |
umls:C3540852 | Rickets, X-Linked Hypophosphatemic | 6 | 0.4000000 | 1.411416 |
umls:C3642347 | Basal-Like Breast Carcinoma | 6 | 0.4000000 | 1.411416 |
umls:C3826457 | Diabetes in children | 6 | 0.4000000 | 1.411416 |
umls:C0027430 | Nasal Polyps | 89 | 0.3991031 | 15.732995 |
umls:C0027626 | Neoplasm Invasiveness | 67 | 0.3988095 | 11.879664 |
umls:C0030354 | Papilloma | 67 | 0.3988095 | 11.879664 |
umls:C0345967 | Malignant mesothelioma | 106 | 0.3984962 | 18.682382 |
umls:C0011875 | Diabetic Angiopathies | 35 | 0.3977273 | 6.352268 |
umls:C0042029 | Urinary tract infection | 35 | 0.3977273 | 6.352268 |
umls:C0079588 | Ichthyosis, X-Linked | 35 | 0.3977273 | 6.352268 |
umls:C0243038 | Carcinoma, Lewis Lung | 33 | 0.3975904 | 6.016944 |
umls:C0206704 | Carcinoma, Large Cell | 27 | 0.3970588 | 4.983595 |
umls:C0011311 | Dengue Fever | 71 | 0.3966480 | 12.452524 |
umls:C0028259 | Nodule | 46 | 0.3965517 | 8.191204 |
umls:C0221013 | Mastocytosis, Systemic | 23 | 0.3965517 | 4.292412 |
umls:C0031099 | Periodontitis | 107 | 0.3962963 | 18.661609 |
umls:C0035220 | Respiratory Distress Syndrome, Newborn | 21 | 0.3962264 | 3.952078 |
umls:C0265325 | Turcot syndrome (disorder) | 21 | 0.3962264 | 3.952078 |
umls:C0021051 | Immunologic Deficiency Syndromes | 169 | 0.3957845 | 29.116675 |
umls:C0206718 | Ganglioneuroblastoma | 17 | 0.3953488 | 3.269089 |
umls:C2945695 | Limb ischemia | 26 | 0.3939394 | 4.748497 |
umls:C0007286 | Carpal Tunnel Syndrome | 13 | 0.3939394 | 2.575273 |
umls:C0023646 | Lichen Planus | 13 | 0.3939394 | 2.575273 |
umls:C0038826 | Superinfection | 13 | 0.3939394 | 2.575273 |
umls:C0730362 | Disorder of macula of retina | 13 | 0.3939394 | 2.575273 |
umls:C0853662 | Oestrogen deficiency | 13 | 0.3939394 | 2.575273 |
umls:C1334811 | Mucinous Neoplasm | 13 | 0.3939394 | 2.575273 |
umls:C1853195 | Prostate Cancer, Hereditary, 7 | 13 | 0.3939394 | 2.575273 |
umls:C0014038 | Encephalitis | 50 | 0.3937008 | 8.758090 |
umls:C2919828 | Chronic ulcerative colitis | 37 | 0.3936170 | 6.566754 |
umls:C0035126 | Reperfusion Injury | 120 | 0.3934426 | 20.515393 |
umls:C1334177 | Infiltrating Cervical Carcinoma | 24 | 0.3934426 | 4.398493 |
umls:C0010709 | Cyst | 68 | 0.3930636 | 11.723897 |
umls:C0206687 | Carcinoma, Endometrioid | 44 | 0.3928571 | 7.710186 |
umls:C0001622 | Adrenal Gland Hyperfunction | 11 | 0.3928571 | 2.229025 |
umls:C0009663 | Condylomata Acuminata | 11 | 0.3928571 | 2.229025 |
umls:C0035328 | Retinal Vein Occlusion | 11 | 0.3928571 | 2.229025 |
umls:C2919945 | Cavernous Hemangioma of Brain | 11 | 0.3928571 | 2.229025 |
umls:C3536984 | Vitamin D-Resistant Rickets, X-Linked | 11 | 0.3928571 | 2.229025 |
umls:C0009447 | Common Variable Immunodeficiency | 51 | 0.3923077 | 8.863452 |
umls:C0085695 | Chronic gastritis | 29 | 0.3918919 | 5.198734 |
umls:C0086692 | Benign Neoplasm | 81 | 0.3913043 | 13.824162 |
umls:C0677055 | CARCINOMA OF VULVA | 18 | 0.3913043 | 3.379779 |
umls:C0003862 | Arthralgia | 9 | 0.3913043 | 1.881518 |
umls:C0279583 | T-cell childhood acute lymphoblastic leukemia | 9 | 0.3913043 | 1.881518 |
umls:C3549742 | Breast cancer, lobular | 9 | 0.3913043 | 1.881518 |
umls:C0016034 | Breast Fibrocystic Disease | 25 | 0.3906250 | 4.505463 |
umls:C0034494 | Rabies (disorder) | 16 | 0.3902439 | 3.034309 |
umls:C0598935 | Tumor Initiation | 71 | 0.3901099 | 12.044903 |
umls:C0027962 | Melanocytic nevus | 55 | 0.3900709 | 9.411207 |
umls:C0041327 | Tuberculosis, Pulmonary | 85 | 0.3899083 | 14.377332 |
umls:C0023474 | Leukemia, Myeloid, Chronic-Phase | 30 | 0.3896104 | 5.307846 |
umls:C0027121 | Myositis | 44 | 0.3893805 | 7.579347 |
umls:C1168327 | High-Grade Prostatic Intraepithelial Neoplasia | 35 | 0.3888889 | 6.094595 |
umls:C1846064 | Recurrent infections (sinusitis and bacterial pneumonia and meningitis) | 21 | 0.3888889 | 3.832540 |
umls:C1306214 | ACTH-Secreting Pituitary Adenoma | 14 | 0.3888889 | 2.681350 |
umls:C2674218 | SPHEROCYTOSIS, TYPE 1 (disorder) | 14 | 0.3888889 | 2.681350 |
umls:C0016952 | Galactosemias | 7 | 0.3888889 | 1.528192 |
umls:C0152451 | Chronic glomerulonephritis | 7 | 0.3888889 | 1.528192 |
umls:C0175699 | Saethre-Chotzen Syndrome | 7 | 0.3888889 | 1.528192 |
umls:C0206715 | Neoplasms, Neuroepithelial | 7 | 0.3888889 | 1.528192 |
umls:C0282513 | Primary Progressive Aphasia (disorder) | 7 | 0.3888889 | 1.528192 |
umls:C0518948 | Chlamydia trachomatis infection | 7 | 0.3888889 | 1.528192 |
umls:C0730607 | Severe chronic obstructive pulmonary disease | 7 | 0.3888889 | 1.528192 |
umls:C1334978 | Non-Hereditary Clear Cell Renal Cell Carcinoma | 7 | 0.3888889 | 1.528192 |
umls:C1801959 | Histiocytic medullary reticulosis (disorder) | 7 | 0.3888889 | 1.528192 |
umls:C3273239 | Proliferative Inflammatory Atrophy | 7 | 0.3888889 | 1.528192 |
umls:C0333516 | Tumor necrosis | 66 | 0.3882353 | 11.116662 |
umls:C0043194 | Wiskott-Aldrich Syndrome | 26 | 0.3880597 | 4.617758 |
umls:C0858252 | Breast adenocarcinoma | 45 | 0.3879310 | 7.688438 |
umls:C0023343 | Leprosy | 64 | 0.3878788 | 10.776811 |
umls:C0024535 | Malaria, Falciparum | 57 | 0.3877551 | 9.615858 |
umls:C0004779 | Basal Cell Nevus Syndrome | 19 | 0.3877551 | 3.489294 |
umls:C0349632 | Splenic Marginal Zone B-Cell Lymphoma | 19 | 0.3877551 | 3.489294 |
umls:C1527311 | Brain Edema | 19 | 0.3877551 | 3.489294 |
umls:C0023893 | Liver Cirrhosis, Experimental | 74 | 0.3874346 | 12.378911 |
umls:C0025007 | Measles | 60 | 0.3870968 | 10.069672 |
umls:C0020258 | Hydrocephalus, Normal Pressure | 12 | 0.3870968 | 2.339476 |
umls:C0158570 | Vascular anomaly | 12 | 0.3870968 | 2.339476 |
umls:C0149521 | Pancreatitis, Chronic | 113 | 0.3869863 | 18.772721 |
umls:C0940937 | precancerous lesions | 41 | 0.3867925 | 6.990337 |
umls:C0269102 | Endometrioma | 29 | 0.3866667 | 5.068208 |
umls:C0036690 | Septicemia | 148 | 0.3864230 | 24.394880 |
umls:C0333186 | Restenosis | 85 | 0.3863636 | 14.122232 |
umls:C0878500 | Intraepithelial Neoplasia | 51 | 0.3863636 | 8.608179 |
umls:C0520459 | Necrotizing Enterocolitis | 34 | 0.3863636 | 5.863610 |
umls:C0003504 | Aortic Valve Insufficiency | 17 | 0.3863636 | 3.144615 |
umls:C0266449 | Congenital anomaly of brain | 17 | 0.3863636 | 3.144615 |
umls:C1298180 | Single tumor | 17 | 0.3863636 | 3.144615 |
umls:C0039538 | Teratoma | 39 | 0.3861386 | 6.647066 |
umls:C0023281 | Leishmaniasis | 22 | 0.3859649 | 3.931916 |
umls:C0555198 | Malignant Glioma | 159 | 0.3859223 | 26.043409 |
umls:C0006840 | Candidiasis | 32 | 0.3855422 | 5.519971 |
umls:C0013537 | Eclampsia | 69 | 0.3854749 | 11.440419 |
umls:C1704436 | Peripheral Arterial Diseases | 37 | 0.3854167 | 6.307182 |
umls:C2931852 | Clear-cell metastatic renal cell carcinoma | 42 | 0.3853211 | 7.101357 |
umls:C0040128 | Thyroid Diseases | 47 | 0.3852459 | 7.907399 |
umls:C0010823 | Cytomegalovirus Infections | 67 | 0.3850575 | 11.098780 |
umls:C2609414 | Acute kidney injury | 45 | 0.3846154 | 7.559883 |
umls:C0043119 | Werner Syndrome | 30 | 0.3846154 | 5.179754 |
umls:C0018378 | Guillain-Barre Syndrome | 20 | 0.3846154 | 3.598164 |
umls:C0393819 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 20 | 0.3846154 | 3.598164 |
umls:C0001849 | AIDS Dementia Complex | 15 | 0.3846154 | 2.799912 |
umls:C2981142 | Refractory anemia, without ringed sideroblasts, without excess blasts | 15 | 0.3846154 | 2.799912 |
umls:C0018922 | hemangiopericytoma | 10 | 0.3846154 | 1.994504 |
umls:C0033817 | Pseudomonas Infections | 10 | 0.3846154 | 1.994504 |
umls:C0037090 | Signs and Symptoms, Respiratory | 10 | 0.3846154 | 1.994504 |
umls:C0346402 | Malignant neoplasm of adrenal cortex | 10 | 0.3846154 | 1.994504 |
umls:C0409979 | Neonatal Systemic lupus erythematosus | 10 | 0.3846154 | 1.994504 |
umls:C0428791 | Aortic valve calcification | 10 | 0.3846154 | 1.994504 |
umls:C1279296 | Chronic leukemia (category) | 10 | 0.3846154 | 1.994504 |
umls:C1837249 | Malformations of Cortical Development, Group II | 10 | 0.3846154 | 1.994504 |
umls:C0155626 | Acute myocardial infarction | 91 | 0.3839662 | 14.897972 |
umls:C0040100 | Thymoma | 66 | 0.3837209 | 10.871981 |
umls:C0238790 | bone destruction | 33 | 0.3837209 | 5.628198 |
umls:C0032964 | Pregnancy Complications, Hematologic | 51 | 0.3834586 | 8.479682 |
umls:C0238463 | Papillary thyroid carcinoma | 171 | 0.3834081 | 27.632958 |
umls:C0013371 | Shigella Infections | 23 | 0.3833333 | 4.040348 |
umls:C1290884 | Inflammatory disorder | 90 | 0.3829787 | 14.659951 |
umls:C1512981 | Mammary Tumorigenesis | 54 | 0.3829787 | 8.935048 |
umls:C0007129 | Merkel cell carcinoma | 36 | 0.3829787 | 6.080297 |
umls:C0018995 | Hemochromatosis | 36 | 0.3829787 | 6.080297 |
umls:C0206681 | Adenocarcinoma, Clear Cell | 36 | 0.3829787 | 6.080297 |
umls:C0268731 | Renal glomerular disease | 36 | 0.3829787 | 6.080297 |
umls:C0035305 | Retinal Detachment | 18 | 0.3829787 | 3.251979 |
umls:C0432408 | Trisomy 12 | 18 | 0.3829787 | 3.251979 |
umls:C0009782 | Connective Tissue Diseases | 75 | 0.3826531 | 12.237486 |
umls:C0409959 | Osteoarthritis, Knee | 44 | 0.3826087 | 7.321803 |
umls:C0206368 | Exfoliation Syndrome | 13 | 0.3823529 | 2.451146 |
umls:C0007095 | Carcinoid Tumor | 68 | 0.3820225 | 11.086348 |
umls:C1997217 | Low grade glioma | 21 | 0.3818182 | 3.702700 |
umls:C3714636 | Pneumonitis | 21 | 0.3818182 | 3.702700 |
umls:C0750952 | Biliary Tract Cancer | 37 | 0.3814433 | 6.182851 |
umls:C0020542 | Pulmonary Hypertension | 127 | 0.3813814 | 20.413304 |
umls:C0242723 | Parasitemia | 32 | 0.3809524 | 5.400679 |
umls:C0023348 | Leprosy, Lepromatous | 16 | 0.3809524 | 2.907547 |
umls:C0017181 | Gastrointestinal Hemorrhage | 8 | 0.3809524 | 1.641404 |
umls:C0037023 | Sialadenitis | 8 | 0.3809524 | 1.641404 |
umls:C0042076 | Urologic Neoplasms | 8 | 0.3809524 | 1.641404 |
umls:C0333355 | Inflammatory disease of mucous membrane | 8 | 0.3809524 | 1.641404 |
umls:C0334520 | Teratoma, Malignant | 8 | 0.3809524 | 1.641404 |
umls:C0521857 | Increased drug resistance | 8 | 0.3809524 | 1.641404 |
umls:C0855073 | Undifferentiated (Embryonal) Sarcoma | 8 | 0.3809524 | 1.641404 |
umls:C3146257 | Stage II Colon Cancer AJCC v7 | 8 | 0.3809524 | 1.641404 |
umls:C3536983 | Familial Hypophosphatemic Rickets | 8 | 0.3809524 | 1.641404 |
umls:C0206701 | Cystadenocarcinoma, Serous | 35 | 0.3804348 | 5.847750 |
umls:C0032580 | Adenomatous Polyposis Coli | 149 | 0.3801020 | 23.795887 |
umls:C0040028 | Thrombocythemia, Essential | 57 | 0.3800000 | 9.250706 |
umls:C0023787 | Lipodystrophy | 38 | 0.3800000 | 6.292765 |
umls:C0280217 | stage, non-small cell lung cancer | 19 | 0.3800000 | 3.367692 |
umls:C0729233 | Dissecting aneurysm of the thoracic aorta | 66 | 0.3793103 | 10.616206 |
umls:C0019340 | Herpes NOS | 33 | 0.3793103 | 5.506550 |
umls:C0042109 | Urticaria | 33 | 0.3793103 | 5.506550 |
umls:C0027659 | Neoplasms, Experimental | 22 | 0.3793103 | 3.817999 |
umls:C0920350 | Autoimmune thyroiditis | 22 | 0.3793103 | 3.817999 |
umls:C0015814 | Femur Head Necrosis | 11 | 0.3793103 | 2.108270 |
umls:C0040715 | Chromosomal translocation | 11 | 0.3793103 | 2.108270 |
umls:C0086438 | Hypogammaglobulinemia | 11 | 0.3793103 | 2.108270 |
umls:C0221406 | Pituitary-dependent Cushing’s disease | 11 | 0.3793103 | 2.108270 |
umls:C0432474 | Klinefelter’s syndrome - male with more than two X chromosomes | 11 | 0.3793103 | 2.108270 |
umls:C0744310 | gastritis h pylori | 11 | 0.3793103 | 2.108270 |
umls:C0010278 | Craniosynostosis | 47 | 0.3790323 | 7.657727 |
umls:C1800706 | Idiopathic Pulmonary Fibrosis | 128 | 0.3786982 | 20.296851 |
umls:C0001314 | Acute Disease | 14 | 0.3783784 | 2.564283 |
umls:C0036117 | Salmonella infections | 14 | 0.3783784 | 2.564283 |
umls:C0036429 | Sclerosis | 14 | 0.3783784 | 2.564283 |
umls:C0740302 | 5q-syndrome | 14 | 0.3783784 | 2.564283 |
umls:C0003872 | Arthritis, Psoriatic | 73 | 0.3782383 | 11.636749 |
umls:C1333990 | Hereditary Nonpolyposis Colorectal Cancer | 45 | 0.3781513 | 7.309790 |
umls:C0002986 | Fabry Disease | 17 | 0.3777778 | 3.022169 |
umls:C0206716 | Ganglioglioma | 17 | 0.3777778 | 3.022169 |
umls:C0333983 | Hyperplastic Polyp | 37 | 0.3775510 | 6.068165 |
umls:C0242852 | Proliferative vitreoretinopathy | 23 | 0.3770492 | 3.921981 |
umls:C0948216 | Ovarian adenocarcinoma | 23 | 0.3770492 | 3.921981 |
umls:C0031090 | Periodontal Diseases | 49 | 0.3769231 | 7.878864 |
umls:C0238190 | Inclusion Body Myositis (disorder) | 26 | 0.3768116 | 4.373010 |
umls:C0334108 | Multiple polyps | 26 | 0.3768116 | 4.373010 |
umls:C0333641 | Atrophic | 29 | 0.3766234 | 4.821134 |
umls:C0685938 | Malignant neoplasm of gastrointestinal tract | 88 | 0.3760684 | 13.835748 |
umls:C0025500 | Mesothelioma | 143 | 0.3753281 | 22.243217 |
umls:C0007113 | Rectal Carcinoma | 105 | 0.3750000 | 16.368289 |
umls:C0338106 | Adenocarcinoma of colon | 90 | 0.3750000 | 14.064699 |
umls:C0036220 | Kaposi Sarcoma | 69 | 0.3750000 | 10.834663 |
umls:C0020517 | Hypersensitivity | 60 | 0.3750000 | 9.458113 |
umls:C0017185 | Gastrointestinal Neoplasms | 45 | 0.3750000 | 7.186087 |
umls:C0334583 | Pilocytic Astrocytoma | 33 | 0.3750000 | 5.390817 |
umls:C0041948 | Uremia | 27 | 0.3750000 | 4.476677 |
umls:C3495801 | Granulomatosis with polyangiitis | 24 | 0.3750000 | 4.030582 |
umls:C0018553 | Hamartoma Syndrome, Multiple | 21 | 0.3750000 | 3.590404 |
umls:C0206669 | Hepatocellular Adenoma | 18 | 0.3750000 | 3.136785 |
umls:C0948480 | Coronary Restenosis | 18 | 0.3750000 | 3.136785 |
umls:C0023486 | Prolymphocytic Leukemia | 15 | 0.3750000 | 2.673781 |
umls:C0037889 | Hereditary spherocytosis | 15 | 0.3750000 | 2.673781 |
umls:C0346627 | Intestinal Cancer | 15 | 0.3750000 | 2.673781 |
umls:C0017150 | Gastrinoma | 12 | 0.3750000 | 2.221825 |
umls:C0339543 | Epiretinal Membrane | 12 | 0.3750000 | 2.221825 |
umls:C1279481 | X-Linked Combined Immunodeficiency Diseases | 12 | 0.3750000 | 2.221825 |
umls:C1519176 | Salivary Gland Pleomorphic Adenoma | 12 | 0.3750000 | 2.221825 |
umls:C0007771 | Intracranial Arteriosclerosis | 9 | 0.3750000 | 1.758727 |
umls:C0282666 | Very Low Birth Weight | 9 | 0.3750000 | 1.758727 |
umls:C0751783 | Lafora Disease | 9 | 0.3750000 | 1.758727 |
umls:C1275808 | Congenital central hypoventilation | 9 | 0.3750000 | 1.758727 |
umls:C3714644 | Thymus Neoplasms | 9 | 0.3750000 | 1.758727 |
umls:C0041341 | Tuberous Sclerosis | 67 | 0.3743017 | 10.481589 |
umls:C0010692 | Cystitis | 37 | 0.3737374 | 5.946697 |
umls:C0011334 | Dental caries | 34 | 0.3736264 | 5.497947 |
umls:C0375023 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 96 | 0.3735409 | 14.847918 |
umls:C0677898 | invasive cancer | 56 | 0.3733333 | 8.786259 |
umls:C0035344 | Retinopathy of Prematurity | 25 | 0.3731343 | 4.139867 |
umls:C2945759 | aggressive cancer | 25 | 0.3731343 | 4.139867 |
umls:C0042373 | Vascular Diseases | 147 | 0.3730964 | 22.538469 |
umls:C1449563 | Cardiomyopathy, Familial Idiopathic | 69 | 0.3729730 | 10.708671 |
umls:C0008677 | Bronchitis, Chronic | 22 | 0.3728814 | 3.695369 |
umls:C0027720 | Nephrosis | 19 | 0.3725490 | 3.248668 |
umls:C0086445 | Idiopathic Membranous Glomerulonephritis | 19 | 0.3725490 | 3.248668 |
umls:C0238462 | Medullary carcinoma of thyroid | 73 | 0.3724490 | 11.273902 |
umls:C0836924 | Thrombocytosis | 35 | 0.3723404 | 5.608294 |
umls:C1134719 | Invasive Ductal Breast Carcinoma | 86 | 0.3722944 | 13.242772 |
umls:C0008354 | Cholera | 32 | 0.3720930 | 5.158196 |
umls:C1519666 | Tumor-Associated Vasculature | 16 | 0.3720930 | 2.793159 |
umls:C1654637 | androgen independent prostate cancer | 58 | 0.3717949 | 9.008104 |
umls:C0023267 | Fibroid Tumor | 117 | 0.3714286 | 17.868558 |
umls:C0039101 | synovial sarcoma | 65 | 0.3714286 | 10.012322 |
umls:C0221355 | Macrocephaly | 13 | 0.3714286 | 2.334383 |
umls:C0342200 | Endemic Cretinism | 13 | 0.3714286 | 2.334383 |
umls:C0279680 | Transitional cell carcinoma of bladder | 43 | 0.3706897 | 6.728719 |
umls:C0003130 | Anoxia | 123 | 0.3704819 | 18.682382 |
umls:C1861172 | Venous Thromboembolism | 50 | 0.3703704 | 7.754962 |
umls:C0392514 | Hereditary hemochromatosis | 30 | 0.3703704 | 4.815406 |
umls:C1328504 | Hormone refractory prostate cancer | 30 | 0.3703704 | 4.815406 |
umls:C0086981 | Sicca Syndrome | 20 | 0.3703704 | 3.364331 |
umls:C0558353 | Tongue Carcinoma | 20 | 0.3703704 | 3.364331 |
umls:C0024205 | Lymphadenitis | 10 | 0.3703704 | 1.878395 |
umls:C0266463 | Lissencephaly | 10 | 0.3703704 | 1.878395 |
umls:C1302790 | Congenital malformation syndrome | 10 | 0.3703704 | 1.878395 |
umls:C2363142 | T-Cell Prolymphocytic Leukemia | 10 | 0.3703704 | 1.878395 |
umls:C0011603 | Dermatitis | 62 | 0.3690476 | 9.448477 |
umls:C0026850 | Muscular Dystrophy | 83 | 0.3688889 | 12.531623 |
umls:C0026470 | Monoclonal Gammopathy of Undetermined Significance | 52 | 0.3687943 | 7.980640 |
umls:C0022593 | Keratosis | 14 | 0.3684211 | 2.449453 |
umls:C0037928 | Spinal Cord Diseases | 14 | 0.3684211 | 2.449453 |
umls:C0085090 | Lymphoma, AIDS-Related | 14 | 0.3684211 | 2.449453 |
umls:C0852036 | Pregnancy associated hypertension | 14 | 0.3684211 | 2.449453 |
umls:C1292779 | Myelodysplastic Syndrome with Isolated del(5q) | 14 | 0.3684211 | 2.449453 |
umls:C1802398 | Chromosome 5, trisomy 5q | 14 | 0.3684211 | 2.449453 |
umls:C2936858 | Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | 14 | 0.3684211 | 2.449453 |
umls:C0007965 | Chediak-Higashi Syndrome | 7 | 0.3684211 | 1.411416 |
umls:C0010246 | Coxsackievirus Infections | 7 | 0.3684211 | 1.411416 |
umls:C0014118 | Endocarditis | 7 | 0.3684211 | 1.411416 |
umls:C0014356 | Enterocolitis | 7 | 0.3684211 | 1.411416 |
umls:C0019214 | Hepatosplenomegaly | 7 | 0.3684211 | 1.411416 |
umls:C0019243 | Angioedemas, Hereditary | 7 | 0.3684211 | 1.411416 |
umls:C0023522 | Leukodystrophy, Metachromatic | 7 | 0.3684211 | 1.411416 |
umls:C0085652 | Pyoderma Gangrenosum | 7 | 0.3684211 | 1.411416 |
umls:C0149725 | Lower respiratory tract infection | 7 | 0.3684211 | 1.411416 |
umls:C0162836 | Hidradenitis Suppurativa | 7 | 0.3684211 | 1.411416 |
umls:C0206658 | Smooth Muscle Tumor | 7 | 0.3684211 | 1.411416 |
umls:C0272236 | Hyperimmunoglobulin M syndrome | 7 | 0.3684211 | 1.411416 |
umls:C0948441 | Venoocclusive disease | 7 | 0.3684211 | 1.411416 |
umls:C0275524 | Coinfection | 53 | 0.3680556 | 8.091422 |
umls:C0409974 | Lupus Erythematosus | 131 | 0.3679775 | 19.577323 |
umls:C0001403 | Addison Disease | 18 | 0.3673469 | 3.021195 |
umls:C0349459 | Cervical intraepithelial neoplasia grade 2 | 18 | 0.3673469 | 3.021195 |
umls:C0684275 | Hemophilia, NOS | 18 | 0.3673469 | 3.021195 |
umls:C0024115 | Lung diseases | 131 | 0.3669468 | 19.462938 |
umls:C0339143 | Thyroid associated opthalmopathies | 33 | 0.3666667 | 5.157026 |
umls:C0008055 | Chikungunya Fever | 11 | 0.3666667 | 1.994504 |
umls:C0026267 | Mitral Valve Prolapse Syndrome | 11 | 0.3666667 | 1.994504 |
umls:C0027149 | Myxoma | 11 | 0.3666667 | 1.994504 |
umls:C0398689 | Hyper-IgM Immunodeficiency Syndrome, Type 1 | 11 | 0.3666667 | 1.994504 |
umls:C1333782 | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 11 | 0.3666667 | 1.994504 |
umls:C1851585 | MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA | 11 | 0.3666667 | 1.994504 |
umls:C2717865 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 11 | 0.3666667 | 1.994504 |
umls:C2986703 | Overgrowth Syndrome | 11 | 0.3666667 | 1.994504 |
umls:C0206698 | Cholangiocarcinoma | 146 | 0.3659148 | 21.504345 |
umls:C0013990 | Pathological accumulation of air in tissues | 15 | 0.3658537 | 2.563665 |
umls:C0024302 | Reticulosarcoma | 15 | 0.3658537 | 2.563665 |
umls:C0686377 | CNS metastases | 15 | 0.3658537 | 2.563665 |
umls:C3714757 | Juvenile rheumatoid arthritis | 68 | 0.3655914 | 10.116907 |
umls:C0000786 | Spontaneous abortion | 91 | 0.3654618 | 13.459072 |
umls:C0993582 | Arthritis, Experimental | 61 | 0.3652695 | 9.109619 |
umls:C0023480 | Leukemia, Myelomonocytic, Chronic | 42 | 0.3652174 | 6.382602 |
umls:C0018889 | Helminthiasis | 23 | 0.3650794 | 3.694009 |
umls:C0023465 | Acute monocytic leukemia | 27 | 0.3648649 | 4.248934 |
umls:C0024312 | Lymphopenia | 27 | 0.3648649 | 4.248934 |
umls:C0162557 | Liver Failure, Acute | 43 | 0.3644068 | 6.497832 |
umls:C0220633 | Uveal melanoma | 75 | 0.3640777 | 11.044087 |
umls:C0850666 | Helicobacter pylori infection | 108 | 0.3636364 | 15.740242 |
umls:C0026857 | Musculoskeletal Diseases | 48 | 0.3636364 | 7.178337 |
umls:C0752308 | Hypoxia-Ischemia, Brain | 24 | 0.3636364 | 3.811057 |
umls:C0015393 | Eye Abnormalities | 16 | 0.3636364 | 2.673781 |
umls:C0028840 | Ocular Hypertension | 16 | 0.3636364 | 2.673781 |
umls:C0162739 | HELLP Syndrome | 16 | 0.3636364 | 2.673781 |
umls:C0559260 | Congenital scoliosis | 16 | 0.3636364 | 2.673781 |
umls:C0013170 | Drug habituation | 8 | 0.3636364 | 1.529922 |
umls:C0155733 | Atherosclerosis of aorta | 8 | 0.3636364 | 1.529922 |
umls:C0278479 | Stage II Colon Cancer | 8 | 0.3636364 | 1.529922 |
umls:C0281267 | bilateral breast cancer | 8 | 0.3636364 | 1.529922 |
umls:C0392788 | Nasal Type Extranodal NK/T-Cell Lymphoma | 8 | 0.3636364 | 1.529922 |
umls:C0850639 | premalignant lesion | 8 | 0.3636364 | 1.529922 |
umls:C1856689 | FRIEDREICH ATAXIA 1 | 8 | 0.3636364 | 1.529922 |
umls:C3839280 | High grade serous carcinoma | 8 | 0.3636364 | 1.529922 |
umls:C0018213 | Graves Disease | 129 | 0.3633803 | 18.772721 |
umls:C0011884 | Diabetic Retinopathy | 81 | 0.3632287 | 11.836850 |
umls:C0001815 | Primary Myelofibrosis | 65 | 0.3631285 | 9.546776 |
umls:C0018133 | Graft-vs-Host Disease | 115 | 0.3627760 | 16.685004 |
umls:C0003507 | Aortic Valve Stenosis | 33 | 0.3626374 | 5.039733 |
umls:C0008312 | Primary biliary cirrhosis | 95 | 0.3625954 | 13.823396 |
umls:C0029882 | Otitis Media | 29 | 0.3625000 | 4.472419 |
umls:C0278484 | Malignant neoplasm of colon stage IV | 25 | 0.3623188 | 3.918262 |
umls:C1397307 | Cardiac fibrosis | 25 | 0.3623188 | 3.918262 |
umls:C1535939 | Pneumocystis jiroveci pneumonia | 25 | 0.3623188 | 3.918262 |
umls:C0006145 | Breast Diseases | 21 | 0.3620690 | 3.364583 |
umls:C0085166 | Bacterial Vaginosis | 17 | 0.3617021 | 2.794752 |
umls:C0008487 | Chordoma | 30 | 0.3614458 | 4.590535 |
umls:C0333875 | High-Grade Squamous Intraepithelial Lesions | 30 | 0.3614458 | 4.590535 |
umls:C0341439 | Chronic liver disease | 52 | 0.3611111 | 7.636315 |
umls:C0279565 | Invasive Lobular Breast Carcinoma | 13 | 0.3611111 | 2.223431 |
umls:C0340068 | Aspirin-sensitive asthma with nasal polyps | 13 | 0.3611111 | 2.223431 |
umls:C1301034 | Pancreatic intraepithelial neoplasia | 22 | 0.3606557 | 3.474237 |
umls:C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 93 | 0.3604651 | 13.357993 |
umls:C0022602 | Actinic keratosis | 31 | 0.3604651 | 4.706248 |
umls:C3495559 | Juvenile arthritis | 120 | 0.3603604 | 17.157372 |
umls:C1527336 | Sjogren’s Syndrome | 49 | 0.3602941 | 7.179454 |
umls:C0032463 | Polycythemia Vera | 67 | 0.3602151 | 9.664521 |
umls:C0007789 | Cerebral Palsy | 27 | 0.3600000 | 4.139867 |
umls:C0263641 | Epithelial hyperplasia of skin | 18 | 0.3600000 | 2.905759 |
umls:C0027666 | Neoplasms, Radiation-Induced | 9 | 0.3600000 | 1.645240 |
umls:C0037221 | Situs Inversus | 9 | 0.3600000 | 1.645240 |
umls:C1276146 | Cutaneous lymphoma | 9 | 0.3600000 | 1.645240 |
umls:C1567435 | Polycystic Kidney - body part | 9 | 0.3600000 | 1.645240 |
umls:C1609538 | Latent Tuberculosis | 9 | 0.3600000 | 1.645240 |
umls:C0014072 | Experimental Autoimmune Encephalomyelitis | 140 | 0.3598972 | 19.906090 |
umls:C0024198 | Lyme Disease | 50 | 0.3597122 | 7.293560 |
umls:C0024143 | Lupus Nephritis | 78 | 0.3594470 | 11.157055 |
umls:C0205748 | Dysplastic Nevus | 23 | 0.3593750 | 3.590404 |
umls:C0206726 | gliosarcoma | 23 | 0.3593750 | 3.590404 |
umls:C2986665 | Early-Stage Breast Carcinoma | 23 | 0.3593750 | 3.590404 |
umls:C0032227 | Pleural effusion disorder | 37 | 0.3592233 | 5.496359 |
umls:C0020523 | Immediate hypersensitivity | 42 | 0.3589744 | 6.166802 |
umls:C1519670 | Tumor Angiogenesis | 159 | 0.3589165 | 22.457975 |
umls:C0085129 | Bronchial Hyperreactivity | 61 | 0.3588235 | 8.784799 |
umls:C1175175 | Severe Acute Respiratory Syndrome | 33 | 0.3586957 | 4.930318 |
umls:C2145472 | Urothelial Carcinoma | 71 | 0.3585859 | 10.121416 |
umls:C0024131 | Lupus Vulgaris | 110 | 0.3583062 | 15.550957 |
umls:C0005779 | Blood Coagulation Disorders | 48 | 0.3582090 | 6.956623 |
umls:C0027726 | Nephrotic Syndrome | 63 | 0.3579545 | 9.008104 |
umls:C0032000 | Pituitary Adenoma | 98 | 0.3576642 | 13.828889 |
umls:C0015929 | Fetal Diseases | 54 | 0.3576159 | 7.756113 |
umls:C2936349 | Plaque, Amyloid | 74 | 0.3574879 | 10.478126 |
umls:C0007114 | Malignant neoplasm of skin | 79 | 0.3574661 | 11.159884 |
umls:C0936223 | Metastatic Prostate Carcinoma | 80 | 0.3571429 | 11.273902 |
umls:C0876973 | Infectious disease of lung | 25 | 0.3571429 | 3.815704 |
umls:C0024899 | Mastocytosis | 20 | 0.3571429 | 3.138656 |
umls:C0035242 | Respiratory Tract Diseases | 20 | 0.3571429 | 3.138656 |
umls:C0206692 | Carcinoma, Lobular | 20 | 0.3571429 | 3.138656 |
umls:C0029401 | Osteitis Deformans | 15 | 0.3571429 | 2.453492 |
umls:C0041834 | Erythema | 15 | 0.3571429 | 2.453492 |
umls:C0013404 | Dyspnea | 10 | 0.3571429 | 1.766054 |
umls:C0013502 | Echinococcosis | 10 | 0.3571429 | 1.766054 |
umls:C0032231 | Pleurisy | 10 | 0.3571429 | 1.766054 |
umls:C0035690 | RNA Virus Infections | 10 | 0.3571429 | 1.766054 |
umls:C2825306 | Treatment related leukaemia | 10 | 0.3571429 | 1.766054 |
umls:C0017563 | Gingival Diseases | 36 | 0.3564356 | 5.276523 |
umls:C0349782 | Ischemic cardiomyopathy | 26 | 0.3561644 | 3.921981 |
umls:C0029445 | Bone necrosis | 16 | 0.3555556 | 2.569076 |
umls:C0085548 | Autosomal Recessive Polycystic Kidney Disease | 16 | 0.3555556 | 2.569076 |
umls:C0677607 | Hashimoto Disease | 43 | 0.3553719 | 6.172193 |
umls:C0235833 | Congenital diaphragmatic hernia | 27 | 0.3552632 | 4.033526 |
umls:C0010606 | Adenoid Cystic Carcinoma | 71 | 0.3550000 | 9.907623 |
umls:C0867389 | Chronic graft-versus-host disease | 33 | 0.3548387 | 4.821362 |
umls:C0278987 | Non-small cell lung cancer metastatic | 11 | 0.3548387 | 1.882015 |
umls:C0558356 | Malignant melanoma of eye | 11 | 0.3548387 | 1.882015 |
umls:C0850803 | Anaphylaxis (non medication) | 11 | 0.3548387 | 1.882015 |
umls:C1623038 | Cirrhosis | 138 | 0.3547558 | 19.022568 |
umls:C0014170 | Endometrial Neoplasms | 94 | 0.3547170 | 13.023418 |
umls:C0376618 | Endotoxemia | 34 | 0.3541667 | 4.935126 |
umls:C0010308 | Congenital Hypothyroidism | 17 | 0.3541667 | 2.680082 |
umls:C0035412 | Rhabdomyosarcoma | 131 | 0.3540541 | 18.024214 |
umls:C0494165 | Secondary malignant neoplasm of liver | 160 | 0.3539823 | 21.940598 |
umls:C0027022 | Myeloproliferative disease | 86 | 0.3539095 | 11.855256 |
umls:C0948089 | Acute Coronary Syndrome | 109 | 0.3538961 | 14.981600 |
umls:C0887833 | Carcinoma, Pancreatic Ductal | 23 | 0.3538462 | 3.481859 |
umls:C0039614 | Tetanus | 29 | 0.3536585 | 4.259087 |
umls:C0026987 | Myelofibrosis | 35 | 0.3535354 | 5.051005 |
umls:C1527390 | Neoplasms, Intracranial | 24 | 0.3529412 | 3.596307 |
umls:C0021345 | Infectious Mononucleosis | 12 | 0.3529412 | 2.001589 |
umls:C0343192 | Microscopic Polyangiitis | 12 | 0.3529412 | 2.001589 |
umls:C0751383 | Juvenile Neuronal Ceroid Lipofuscinosis | 12 | 0.3529412 | 2.001589 |
umls:C1292780 | Therapy-related myelodysplastic syndrome | 12 | 0.3529412 | 2.001589 |
umls:C1621958 | Glioblastoma Multiforme | 153 | 0.3525346 | 20.763504 |
umls:C0079774 | Peripheral T-Cell Lymphoma | 43 | 0.3524590 | 6.069876 |
umls:C0035222 | Respiratory Distress Syndrome, Adult | 50 | 0.3521127 | 6.965006 |
umls:C0007120 | Bronchioloalveolar Adenocarcinoma | 25 | 0.3521127 | 3.704072 |
umls:C0014173 | Endometrial Hyperplasia | 19 | 0.3518519 | 2.915234 |
umls:C0750974 | Brain Tumor, Primary | 19 | 0.3518519 | 2.915234 |
umls:C0239946 | Fibrosis, Liver | 115 | 0.3516820 | 15.578694 |
umls:C0011633 | Dermatomyositis | 39 | 0.3513514 | 5.508051 |
umls:C0001857 | AIDS related complex | 13 | 0.3513514 | 2.119665 |
umls:C0027721 | Lipoid nephrosis | 13 | 0.3513514 | 2.119665 |
umls:C0852654 | 21-hydroxylase deficiency | 13 | 0.3513514 | 2.119665 |
umls:C1334699 | Mesenchymal Cell Neoplasm | 13 | 0.3513514 | 2.119665 |
umls:C0024138 | Lupus Erythematosus, Discoid | 111 | 0.3512658 | 14.998028 |
umls:C0153452 | Malignant neoplasm of gallbladder | 59 | 0.3511905 | 8.113623 |
umls:C0035235 | Respiratory Syncytial Virus Infections | 105 | 0.3511706 | 14.204427 |
umls:C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 66 | 0.3510638 | 9.028288 |
umls:C0007115 | Malignant neoplasm of thyroid | 159 | 0.3509934 | 21.404558 |
umls:C0343641 | Human papilloma virus infection | 20 | 0.3508772 | 3.032970 |
umls:C1290886 | Chronic inflammatory disorder | 27 | 0.3506494 | 3.930300 |
umls:C0017612 | Glaucoma, Open-Angle | 34 | 0.3505155 | 4.830976 |
umls:C0812413 | Malignant Pleural Mesothelioma | 84 | 0.3500000 | 11.302281 |
umls:C0032285 | Pneumonia | 141 | 0.3498759 | 18.859557 |
umls:C0018939 | Hematological Disease | 50 | 0.3496503 | 6.868983 |
umls:C1306759 | Eosinophilic disorder | 50 | 0.3496503 | 6.868983 |
umls:C0241910 | Hepatitis, Autoimmune | 43 | 0.3495935 | 5.963502 |
umls:C0281361 | Adenocarcinoma of pancreas | 108 | 0.3495146 | 14.440166 |
umls:C0019189 | Hepatitis, Chronic | 66 | 0.3492063 | 8.933504 |
umls:C0033774 | Pruritus | 22 | 0.3492063 | 3.260076 |
umls:C0014457 | Eosinophilia | 52 | 0.3489933 | 7.092965 |
umls:C0235782 | Gallbladder Carcinoma | 67 | 0.3489583 | 9.036908 |
umls:C0279671 | Cervical Squamous Cell Carcinoma | 45 | 0.3488372 | 6.187585 |
umls:C0268800 | Simple renal cyst | 15 | 0.3488372 | 2.348868 |
umls:C0600327 | Toxic Shock Syndrome | 15 | 0.3488372 | 2.348868 |
umls:C0032131 | Plasmacytoma | 31 | 0.3483146 | 4.386762 |
umls:C1368683 | Epithelioma | 96 | 0.3478261 | 12.710617 |
umls:C0018552 | Hamartoma | 24 | 0.3478261 | 3.493081 |
umls:C0751778 | Myoclonic Epilepsies, Progressive | 16 | 0.3478261 | 2.466679 |
umls:C0024137 | Lupus Erythematosus, Cutaneous | 8 | 0.3478261 | 1.421943 |
umls:C0024140 | Lupus Erythematosus, Subacute Cutaneous | 8 | 0.3478261 | 1.421943 |
umls:C0032339 | Rothmund-Thomson syndrome | 8 | 0.3478261 | 1.421943 |
umls:C0205721 | Infections, Hospital | 8 | 0.3478261 | 1.421943 |
umls:C0334381 | Non-infiltrating lobular carcinoma | 8 | 0.3478261 | 1.421943 |
umls:C0343804 | Chronic Chagas’ disease | 8 | 0.3478261 | 1.421943 |
umls:C0006413 | Burkitt Lymphoma | 73 | 0.3476190 | 9.712372 |
umls:C1636667 | Disorder characterized by eosinophilia | 49 | 0.3475177 | 6.644421 |
umls:C0001339 | Acute pancreatitis | 33 | 0.3473684 | 4.617006 |
umls:C0025286 | Meningioma | 149 | 0.3473193 | 19.592982 |
umls:C0020445 | Hypercholesterolemia, Familial | 58 | 0.3473054 | 7.790850 |
umls:C0085207 | Gestational Diabetes | 68 | 0.3469388 | 9.047066 |
umls:C0032787 | Postoperative Complications | 26 | 0.3466667 | 3.717224 |
umls:C0024314 | Lymphoproliferative Disorders | 81 | 0.3461538 | 10.655052 |
umls:C0278504 | Non-small cell lung cancer stage I | 27 | 0.3461538 | 3.837703 |
umls:C0005426 | Biliary Tract Neoplasm | 18 | 0.3461538 | 2.694085 |
umls:C0079298 | Epidermolysis Bullosa Simplex | 9 | 0.3461538 | 1.546414 |
umls:C0205944 | Sarcoma, Epithelioid | 9 | 0.3461538 | 1.546414 |
umls:C0278519 | recurrent childhood acute lymphoblastic leukemia | 9 | 0.3461538 | 1.546414 |
umls:C0302809 | Fulminant hepatitis | 9 | 0.3461538 | 1.546414 |
umls:C1292778 | Chronic myeloproliferative disorder | 55 | 0.3459119 | 7.337654 |
umls:C0025267 | Multiple Endocrine Neoplasia Type 1 | 28 | 0.3456790 | 3.943591 |
umls:C0178664 | Glomerulosclerosis (disorder) | 28 | 0.3456790 | 3.943591 |
umls:C0339573 | Glaucoma, Primary Open Angle | 58 | 0.3452381 | 7.688438 |
umls:C0017154 | Gastritis, Atrophic | 39 | 0.3451327 | 5.307846 |
umls:C0020676 | Hypothyroidism | 70 | 0.3448276 | 9.180359 |
umls:C0022680 | Polycystic Kidney Diseases | 40 | 0.3448276 | 5.420642 |
umls:C0034152 | Henoch-Schoenlein Purpura | 20 | 0.3448276 | 2.926748 |
umls:C0034341 | Pyruvate Carboxylase Deficiency Disease | 10 | 0.3448276 | 1.660906 |
umls:C0265554 | Ectrodactyly | 10 | 0.3448276 | 1.660906 |
umls:C1292772 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 10 | 0.3448276 | 1.660906 |
umls:C0042133 | Uterine Fibroids | 112 | 0.3446154 | 14.495367 |
umls:C0153381 | Malignant neoplasm of mouth | 144 | 0.3444976 | 18.638331 |
umls:C0206650 | Fibroadenoma | 21 | 0.3442623 | 3.047870 |
umls:C0026269 | Mitral Valve Stenosis | 77 | 0.3437500 | 9.974381 |
umls:C1335177 | Ovarian Serous Adenocarcinoma | 22 | 0.3437500 | 3.163731 |
umls:C0262404 | Cerebellar degeneration | 11 | 0.3437500 | 1.782221 |
umls:C0729353 | Subfertility | 11 | 0.3437500 | 1.782221 |
umls:C0017668 | Focal glomerulosclerosis | 35 | 0.3431373 | 4.748212 |
umls:C0024668 | Mammary Neoplasms, Experimental | 71 | 0.3429952 | 9.191821 |
umls:C2973725 | Pulmonary arterial hypertension | 60 | 0.3428571 | 7.820301 |
umls:C0037284 | Skin lesion | 24 | 0.3428571 | 3.394195 |
umls:C0014661 | Equine Infectious Anemia | 12 | 0.3428571 | 1.900632 |
umls:C0032533 | Polymyalgia Rheumatica | 12 | 0.3428571 | 1.900632 |
umls:C0856169 | Endothelial dysfunction | 74 | 0.3425926 | 9.526099 |
umls:C0872054 | latent infection | 25 | 0.3424658 | 3.507945 |
umls:C0037286 | Skin Neoplasms | 115 | 0.3422619 | 14.644471 |
umls:C0007786 | Brain Ischemia | 142 | 0.3421687 | 18.066529 |
umls:C0021400 | Influenza | 169 | 0.3421053 | 21.444983 |
umls:C0278488 | Carcinoma breast stage IV | 117 | 0.3421053 | 14.881017 |
umls:C0206655 | Alveolar rhabdomyosarcoma | 26 | 0.3421053 | 3.621170 |
umls:C0684337 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 26 | 0.3421053 | 3.621170 |
umls:C0019372 | Herpesviridae Infections | 13 | 0.3421053 | 2.018987 |
umls:C0032969 | Pregnancy in Diabetics | 13 | 0.3421053 | 2.018987 |
umls:C0745744 | End Stage Liver Disease | 13 | 0.3421053 | 2.018987 |
umls:C0023827 | liposarcoma | 41 | 0.3416667 | 5.436141 |
umls:C0278701 | Gastric Adenocarcinoma | 97 | 0.3415493 | 12.321735 |
umls:C0004943 | Behcet Syndrome | 111 | 0.3415385 | 14.085726 |
umls:C0403592 | Chronic rejection of renal transplant | 14 | 0.3414634 | 2.135450 |
umls:C2607914 | Allergic rhinitis (disorder) | 58 | 0.3411765 | 7.484807 |
umls:C0151779 | Cutaneous Melanoma | 89 | 0.3409962 | 11.273902 |
umls:C0027877 | Neuronal Ceroid-Lipofuscinoses | 15 | 0.3409091 | 2.252845 |
umls:C0153014 | Non-arthropod borne lymphocytic choriomeningitis | 15 | 0.3409091 | 2.252845 |
umls:C0280803 | Primary central nervous system lymphoma | 15 | 0.3409091 | 2.252845 |
umls:C1704321 | Nephrotic Syndrome, Minimal Change | 15 | 0.3409091 | 2.252845 |
umls:C0524909 | Hepatitis B, Chronic | 91 | 0.3408240 | 11.507899 |
umls:C0699949 | airway disease | 32 | 0.3404255 | 4.299604 |
umls:C0024236 | Lymphedema | 17 | 0.3400000 | 2.482137 |
umls:C0035920 | Rubella | 17 | 0.3400000 | 2.482137 |
umls:C0042138 | Uterine Neoplasms | 17 | 0.3400000 | 2.482137 |
umls:C0153349 | Malignant neoplasm of tongue | 17 | 0.3400000 | 2.482137 |
umls:C3811653 | Experimental Organism Basal Cell Carcinoma | 90 | 0.3396226 | 11.290218 |
umls:C1336735 | Treatment related acute myeloid leukaemia | 18 | 0.3396226 | 2.596155 |
umls:C0039590 | Testicular Neoplasms | 40 | 0.3389831 | 5.225435 |
umls:C0027947 | Neutropenia | 62 | 0.3387978 | 7.853417 |
umls:C0039483 | Giant Cell Arteritis | 43 | 0.3385827 | 5.565454 |
umls:C0007570 | Celiac Disease | 132 | 0.3384615 | 16.369912 |
umls:C0949690 | Spondylarthritis | 22 | 0.3384615 | 3.066644 |
umls:C0006287 | Bronchopulmonary Dysplasia | 69 | 0.3382353 | 8.676972 |
umls:C0007820 | Cerebrovascular Disorders | 23 | 0.3382353 | 3.182126 |
umls:C0028797 | Occupational Diseases | 23 | 0.3382353 | 3.182126 |
umls:C0398686 | Primary immune deficiency disorder | 23 | 0.3382353 | 3.182126 |
umls:C0040136 | Thyroid Neoplasm | 153 | 0.3377483 | 18.859557 |
umls:C0023290 | Leishmaniasis, Visceral | 26 | 0.3376623 | 3.525434 |
umls:C0033626 | Protein Deficiency | 26 | 0.3376623 | 3.525434 |
umls:C0026918 | Mycobacterium Infections | 29 | 0.3372093 | 3.871258 |
umls:C0020503 | Hyperparathyroidism, Secondary | 60 | 0.3370787 | 7.522730 |
umls:C1565489 | Renal Insufficiency | 35 | 0.3365385 | 4.549025 |
umls:C0238461 | Anaplastic thyroid carcinoma | 75 | 0.3363229 | 9.257726 |
umls:C2937358 | Cerebral Hemorrhage | 76 | 0.3362832 | 9.374707 |
umls:C0026946 | Mycoses | 81 | 0.3360996 | 9.947712 |
umls:C0376545 | Hematologic Neoplasms | 167 | 0.3360161 | 20.316656 |
umls:C0038013 | Ankylosing spondylitis | 90 | 0.3358209 | 11.015369 |
umls:C0242383 | Age related macular degeneration | 137 | 0.3357843 | 16.676003 |
umls:C0007124 | Noninfiltrating Intraductal Carcinoma | 98 | 0.3356164 | 11.929852 |
umls:C0001175 | Acquired Immunodeficiency Syndrome | 50 | 0.3355705 | 6.269658 |
umls:C0238198 | Gastrointestinal Stromal Tumors | 108 | 0.3354037 | 13.132789 |
umls:C1302401 | Adenoma of large intestine | 86 | 0.3346304 | 10.443963 |
umls:C0220641 | Lip and Oral Cavity Carcinoma | 140 | 0.3341289 | 16.832778 |
umls:C0032927 | Precancerous Conditions | 152 | 0.3340659 | 18.282637 |
umls:C0019829 | Hodgkin Disease | 130 | 0.3333333 | 15.550957 |
umls:C0152171 | Idiopathic pulmonary hypertension | 74 | 0.3333333 | 8.967605 |
umls:C3714844 | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 63 | 0.3333333 | 7.680127 |
umls:C0334590 | Anaplastic Oligodendroglioma | 45 | 0.3333333 | 5.605516 |
umls:C0752347 | Lewy Body Disease | 43 | 0.3333333 | 5.381062 |
umls:C0747845 | early pregnancy | 38 | 0.3333333 | 4.799642 |
umls:C0162820 | Dermatitis, Allergic Contact | 37 | 0.3333333 | 4.686580 |
umls:C0262584 | Carcinoma, Small Cell | 36 | 0.3333333 | 4.570744 |
umls:C0023891 | Liver Cirrhosis, Alcoholic | 34 | 0.3333333 | 4.341519 |
umls:C0260037 | Multiple tumors | 32 | 0.3333333 | 4.113270 |
umls:C0001627 | Congenital adrenal hyperplasia | 23 | 0.3333333 | 3.087863 |
umls:C0595936 | Aqueous Humor Disorders | 22 | 0.3333333 | 2.967974 |
umls:C0037769 | West Syndrome | 21 | 0.3333333 | 2.854986 |
umls:C0280313 | Squamous cell carcinoma of oropharynx | 19 | 0.3333333 | 2.615140 |
umls:C0023364 | Leptospirosis | 17 | 0.3333333 | 2.389398 |
umls:C0039075 | Syndactyly | 16 | 0.3333333 | 2.275770 |
umls:C1851710 | LATERAL MENINGOCELE SYNDROME | 16 | 0.3333333 | 2.275770 |
umls:C0410702 | Adolescent idiopathic scoliosis | 15 | 0.3333333 | 2.154460 |
umls:C0740277 | Bile duct carcinoma | 15 | 0.3333333 | 2.154460 |
umls:C0151332 | Active tuberculosis | 14 | 0.3333333 | 2.043592 |
umls:C2936179 | Obesity, Visceral | 14 | 0.3333333 | 2.043592 |
umls:C0242363 | Islet Cell Tumor | 13 | 0.3333333 | 1.923512 |
umls:C0265962 | Ichthyosis linearis circumflexa | 13 | 0.3333333 | 1.923512 |
umls:C0268318 | Cholestasis of pregnancy | 13 | 0.3333333 | 1.923512 |
umls:C1333762 | Gastric Cardia Adenocarcinoma | 13 | 0.3333333 | 1.923512 |
umls:C0008372 | Intrahepatic Cholestasis | 12 | 0.3333333 | 1.803878 |
umls:C0008728 | Churg-Strauss Syndrome | 12 | 0.3333333 | 1.803878 |
umls:C0206734 | Hemangioblastoma | 12 | 0.3333333 | 1.803878 |
umls:C0280220 | stage, ovarian epithelial cancer | 12 | 0.3333333 | 1.803878 |
umls:C0037268 | Skin Abnormalities | 11 | 0.3333333 | 1.686419 |
umls:C0278510 | Medulloblastoma, Childhood | 11 | 0.3333333 | 1.686419 |
umls:C0334276 | Adenocarcinoma in Situ | 11 | 0.3333333 | 1.686419 |
umls:C0406810 | Carney Complex | 11 | 0.3333333 | 1.686419 |
umls:C0235989 | Renal interstitial fibrosis | 10 | 0.3333333 | 1.567183 |
umls:C0015923 | Fetal Alcohol Syndrome | 9 | 0.3333333 | 1.443383 |
umls:C0020295 | Hydronephrosis | 9 | 0.3333333 | 1.443383 |
umls:C0152031 | Joint swelling | 9 | 0.3333333 | 1.443383 |
umls:C0206182 | Lymphomatoid Papulosis | 9 | 0.3333333 | 1.443383 |
umls:C0751785 | Unverricht-Lundborg Syndrome | 9 | 0.3333333 | 1.443383 |
umls:C0030246 | Pustulosis of Palms and Soles | 8 | 0.3333333 | 1.323062 |
umls:C0267797 | Acute hepatitis | 8 | 0.3333333 | 1.323062 |
umls:C0333980 | Focal Nodular Hyperplasia | 8 | 0.3333333 | 1.323062 |
umls:C0679247 | Terminal illness | 8 | 0.3333333 | 1.323062 |
umls:C0524910 | Hepatitis C, Chronic | 150 | 0.3325942 | 17.858211 |
umls:C0006274 | Bronchiolitis, Viral | 70 | 0.3317536 | 8.405177 |
umls:C0521158 | Recurrent tumor | 106 | 0.3312500 | 12.506302 |
umls:C0029928 | Ovarian Diseases | 78 | 0.3305085 | 9.231506 |
umls:C1153706 | Endometrial adenocarcinoma | 34 | 0.3300971 | 4.245856 |
umls:C0022660 | Kidney Failure, Acute | 58 | 0.3295455 | 6.912462 |
umls:C0007787 | Transient Ischemic Attack | 57 | 0.3294798 | 6.797387 |
umls:C0262587 | Parathyroid Adenoma | 28 | 0.3294118 | 3.572962 |
umls:C1378511 | Undifferentiated leukemia | 25 | 0.3289474 | 3.224363 |
umls:C0026640 | Mouth Neoplasms | 69 | 0.3285714 | 8.095282 |
umls:C0020541 | Hypertension, Portal | 23 | 0.3285714 | 2.993873 |
umls:C0027658 | Neoplasms, Germ Cell and Embryonal | 21 | 0.3281250 | 2.760998 |
umls:C0917798 | Cerebral Ischemia | 62 | 0.3280423 | 7.283987 |
umls:C0007785 | Cerebral Infarction | 96 | 0.3276451 | 11.053623 |
umls:C0024266 | Lymphocytic Choriomeningitis | 19 | 0.3275862 | 2.529882 |
umls:C0149721 | Left Ventricular Hypertrophy | 75 | 0.3275109 | 8.713178 |
umls:C0020550 | Hyperthyroidism | 36 | 0.3272727 | 4.386970 |
umls:C1145670 | Respiratory Failure | 18 | 0.3272727 | 2.412859 |
umls:C1841972 | Glucocorticoid Receptor Deficiency | 18 | 0.3272727 | 2.412859 |
umls:C1762616 | Meningioma, benign, no ICD-O subtype | 71 | 0.3271889 | 8.239913 |
umls:C0007112 | Adenocarcinoma of prostate | 52 | 0.3270440 | 6.132433 |
umls:C0025284 | Meningeal Neoplasms | 17 | 0.3269231 | 2.303357 |
umls:C0079773 | Lymphoma, T-Cell, Cutaneous | 83 | 0.3267717 | 9.526099 |
umls:C3539878 | Triple Negative Breast Neoplasms | 149 | 0.3267544 | 16.969737 |
umls:C0032019 | Pituitary Neoplasms | 98 | 0.3266667 | 11.189398 |
umls:C0751956 | Acute Cerebrovascular Accidents | 16 | 0.3265306 | 2.183217 |
umls:C1266184 | Atypical teratoid/rhabdoid tumor | 16 | 0.3265306 | 2.183217 |
umls:C2931456 | Prostate cancer, familial | 16 | 0.3265306 | 2.183217 |
umls:C0007138 | Carcinoma, Transitional Cell | 127 | 0.3264781 | 14.437785 |
umls:C0023493 | Adult T-Cell Lymphoma/Leukemia | 153 | 0.3262260 | 17.358081 |
umls:C0242656 | Disease Progression | 76 | 0.3261803 | 8.736539 |
umls:C0374997 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 105 | 0.3260870 | 11.909687 |
umls:C0025322 | Premature Menopause | 30 | 0.3260870 | 3.703760 |
umls:C0015967 | Fever | 15 | 0.3260870 | 2.071252 |
umls:C1559271 | Non-Malignant Ascites Adverse Event | 59 | 0.3259669 | 6.848328 |
umls:C0002965 | Angina, Unstable | 29 | 0.3258427 | 3.596094 |
umls:C1527349 | Ductal Breast Carcinoma | 29 | 0.3258427 | 3.596094 |
umls:C0751688 | Malignant Squamous Cell Neoplasm | 43 | 0.3257576 | 5.102829 |
umls:C0032962 | Pregnancy Complications | 42 | 0.3255814 | 4.985702 |
umls:C0027766 | Nervous System Neoplasms | 14 | 0.3255814 | 1.953286 |
umls:C0162565 | Acute intermittent porphyria | 14 | 0.3255814 | 1.953286 |
umls:C0017178 | Gastrointestinal Diseases | 27 | 0.3253012 | 3.367692 |
umls:C0023892 | Biliary cirrhosis | 40 | 0.3252033 | 4.759380 |
umls:C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 52 | 0.3250000 | 6.046553 |
umls:C0349566 | Squamous cell carcinoma of tongue | 39 | 0.3250000 | 4.642933 |
umls:C1318544 | M5b Acute differentiated monocytic leukemia | 26 | 0.3250000 | 3.250620 |
umls:C0032064 | Plague | 13 | 0.3250000 | 1.833392 |
umls:C0751882 | Myasthenic Syndromes, Congenital | 13 | 0.3250000 | 1.833392 |
umls:C0020557 | Hypertriglyceridemia | 24 | 0.3243243 | 3.021669 |
umls:C0030421 | Paraganglioma | 24 | 0.3243243 | 3.021669 |
umls:C0032461 | Polycythemia | 24 | 0.3243243 | 3.021669 |
umls:C0085136 | Central Nervous System Neoplasms | 24 | 0.3243243 | 3.021669 |
umls:C0206172 | Diabetic Foot | 12 | 0.3243243 | 1.711994 |
umls:C0263746 | Osteoarthritis of the hand | 12 | 0.3243243 | 1.711994 |
umls:C1737329 | Dysmorphism | 12 | 0.3243243 | 1.711994 |
umls:C0740457 | Malignant neoplasm of kidney | 129 | 0.3241206 | 14.403460 |
umls:C0206624 | Hepatoblastoma | 69 | 0.3239437 | 7.826007 |
umls:C0282612 | Prostatic Intraepithelial Neoplasias | 46 | 0.3239437 | 5.363085 |
umls:C0242488 | Acute Lung Injury | 23 | 0.3239437 | 2.905034 |
umls:C0085605 | Liver Failure | 34 | 0.3238095 | 4.072004 |
umls:C0023492 | Leukemia, T-Cell | 111 | 0.3236152 | 12.359964 |
umls:C0085655 | Polymyositis | 33 | 0.3235294 | 3.952775 |
umls:C0030524 | Paratuberculosis | 11 | 0.3235294 | 1.599015 |
umls:C0333693 | Triploidy syndrome | 11 | 0.3235294 | 1.599015 |
umls:C0206062 | Lung Diseases, Interstitial | 43 | 0.3233083 | 5.012310 |
umls:C0278996 | Cancer of Head and Neck | 139 | 0.3232558 | 15.415349 |
umls:C0263361 | Psoriasis vulgaris | 42 | 0.3230769 | 4.896932 |
umls:C0018800 | Cardiomegaly | 62 | 0.3229167 | 7.007801 |
umls:C0019284 | Diaphragmatic Hernia | 20 | 0.3225806 | 2.560283 |
umls:C0023652 | Lichen Sclerosus et Atrophicus | 10 | 0.3225806 | 1.477477 |
umls:C1168198 | Recurrent respiratory papillomatosis | 10 | 0.3225806 | 1.477477 |
umls:C0206708 | Cervical Intraepithelial Neoplasia | 68 | 0.3222749 | 7.622226 |
umls:C0002874 | Aplastic Anemia | 48 | 0.3221477 | 5.498313 |
umls:C0151514 | Atrophic condition of skin | 38 | 0.3220339 | 4.436841 |
umls:C0432412 | Chromosome 8, trisomy | 19 | 0.3220339 | 2.443560 |
umls:C1318485 | Liver regeneration disorder | 28 | 0.3218391 | 3.394195 |
umls:C0001925 | Albuminuria | 45 | 0.3214286 | 5.157026 |
umls:C0853897 | Diabetic Cardiomyopathies | 18 | 0.3214286 | 2.332206 |
umls:C2349952 | Oropharyngeal Carcinoma | 18 | 0.3214286 | 2.332206 |
umls:C0014061 | Tick-Borne Encephalitis | 9 | 0.3214286 | 1.358430 |
umls:C0026272 | Mixed Connective Tissue Disease | 9 | 0.3214286 | 1.358430 |
umls:C0311213 | Dermatitis verrucosa | 9 | 0.3214286 | 1.358430 |
umls:C0042111 | Urticaria Pigmentosa | 17 | 0.3207547 | 2.215356 |
umls:C1096184 | West Nile viral infection | 25 | 0.3205128 | 3.049545 |
umls:C0270814 | Spastic syndrome | 32 | 0.3200000 | 3.761915 |
umls:C0023530 | Leukopenia | 63 | 0.3197970 | 6.953875 |
umls:C0027092 | Myopia | 47 | 0.3197279 | 5.301994 |
umls:C0041671 | Attention Deficit Disorder | 15 | 0.3191489 | 1.983205 |
umls:C0242621 | Isochromosomes | 15 | 0.3191489 | 1.983205 |
umls:C0740380 | Varicella zoster | 15 | 0.3191489 | 1.983205 |
umls:C0032584 | polyps | 89 | 0.3189964 | 9.601530 |
umls:C0014474 | Ependymoma | 37 | 0.3189655 | 4.237203 |
umls:C0598608 | Hyperhomocysteinemia | 37 | 0.3189655 | 4.237203 |
umls:C0333463 | Senile Plaques | 81 | 0.3188976 | 8.785549 |
umls:C2316810 | Chronic kidney disease stage 5 | 64 | 0.3184080 | 6.976728 |
umls:C0153633 | Malignant neoplasm of brain | 49 | 0.3181818 | 5.442209 |
umls:C0019569 | Hirschsprung Disease | 28 | 0.3181818 | 3.308350 |
umls:C0027746 | Nerve Degeneration | 28 | 0.3181818 | 3.308350 |
umls:C0154830 | Proliferative diabetic retinopathy | 21 | 0.3181818 | 2.585618 |
umls:C0686353 | Muscular Dystrophies, Limb-Girdle | 21 | 0.3181818 | 2.585618 |
umls:C0038522 | Subacute Sclerosing Panencephalitis | 14 | 0.3181818 | 1.867945 |
umls:C0036920 | Sezary Syndrome | 48 | 0.3178808 | 5.331333 |
umls:C0152021 | Congenital heart disease | 27 | 0.3176471 | 3.193768 |
umls:C3203102 | Idiopathic pulmonary arterial hypertension | 27 | 0.3176471 | 3.193768 |
umls:C0280449 | secondary acute myeloid leukemia | 20 | 0.3174603 | 2.471702 |
umls:C0151744 | Myocardial Ischemia | 151 | 0.3172269 | 15.942379 |
umls:C0020217 | Hydatidiform Mole | 26 | 0.3170732 | 3.080004 |
umls:C0007121 | Bronchogenic Carcinoma | 13 | 0.3170732 | 1.747344 |
umls:C3662483 | Allergic sensitization | 13 | 0.3170732 | 1.747344 |
umls:C0026948 | Mycosis Fungoides | 45 | 0.3169014 | 4.983595 |
umls:C3241937 | Nonalcoholic Steatohepatitis | 50 | 0.3164557 | 5.470772 |
umls:C0018621 | Hay fever | 36 | 0.3157895 | 4.041508 |
umls:C0206743 | Rhabdoid Tumor | 18 | 0.3157895 | 2.244372 |
umls:C0015230 | Exanthema | 83 | 0.3155894 | 8.761696 |
umls:C0085400 | Neurofibrillary degeneration (morphologic abnormality) | 53 | 0.3154762 | 5.727511 |
umls:C1292769 | Precursor B-cell lymphoblastic leukemia | 121 | 0.3151042 | 12.575633 |
umls:C0010674 | Cystic Fibrosis | 138 | 0.3150685 | 14.336976 |
umls:C0346153 | Breast Cancer, Familial | 46 | 0.3150685 | 5.012757 |
umls:C0023269 | leiomyosarcoma | 40 | 0.3149606 | 4.411589 |
umls:C0019187 | Hepatitis, Alcoholic | 17 | 0.3148148 | 2.129423 |
umls:C0158646 | Cleft palate with cleft lip | 17 | 0.3148148 | 2.129423 |
umls:C0206634 | Liposarcoma, Myxoid | 17 | 0.3148148 | 2.129423 |
umls:C1522378 | Leukemia, Large Granular Lymphocytic | 17 | 0.3148148 | 2.129423 |
umls:C0021053 | Immune System Diseases | 61 | 0.3144330 | 6.466239 |
umls:C0038525 | Subarachnoid Hemorrhage | 77 | 0.3142857 | 8.062055 |
umls:C3539909 | Allergic disposition | 66 | 0.3142857 | 6.958160 |
umls:C0020255 | Hydrocephalus | 22 | 0.3142857 | 2.613005 |
umls:C0024591 | Malignant hyperpyrexia due to anesthesia | 11 | 0.3142857 | 1.516963 |
umls:C0409957 | Osteoarthritis of distal interphalangeal joint | 11 | 0.3142857 | 1.516963 |
umls:C0687150 | Parathyroid Gland Adenocarcinoma | 11 | 0.3142857 | 1.516963 |
umls:C0854467 | Myelosuppression | 11 | 0.3142857 | 1.516963 |
umls:C0027643 | Neoplasm Recurrence, Local | 87 | 0.3140794 | 9.045526 |
umls:C1292753 | Primary Effusion Lymphoma | 38 | 0.3140496 | 4.185791 |
umls:C0037579 | Soft Tissue Neoplasms | 27 | 0.3139535 | 3.111721 |
umls:C0280324 | Laryngeal Squamous Cell Carcinoma | 42 | 0.3134328 | 4.558184 |
umls:C1561643 | Chronic Kidney Diseases | 89 | 0.3133803 | 9.191821 |
umls:C0035078 | Kidney Failure | 104 | 0.3132530 | 10.675942 |
umls:C0520463 | Chronic active hepatitis | 26 | 0.3132530 | 2.995425 |
umls:C0206754 | Neuroendocrine Tumors | 76 | 0.3127572 | 7.862792 |
umls:C0042900 | Vitiligo | 65 | 0.3125000 | 6.762168 |
umls:C0019562 | Von Hippel-Lindau Syndrome | 35 | 0.3125000 | 3.855752 |
umls:C0025568 | Metaplasia | 25 | 0.3125000 | 2.879647 |
umls:C0730345 | Microalbuminuria | 20 | 0.3125000 | 2.390475 |
umls:C0856536 | Philadelphia chromosome positive | 10 | 0.3125000 | 1.398470 |
umls:C0026985 | Myelodysplasia | 29 | 0.3118280 | 3.253223 |
umls:C0699893 | Skin carcinoma | 29 | 0.3118280 | 3.253223 |
umls:C1514422 | Primary Glioblastoma | 19 | 0.3114754 | 2.278816 |
umls:C0018790 | Cardiac Arrest | 47 | 0.3112583 | 4.963372 |
umls:C0027055 | Myocardial Reperfusion Injury | 61 | 0.3112245 | 6.304921 |
umls:C0019158 | Hepatitis | 83 | 0.3108614 | 8.428542 |
umls:C0205734 | Diabetes, Autoimmune | 27 | 0.3103448 | 3.029154 |
umls:C0206093 | Neuroectodermal Tumors | 18 | 0.3103448 | 2.160025 |
umls:C3463897 | HYDATIDIFORM MOLE, RECURRENT, 1 | 18 | 0.3103448 | 2.160025 |
umls:C0948008 | Ischemic stroke | 119 | 0.3098958 | 11.836850 |
umls:C0025268 | Multiple Endocrine Neoplasia Type 2a | 22 | 0.3098592 | 2.538887 |
umls:C0035369 | Retroviridae Infections | 22 | 0.3098592 | 2.538887 |
umls:C0019159 | Hepatitis A | 83 | 0.3097015 | 8.345154 |
umls:C0750979 | Primary malignant neoplasm of brain | 13 | 0.3095238 | 1.663991 |
umls:C0338451 | Frontotemporal dementia | 34 | 0.3090909 | 3.662117 |
umls:C0333519 | Caries (morphologic abnormality) | 17 | 0.3090909 | 2.052005 |
umls:C2827407 | Infectious Otitis Media | 17 | 0.3090909 | 2.052005 |
umls:C0280141 | Acute Undifferentiated Leukemia | 25 | 0.3086420 | 2.802706 |
umls:C0001624 | Adrenal Gland Neoplasms | 29 | 0.3085106 | 3.178434 |
umls:C0751396 | Well Differentiated Oligodendroglioma | 52 | 0.3076923 | 5.296119 |
umls:C0034050 | Pulmonary Alveolar Proteinosis | 12 | 0.3076923 | 1.547751 |
umls:C0270921 | Axonal neuropathy | 12 | 0.3076923 | 1.547751 |
umls:C0278694 | Disseminated neuroblastoma | 12 | 0.3076923 | 1.547751 |
umls:C0280280 | stage, prostate cancer | 12 | 0.3076923 | 1.547751 |
umls:C0178468 | Autoimmune thyroid disease | 35 | 0.3070175 | 3.692894 |
umls:C0033375 | Prolactinoma | 27 | 0.3068182 | 2.946860 |
umls:C0079772 | T-Cell Lymphoma | 92 | 0.3066667 | 8.980420 |
umls:C0021831 | Intestinal Diseases | 23 | 0.3066667 | 2.572749 |
umls:C0034063 | Pulmonary Edema | 23 | 0.3066667 | 2.572749 |
umls:C0403447 | Chronic Kidney Insufficiency | 57 | 0.3064516 | 5.698555 |
umls:C0751356 | Idiopathic Inflammatory Myopathies | 19 | 0.3064516 | 2.199398 |
umls:C0853879 | Invasive breast carcinoma | 113 | 0.3062331 | 10.912502 |
umls:C0001883 | Airway Obstruction | 15 | 0.3061224 | 1.818451 |
umls:C1512326 | Human T-cell lymphotropic virus 1 infection | 15 | 0.3061224 | 1.818451 |
umls:C1853118 | Severe congenital neutropenia | 15 | 0.3061224 | 1.818451 |
umls:C0007621 | Neoplastic Cell Transformation | 44 | 0.3055556 | 4.463136 |
umls:C2931876 | Hirschsprung disease 1 | 22 | 0.3055556 | 2.460194 |
umls:C0004997 | Benign Ovarian Neoplasm | 11 | 0.3055556 | 1.433268 |
umls:C1135868 | Gestational Trophoblastic Neoplasms | 11 | 0.3055556 | 1.433268 |
umls:C0005695 | Bladder Neoplasm | 135 | 0.3054299 | 12.905757 |
umls:C0029456 | Osteoporosis | 134 | 0.3052392 | 12.782933 |
umls:C0011853 | Diabetes Mellitus, Experimental | 147 | 0.3049793 | 14.009656 |
umls:C0017152 | Gastritis | 68 | 0.3049327 | 6.623448 |
umls:C1176475 | Ductal Carcinoma | 68 | 0.3049327 | 6.623448 |
umls:C0037274 | Dermatologic disorders | 146 | 0.3048017 | 13.887026 |
umls:C0004135 | Ataxia Telangiectasia | 64 | 0.3047619 | 6.251795 |
umls:C0264408 | Childhood asthma | 32 | 0.3047619 | 3.364331 |
umls:C0027796 | Neuralgia | 28 | 0.3043478 | 2.984923 |
umls:C0221505 | Lesion of brain | 21 | 0.3043478 | 2.347712 |
umls:C0206623 | Adenosquamous carcinoma | 14 | 0.3043478 | 1.700124 |
umls:C0004565 | Melanoma, B16 | 31 | 0.3039216 | 3.248668 |
umls:C0027960 | Nevus | 31 | 0.3039216 | 3.248668 |
umls:C0020456 | Hyperglycemia | 134 | 0.3038549 | 12.628632 |
umls:C0017601 | Glaucoma | 65 | 0.3037383 | 6.284318 |
umls:C0376544 | Hematopoietic Neoplasms | 51 | 0.3035714 | 5.020359 |
umls:C0206664 | Teratocarcinoma | 30 | 0.3030303 | 3.136785 |
umls:C0162283 | Nephrogenic Diabetes Insipidus | 10 | 0.3030303 | 1.312189 |
umls:C0275522 | Asymptomatic Infections | 10 | 0.3030303 | 1.312189 |
umls:C0278688 | Stage IV Ovarian Carcinoma | 10 | 0.3030303 | 1.312189 |
umls:C0751951 | Central Core Myopathy (disorder) | 10 | 0.3030303 | 1.312189 |
umls:C0752353 | Atrophy, Muscular, Spinobulbar | 10 | 0.3030303 | 1.312189 |
umls:C0020437 | Hypercalcemia | 23 | 0.3026316 | 2.495565 |
umls:C0947751 | Vascular inflammations | 36 | 0.3025210 | 3.655612 |
umls:C0011882 | Diabetic Neuropathies | 26 | 0.3023256 | 2.758321 |
umls:C0016781 | Fuchs Endothelial Dystrophy | 13 | 0.3023256 | 1.590749 |
umls:C0032987 | Ectopic Pregnancy | 13 | 0.3023256 | 1.590749 |
umls:C0162316 | Iron deficiency anemia | 13 | 0.3023256 | 1.590749 |
umls:C0745103 | Hyperlipoproteinemia Type IIa | 13 | 0.3023256 | 1.590749 |
umls:C1306837 | Papillary Renal Cell Carcinoma | 13 | 0.3023256 | 1.590749 |
umls:C0038220 | Status Epilepticus | 48 | 0.3018868 | 4.686580 |
umls:C0751713 | Inclusion Body Myopathy, Sporadic | 16 | 0.3018868 | 1.859842 |
umls:C0028945 | oligodendroglioma | 57 | 0.3015873 | 5.470772 |
umls:C0920269 | Microsatellite Instability | 19 | 0.3015873 | 2.122421 |
umls:C1378703 | Renal carcinoma | 142 | 0.3014862 | 13.099415 |
umls:C0553723 | Squamous cell carcinoma of skin | 44 | 0.3013699 | 4.312440 |
umls:C0002871 | Anemia | 97 | 0.3012422 | 9.004404 |
umls:C0221056 | Adult type dermatomyositis | 25 | 0.3012048 | 2.643462 |
umls:C0740392 | Infarction, Middle Cerebral Artery | 25 | 0.3012048 | 2.643462 |
umls:C1319315 | Adenocarcinoma of large intestine | 56 | 0.3010753 | 5.363085 |
umls:C0015397 | Disorder of eye | 40 | 0.3007519 | 3.943591 |
umls:C0025517 | Metabolic Diseases | 115 | 0.3002611 | 10.509462 |
umls:C0004238 | Atrial Fibrillation | 36 | 0.3000000 | 3.584657 |
umls:C0151546 | Oral Cavity Carcinoma | 27 | 0.3000000 | 2.799309 |
umls:C0340970 | Congenital neutropenia | 15 | 0.3000000 | 1.742535 |
umls:C0021846 | Intestinal Polyps | 12 | 0.3000000 | 1.472567 |
umls:C0033575 | Prostatic Diseases | 12 | 0.3000000 | 1.472567 |
umls:C0026846 | Muscular Atrophy | 53 | 0.2994350 | 5.018753 |
umls:C0042164 | Uveitis | 38 | 0.2992126 | 3.724662 |
umls:C0266999 | Vesicular Stomatitis | 29 | 0.2989691 | 2.944573 |
umls:C0848332 | Spots on skin | 59 | 0.2979798 | 5.470772 |
umls:C0018799 | Heart Diseases | 106 | 0.2977528 | 9.480316 |
umls:C0011615 | Dermatitis, Atopic | 142 | 0.2976939 | 12.632061 |
umls:C0013336 | Dwarfism | 61 | 0.2975610 | 5.617963 |
umls:C0026499 | Monosomy | 47 | 0.2974684 | 4.422558 |
umls:C0577631 | Carotid Atherosclerosis | 33 | 0.2972973 | 3.248668 |
umls:C3495426 | Homocysteinemia | 22 | 0.2972973 | 2.313967 |
umls:C0014132 | Endocrine Gland Neoplasms | 11 | 0.2972973 | 1.358430 |
umls:C0033377 | Ptosis | 11 | 0.2972973 | 1.358430 |
umls:C0042870 | Vitamin D Deficiency | 11 | 0.2972973 | 1.358430 |
umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 65 | 0.2968037 | 5.916503 |
umls:C0007104 | Female Breast Carcinoma | 16 | 0.2962963 | 1.783524 |
umls:C0276275 | Disease due to Parvoviridae | 16 | 0.2962963 | 1.783524 |
umls:C0752120 | Spinocerebellar Ataxia Type 1 | 16 | 0.2962963 | 1.783524 |
umls:C0796126 | AICARDI-GOUTIERES SYNDROME 1 | 16 | 0.2962963 | 1.783524 |
umls:C0041107 | Trisomy | 53 | 0.2960894 | 4.873490 |
umls:C0079748 | Precursor cell lymphoblastic lymphoma | 13 | 0.2954545 | 1.519122 |
umls:C0342793 | Malonic aciduria | 13 | 0.2954545 | 1.519122 |
umls:C0242994 | Hantavirus Infections | 18 | 0.2950820 | 1.938076 |
umls:C0553580 | Ewings sarcoma | 64 | 0.2949309 | 5.732154 |
umls:C0149940 | Sciatic Neuropathy | 23 | 0.2948718 | 2.348868 |
umls:C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 108 | 0.2942779 | 9.351418 |
umls:C0520679 | Sleep Apnea, Obstructive | 45 | 0.2941176 | 4.133045 |
umls:C0235653 | Malignant neoplasm of female breast | 15 | 0.2941176 | 1.668941 |
umls:C0264490 | Acute respiratory failure | 15 | 0.2941176 | 1.668941 |
umls:C1851841 | ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | 15 | 0.2941176 | 1.668941 |
umls:C0036095 | Salivary Gland Neoplasms | 22 | 0.2933333 | 2.240808 |
umls:C0020981 | Angioimmunoblastic Lymphadenopathy | 17 | 0.2931034 | 1.824195 |
umls:C1270972 | Mild cognitive disorder | 41 | 0.2928571 | 3.771821 |
umls:C0035204 | Respiration Disorders | 24 | 0.2926829 | 2.390475 |
umls:C0153252 | Systemic candidiasis | 12 | 0.2926829 | 1.406253 |
umls:C0271084 | Exudative age-related macular degeneration | 12 | 0.2926829 | 1.406253 |
umls:C1636149 | Macular dystrophy, corneal type 1 | 12 | 0.2926829 | 1.406253 |
umls:C0279980 | Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 19 | 0.2923077 | 1.980035 |
umls:C0585362 | Squamous cell carcinoma of mouth | 14 | 0.2916667 | 1.556259 |
umls:C0023896 | Alcoholic Liver Diseases | 30 | 0.2912621 | 2.846271 |
umls:C0013182 | Drug Allergy | 23 | 0.2911392 | 2.282745 |
umls:C0497327 | Dementia | 117 | 0.2910448 | 9.776874 |
umls:C0013595 | Eczema | 118 | 0.2906404 | 9.820451 |
umls:C0015625 | Fanconi Anemia | 72 | 0.2903226 | 6.122146 |
umls:C0009241 | Cognition Disorders | 18 | 0.2903226 | 1.870389 |
umls:C0038868 | Progressive supranuclear palsy | 18 | 0.2903226 | 1.870389 |
umls:C1332977 | Childhood Leukemia | 18 | 0.2903226 | 1.870389 |
umls:C0279628 | Adenocarcinoma Of Esophagus | 87 | 0.2900000 | 7.287731 |
umls:C0155877 | Allergic asthma | 58 | 0.2900000 | 5.002383 |
umls:C0079745 | Lymphoma, Large-Cell, Follicular | 51 | 0.2897727 | 4.439049 |
umls:C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 94 | 0.2892308 | 7.790473 |
umls:C0595989 | Carcinoma of larynx | 52 | 0.2888889 | 4.477275 |
umls:C0014145 | Yolk Sac Tumor | 13 | 0.2888889 | 1.441776 |
umls:C0040558 | Toxoplasmosis | 13 | 0.2888889 | 1.441776 |
umls:C0282607 | Vascular Neoplasms | 13 | 0.2888889 | 1.441776 |
umls:C1337011 | Well Differentiated Pancreatic Endocrine Tumor | 13 | 0.2888889 | 1.441776 |
umls:C0376634 | Craniofacial Abnormalities | 58 | 0.2885572 | 4.930859 |
umls:C0035335 | Retinoblastoma | 136 | 0.2881356 | 11.019397 |
umls:C0020429 | Hyperalgesia | 51 | 0.2881356 | 4.375418 |
umls:C0206081 | Hyperandrogenism | 19 | 0.2878788 | 1.908303 |
umls:C0027868 | Neuromuscular Diseases | 25 | 0.2873563 | 2.361102 |
umls:C0236642 | Pick Disease of the Brain | 29 | 0.2871287 | 2.660531 |
umls:C0043346 | Xeroderma Pigmentosum | 31 | 0.2870370 | 2.819107 |
umls:C3272363 | Ischemic Cerebrovascular Accident | 97 | 0.2869822 | 7.848413 |
umls:C0751955 | Brain Infarction | 22 | 0.2857143 | 2.106201 |
umls:C0024437 | Macular degeneration | 20 | 0.2857143 | 1.954759 |
umls:C0870082 | Hyperkeratosis | 18 | 0.2857143 | 1.799127 |
umls:C0025261 | Memory Disorders | 16 | 0.2857143 | 1.644471 |
umls:C0027832 | Neurofibromatosis 2 | 16 | 0.2857143 | 1.644471 |
umls:C0151313 | Sensory neuropathy | 16 | 0.2857143 | 1.644471 |
umls:C0026837 | Muscle Rigidity | 12 | 0.2857143 | 1.330035 |
umls:C0005699 | Blast Phase | 63 | 0.2850679 | 5.144152 |
umls:C0006012 | Borderline Personality Disorder | 49 | 0.2848837 | 4.091361 |
umls:C0424605 | Developmental delay (disorder) | 54 | 0.2842105 | 4.429101 |
umls:C0205851 | Germ cell tumor | 64 | 0.2831858 | 5.120136 |
umls:C0026847 | Spinal Muscular Atrophy | 47 | 0.2831325 | 3.883523 |
umls:C0233794 | Memory impairment | 47 | 0.2831325 | 3.883523 |
umls:C0027708 | Nephroblastoma | 92 | 0.2830769 | 7.160219 |
umls:C0221002 | Hyperparathyroidism, Primary | 15 | 0.2830189 | 1.537489 |
umls:C0175754 | Agenesis of corpus callosum | 43 | 0.2828947 | 3.588996 |
umls:C0003865 | Arthritis, Adjuvant-Induced | 13 | 0.2826087 | 1.380641 |
umls:C0338656 | Impaired cognition | 113 | 0.2817955 | 8.615436 |
umls:C0031269 | Peutz-Jeghers Syndrome | 20 | 0.2816901 | 1.885387 |
umls:C1516170 | Cancer Cell Growth | 90 | 0.2812500 | 6.881051 |
umls:C0010414 | Infection by Cryptococcus neoformans | 16 | 0.2807018 | 1.581254 |
umls:C0020473 | Hyperlipidemia | 65 | 0.2801724 | 5.030138 |
umls:C0242422 | Parkinsonian Disorders | 56 | 0.2800000 | 4.388256 |
umls:C0206663 | Neuroectodermal Tumor, Primitive | 35 | 0.2800000 | 2.920848 |
umls:C0017075 | Ganglioneuroma | 14 | 0.2800000 | 1.423579 |
umls:C0085183 | Neoplasms, Second Primary | 54 | 0.2797927 | 4.237203 |
umls:C0022336 | Creutzfeldt-Jakob disease | 26 | 0.2795699 | 2.279224 |
umls:C0242596 | Neoplasm, Residual | 58 | 0.2788462 | 4.470704 |
umls:C0035309 | Retinal Diseases | 97 | 0.2787356 | 7.184049 |
umls:C0002875 | Cooley’s anemia | 17 | 0.2786885 | 1.624563 |
umls:C0240066 | Iron deficiency | 17 | 0.2786885 | 1.624563 |
umls:C0085669 | Acute leukemia | 133 | 0.2782427 | 9.674371 |
umls:C0007193 | Cardiomyopathy, Dilated | 111 | 0.2775000 | 8.069265 |
umls:C0282193 | Iron Overload | 23 | 0.2771084 | 2.020961 |
umls:C0393571 | Multiple System Atrophy | 26 | 0.2765957 | 2.218811 |
umls:C0023186 | Learning Disorders | 13 | 0.2765957 | 1.311284 |
umls:C0032460 | Polycystic Ovary Syndrome | 120 | 0.2764977 | 8.610624 |
umls:C0008497 | Choriocarcinoma | 77 | 0.2759857 | 5.619702 |
umls:C0030920 | Peptic Ulcer | 27 | 0.2755102 | 2.260472 |
umls:C0265219 | Miller Dieker syndrome | 19 | 0.2753623 | 1.712949 |
umls:C0011265 | Presenile dementia | 82 | 0.2751678 | 5.904597 |
umls:C0521707 | Bilateral cataracts (disorder) | 33 | 0.2750000 | 2.644283 |
umls:C0235946 | Cerebral atrophy | 22 | 0.2750000 | 1.914011 |
umls:C0005283 | beta Thalassemia | 36 | 0.2748092 | 2.845710 |
umls:C0162534 | Prion Diseases | 25 | 0.2747253 | 2.111060 |
umls:C0033027 | Preleukemia | 70 | 0.2745098 | 5.065834 |
umls:C1336708 | Testicular Germ Cell Tumor | 28 | 0.2745098 | 2.309407 |
umls:C0033300 | Progeria | 14 | 0.2745098 | 1.362376 |
umls:C0392525 | Nephrolithiasis | 14 | 0.2745098 | 1.362376 |
umls:C0677776 | Hereditary Breast and Ovarian Cancer Syndrome | 14 | 0.2745098 | 1.362376 |
umls:C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 136 | 0.2741935 | 9.448477 |
umls:C0002878 | Anemia, Hemolytic | 23 | 0.2738095 | 1.963273 |
umls:C0346429 | Multiple malignancy | 52 | 0.2736842 | 3.854598 |
umls:C0031511 | Pheochromocytoma | 67 | 0.2734694 | 4.810914 |
umls:C0023487 | Acute Promyelocytic Leukemia | 117 | 0.2733645 | 8.093777 |
umls:C1709246 | Non-Neoplastic Disorder | 126 | 0.2733189 | 8.701977 |
umls:C0018671 | Head and Neck Neoplasms | 91 | 0.2732733 | 6.359950 |
umls:C0008925 | Cleft Palate | 68 | 0.2730924 | 4.855769 |
umls:C0022665 | Kidney Neoplasm | 83 | 0.2730263 | 5.828399 |
umls:C0341106 | Eosinophilic esophagitis | 18 | 0.2727273 | 1.614046 |
umls:C0023055 | Laryngeal neoplasm | 28 | 0.2718447 | 2.246272 |
umls:C0038436 | Post-Traumatic Stress Disorder | 28 | 0.2718447 | 2.246272 |
umls:C0023440 | Acute Erythroblastic Leukemia | 53 | 0.2717949 | 3.839613 |
umls:C0008625 | Chromosome Aberrations | 22 | 0.2716049 | 1.857767 |
umls:C0949541 | Hurthle Cell Tumor | 22 | 0.2716049 | 1.857767 |
umls:C0019202 | Hepatolenticular Degeneration | 16 | 0.2711864 | 1.453946 |
umls:C0242698 | Ventricular Dysfunction, Left | 16 | 0.2711864 | 1.453946 |
umls:C0149782 | Squamous cell carcinoma of lung | 52 | 0.2708333 | 3.732364 |
umls:C0206659 | Embryonal Carcinoma | 49 | 0.2707182 | 3.544411 |
umls:C0020459 | Hyperinsulinism | 69 | 0.2705882 | 4.786625 |
umls:C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 46 | 0.2705882 | 3.355076 |
umls:C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 98 | 0.2699725 | 6.565303 |
umls:C0220615 | Adult Acute Myeloblastic Leukemia | 24 | 0.2696629 | 1.949437 |
umls:C1512409 | Hepatocarcinogenesis | 127 | 0.2696391 | 8.385089 |
umls:C3887873 | Hearing Loss | 31 | 0.2695652 | 2.380857 |
umls:C0036631 | Seminoma | 59 | 0.2694064 | 4.101201 |
umls:C0021655 | Insulin Resistance | 80 | 0.2693603 | 5.402232 |
umls:C3463824 | MYELODYSPLASTIC SYNDROME | 80 | 0.2693603 | 5.402232 |
umls:C0086543 | Cataract | 57 | 0.2688679 | 3.952078 |
umls:C0235031 | Neurologic Symptoms | 26 | 0.2680412 | 2.042040 |
umls:C0008073 | Developmental Disabilities | 41 | 0.2679739 | 2.948682 |
umls:C0027540 | Necrosis | 15 | 0.2678571 | 1.351135 |
umls:C1998028 | Photoreceptor degeneration | 15 | 0.2678571 | 1.351135 |
umls:C0232197 | Fibrillation | 34 | 0.2677165 | 2.516354 |
umls:C0023524 | Leukoencephalopathy, Progressive Multifocal | 27 | 0.2673267 | 2.091392 |
umls:C0023485 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 28 | 0.2666667 | 2.131122 |
umls:C0442874 | Neuropathy | 61 | 0.2663755 | 4.080554 |
umls:C0085215 | Ovarian Failure, Premature | 53 | 0.2663317 | 3.612187 |
umls:C0017168 | Gastroesophageal reflux disease | 33 | 0.2661290 | 2.413965 |
umls:C0014556 | Epilepsy, Temporal Lobe | 51 | 0.2656250 | 3.463416 |
umls:C0007682 | CNS disorder | 30 | 0.2654867 | 2.223431 |
umls:C1336076 | Sporadic Breast Carcinoma | 39 | 0.2653061 | 2.745371 |
umls:C0878544 | Cardiomyopathies | 126 | 0.2652632 | 7.872400 |
umls:C0011303 | Demyelinating Diseases | 22 | 0.2650602 | 1.739732 |
umls:C0015934 | Fetal Growth Retardation | 28 | 0.2641509 | 2.081143 |
umls:C0027765 | nervous system disorder | 119 | 0.2638581 | 7.313602 |
umls:C0024301 | Lymphoma, Follicular | 100 | 0.2631579 | 6.150683 |
umls:C0018203 | Chronic granulomatous disease | 20 | 0.2631579 | 1.592075 |
umls:C0011991 | Diarrhea | 56 | 0.2629108 | 3.638301 |
umls:C0271650 | Impaired glucose tolerance | 77 | 0.2627986 | 4.812123 |
umls:C0009376 | Colonic Polyps | 16 | 0.2622951 | 1.342949 |
umls:C0270612 | Leukoencephalopathies | 16 | 0.2622951 | 1.342949 |
umls:C0221757 | alpha 1-Antitrypsin Deficiency | 17 | 0.2615385 | 1.396527 |
umls:C0040822 | Tremor | 23 | 0.2613636 | 1.731679 |
umls:C0162309 | Adrenoleukodystrophy | 36 | 0.2608696 | 2.447554 |
umls:C0855197 | Testicular malignant germ cell tumor | 25 | 0.2604167 | 1.827671 |
umls:C2004493 | Leukemia, B-Cell | 26 | 0.2600000 | 1.878395 |
umls:C0494463 | Alzheimer Disease, Late Onset | 20 | 0.2597403 | 1.540324 |
umls:C0039730 | Thalassemia | 27 | 0.2596154 | 1.922634 |
umls:C0151699 | Intracranial Hemorrhages | 41 | 0.2594937 | 2.673781 |
umls:C0020443 | Hypercholesterolemia | 49 | 0.2592593 | 3.105965 |
umls:C0043144 | Wheezing | 21 | 0.2592593 | 1.586771 |
umls:C0020615 | Hypoglycemia | 38 | 0.2585034 | 2.484671 |
umls:C0015695 | Fatty Liver | 94 | 0.2575342 | 5.400679 |
umls:C0008350 | Cholelithiasis | 27 | 0.2571429 | 1.874111 |
umls:C0025521 | Inborn Errors of Metabolism | 18 | 0.2571429 | 1.392077 |
umls:C0042749 | Viremia | 18 | 0.2571429 | 1.392077 |
umls:C0007117 | Basal cell carcinoma | 28 | 0.2568807 | 1.917726 |
umls:C0011053 | Deafness | 38 | 0.2567568 | 2.436401 |
umls:C0007194 | Hypertrophic Cardiomyopathy | 48 | 0.2566845 | 2.950313 |
umls:C0024408 | Machado-Joseph Disease | 20 | 0.2564103 | 1.485329 |
umls:C0031117 | Peripheral Neuropathy | 115 | 0.2561247 | 6.377235 |
umls:C0947622 | Cholecystolithiasis | 22 | 0.2558140 | 1.583023 |
umls:C0206686 | Adrenocortical carcinoma | 38 | 0.2550336 | 2.385891 |
umls:C0024667 | Animal Mammary Neoplasms | 51 | 0.2550000 | 3.044957 |
umls:C0007959 | Charcot-Marie-Tooth Disease | 40 | 0.2547771 | 2.477267 |
umls:C0007273 | Carotid Artery Diseases | 42 | 0.2545455 | 2.572112 |
umls:C0007107 | Malignant neoplasm of larynx | 33 | 0.2538462 | 2.105303 |
umls:C0015672 | Fatigue | 34 | 0.2537313 | 2.147655 |
umls:C0037019 | Shy-Drager Syndrome | 20 | 0.2531646 | 1.435219 |
umls:C0085648 | Synovial Cyst | 44 | 0.2528736 | 2.610841 |
umls:C0023452 | Leukemia, Lymphocytic, Acute, L1 | 98 | 0.2525773 | 5.238531 |
umls:C0008924 | Cleft Lip | 50 | 0.2525253 | 2.898628 |
umls:C0400966 | Non-alcoholic Fatty Liver Disease | 80 | 0.2523659 | 4.339609 |
umls:C0030552 | Paresis | 28 | 0.2522523 | 1.817980 |
umls:C0949664 | Tauopathies | 31 | 0.2520325 | 1.963273 |
umls:C0013421 | Dystonia | 35 | 0.2517986 | 2.146328 |
umls:C0008370 | Cholestasis | 44 | 0.2500000 | 2.519979 |
umls:C0085084 | Motor Neuron Disease | 34 | 0.2500000 | 2.056295 |
umls:C1561955 | Fibrinogen Adverse Event | 27 | 0.2500000 | 1.719623 |
umls:C0751606 | Adult Acute Lymphocytic Leukemia | 26 | 0.2500000 | 1.673435 |
umls:C2937421 | Prostatic Hyperplasia | 24 | 0.2500000 | 1.580958 |
umls:C0004763 | Barrett Esophagus | 36 | 0.2482759 | 2.103259 |
umls:C2711227 | Steatohepatitis | 55 | 0.2477477 | 2.940733 |
umls:C0085298 | Sudden Cardiac Death | 23 | 0.2473118 | 1.484501 |
umls:C1258666 | Myxoid cyst | 45 | 0.2472527 | 2.474355 |
umls:C0023448 | Lymphoid leukemia | 61 | 0.2469636 | 3.180326 |
umls:C0012236 | DiGeorge Syndrome | 20 | 0.2469136 | 1.337716 |
umls:C0021670 | insulinoma | 38 | 0.2467532 | 2.146770 |
umls:C0497406 | Overweight | 53 | 0.2465116 | 2.805867 |
umls:C0023976 | Long QT Syndrome | 26 | 0.2452830 | 1.583858 |
umls:C0030193 | Pain | 58 | 0.2436975 | 2.904357 |
umls:C0740391 | Middle Cerebral Artery Occlusion | 26 | 0.2429907 | 1.540924 |
umls:C0027404 | Narcolepsy | 64 | 0.2415094 | 3.054676 |
umls:C0162429 | Malnutrition | 27 | 0.2410714 | 1.545487 |
umls:C0020179 | Huntington Disease | 76 | 0.2397476 | 3.440282 |
umls:C1704272 | Benign Prostatic Hyperplasia | 89 | 0.2386059 | 3.874942 |
umls:C0025362 | Mental Retardation | 97 | 0.2365854 | 4.032810 |
umls:C0035304 | Retinal Degeneration | 55 | 0.2360515 | 2.470210 |
umls:C0018772 | Hearing Loss, Partial | 35 | 0.2348993 | 1.707944 |
umls:C0006111 | Brain Diseases | 44 | 0.2328042 | 1.970813 |
umls:C0018798 | Congenital Heart Defects | 58 | 0.2320000 | 2.412645 |
umls:C0041408 | Turner Syndrome | 35 | 0.2317881 | 1.633992 |
umls:C2745900 | Promyelocytic leukemia | 55 | 0.2310924 | 2.280984 |
umls:C1384666 | hearing impairment | 42 | 0.2258065 | 1.696599 |
umls:C0026848 | Myopathy | 67 | 0.2248322 | 2.385891 |
umls:C0013080 | Down Syndrome | 105 | 0.2219873 | 3.276579 |
umls:C0525045 | Mood Disorders | 61 | 0.2218182 | 2.093360 |
umls:C0018784 | Sensorineural Hearing Loss (disorder) | 37 | 0.2202381 | 1.411416 |
umls:C0022104 | Irritable Bowel Syndrome | 35 | 0.2201258 | 1.352608 |
umls:C0242339 | Dyslipidemias | 50 | 0.2192982 | 1.711984 |
umls:C0043094 | Weight Gain | 51 | 0.2161017 | 1.634770 |
umls:C0041696 | Unipolar Depression | 87 | 0.2142857 | 2.359344 |
umls:C0085580 | Essential Hypertension | 64 | 0.2133333 | 1.822555 |
umls:C3714756 | Intellectual Disability | 97 | 0.2131868 | 2.511647 |
umls:C0018817 | Atrial Septal Defects | 59 | 0.2122302 | 1.674205 |
umls:C1272641 | Systemic arterial pressure | 92 | 0.2081448 | 2.128702 |
umls:C0003469 | Anxiety Disorders | 79 | 0.2073491 | 1.858375 |
umls:C0033975 | Psychotic Disorders | 51 | 0.2056452 | 1.301233 |
umls:C1269683 | Major Depressive Disorder | 100 | 0.2053388 | 2.109974 |
umls:C1263846 | Attention deficit hyperactivity disorder | 86 | 0.2052506 | 1.877998 |
ID | Term | Genes involved | Match ratio | -log10 p-value |
---|---|---|---|---|
hsa00510 | N-Glycan biosynthesis | 49 | 1.0000000 | 27.377345 |
hsa00512 | Mucin type O-glycan biosynthesis | 31 | 1.0000000 | 17.324314 |
hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 27 | 1.0000000 | 15.112999 |
hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 25 | 1.0000000 | 14.025751 |
hsa00514 | Other types of O-glycan biosynthesis | 22 | 1.0000000 | 12.312131 |
hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 20 | 1.0000000 | 11.196694 |
hsa00511 | Other glycan degradation | 18 | 1.0000000 | 10.082981 |
hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 15 | 1.0000000 | 8.394584 |
hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 15 | 1.0000000 | 8.394584 |
hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 14 | 1.0000000 | 7.828320 |
hsa00600 | Sphingolipid metabolism | 46 | 0.9787234 | 24.287570 |
hsa03050 | Proteasome | 43 | 0.9555556 | 21.417542 |
hsa04512 | ECM-receptor interaction | 78 | 0.9512195 | 38.369464 |
hsa00531 | Glycosaminoglycan degradation | 18 | 0.9473684 | 8.977314 |
hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 22 | 0.9166667 | 10.248197 |
hsa00515 | Mannose type O-glycan biosynthesis | 20 | 0.8695652 | 8.456387 |
hsa05150 | Staphylococcus aureus infection | 47 | 0.8392857 | 18.051160 |
hsa04662 | B cell receptor signaling pathway | 54 | 0.7605634 | 17.166603 |
hsa05140 | Leishmaniasis | 56 | 0.7567568 | 17.590081 |
hsa04664 | Fc epsilon RI signaling pathway | 51 | 0.7500000 | 15.820775 |
hsa04660 | T cell receptor signaling pathway | 77 | 0.7475728 | 23.518697 |
hsa04610 | Complement and coagulation cascades | 59 | 0.7468354 | 18.051160 |
hsa05416 | Viral myocarditis | 44 | 0.7457627 | 13.628623 |
hsa04012 | ErbB signaling pathway | 64 | 0.7441860 | 19.360465 |
hsa00053 | Ascorbate and aldarate metabolism | 20 | 0.7407407 | 6.338955 |
hsa05214 | Glioma | 51 | 0.7183099 | 14.586649 |
hsa04370 | VEGF signaling pathway | 42 | 0.7118644 | 11.928870 |
hsa01522 | Endocrine resistance | 68 | 0.7083333 | 18.690885 |
hsa00520 | Amino sugar and nucleotide sugar metabolism | 34 | 0.7083333 | 9.654884 |
hsa05219 | Bladder cancer | 29 | 0.7073171 | 8.289155 |
hsa05213 | Endometrial cancer | 41 | 0.7068966 | 11.492093 |
hsa04612 | Antigen processing and presentation | 54 | 0.7012987 | 14.710187 |
hsa05133 | Pertussis | 53 | 0.6973684 | 14.326756 |
hsa05218 | Melanoma | 53 | 0.6973684 | 14.326756 |
hsa00500 | Starch and sucrose metabolism | 25 | 0.6944444 | 6.953848 |
hsa05130 | Pathogenic Escherichia coli infection | 38 | 0.6909091 | 10.234347 |
hsa05020 | Prion diseases | 24 | 0.6857143 | 6.519361 |
hsa04658 | Th1 and Th2 cell differentiation | 63 | 0.6847826 | 16.242664 |
hsa05330 | Allograft rejection | 26 | 0.6842105 | 7.013285 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 54 | 0.6835443 | 14.025751 |
hsa05332 | Graft-versus-host disease | 28 | 0.6829268 | 7.495701 |
hsa05212 | Pancreatic cancer | 51 | 0.6800000 | 13.134333 |
hsa05310 | Asthma | 21 | 0.6774194 | 5.643709 |
hsa00040 | Pentose and glucuronate interconversions | 23 | 0.6764706 | 6.112923 |
hsa05205 | Proteoglycans in cancer | 137 | 0.6748768 | 33.943566 |
hsa05145 | Toxoplasmosis | 76 | 0.6725664 | 18.774127 |
hsa04145 | Phagosome | 102 | 0.6710526 | 25.013495 |
hsa04640 | Hematopoietic cell lineage | 65 | 0.6701031 | 16.048134 |
hsa04510 | Focal adhesion | 133 | 0.6683417 | 32.363782 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 66 | 0.6666667 | 16.108846 |
hsa04722 | Neurotrophin signaling pathway | 79 | 0.6638655 | 18.977699 |
hsa04720 | Long-term potentiation | 44 | 0.6567164 | 10.640011 |
hsa05220 | Chronic myeloid leukemia | 51 | 0.6538462 | 12.135674 |
hsa04620 | Toll-like receptor signaling pathway | 67 | 0.6442308 | 15.267235 |
hsa05211 | Renal cell carcinoma | 44 | 0.6376812 | 10.033278 |
hsa04962 | Vasopressin-regulated water reabsorption | 28 | 0.6363636 | 6.518633 |
hsa05222 | Small cell lung cancer | 59 | 0.6344086 | 13.132418 |
hsa05144 | Malaria | 31 | 0.6326531 | 7.092254 |
hsa04940 | Type I diabetes mellitus | 27 | 0.6279070 | 6.136258 |
hsa04071 | Sphingolipid signaling pathway | 74 | 0.6271186 | 15.873488 |
hsa05210 | Colorectal cancer | 45 | 0.6250000 | 9.834593 |
hsa05226 | Gastric cancer | 95 | 0.6209150 | 19.760102 |
hsa04912 | GnRH signaling pathway | 57 | 0.6195652 | 12.079782 |
hsa04659 | Th17 cell differentiation | 66 | 0.6168224 | 13.787952 |
hsa05146 | Amoebiasis | 59 | 0.6145833 | 12.268651 |
hsa04142 | Lysosome | 75 | 0.6097561 | 15.163027 |
hsa05215 | Prostate cancer | 59 | 0.6082474 | 12.007000 |
hsa05223 | Non-small cell lung cancer | 40 | 0.6060606 | 8.259892 |
hsa04666 | Fc gamma R-mediated phagocytosis | 55 | 0.6043956 | 11.073942 |
hsa05152 | Tuberculosis | 108 | 0.6033520 | 21.083089 |
hsa04668 | TNF signaling pathway | 65 | 0.6018519 | 12.878880 |
hsa04917 | Prolactin signaling pathway | 42 | 0.6000000 | 8.447095 |
hsa05131 | Shigellosis | 39 | 0.6000000 | 7.887547 |
hsa05142 | Chagas disease (American trypanosomiasis) | 61 | 0.5980392 | 11.953983 |
hsa04340 | Hedgehog signaling pathway | 28 | 0.5957447 | 5.706799 |
hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 28 | 0.5957447 | 5.706799 |
hsa04380 | Osteoclast differentiation | 76 | 0.5937500 | 14.506817 |
hsa05132 | Salmonella infection | 51 | 0.5930233 | 9.900677 |
hsa05221 | Acute myeloid leukemia | 39 | 0.5909091 | 7.634659 |
hsa04210 | Apoptosis | 81 | 0.5869565 | 15.035080 |
hsa04650 | Natural killer cell mediated cytotoxicity | 78 | 0.5864662 | 14.489174 |
hsa05320 | Autoimmune thyroid disease | 31 | 0.5849057 | 6.026657 |
hsa05161 | Hepatitis B | 84 | 0.5833333 | 15.329737 |
hsa04350 | TGF-beta signaling pathway | 49 | 0.5833333 | 9.195828 |
hsa04540 | Gap junction | 51 | 0.5795455 | 9.403253 |
hsa05322 | Systemic lupus erythematosus | 77 | 0.5789474 | 13.913550 |
hsa05224 | Breast cancer | 87 | 0.5761589 | 15.413250 |
hsa04916 | Melanogenesis | 58 | 0.5742574 | 10.407669 |
hsa05169 | Epstein-Barr virus infection | 116 | 0.5714286 | 19.960273 |
hsa04672 | Intestinal immune network for IgA production | 28 | 0.5714286 | 5.227956 |
hsa04974 | Protein digestion and absorption | 51 | 0.5666667 | 8.946988 |
hsa05166 | HTLV-I infection | 144 | 0.5647059 | 24.204220 |
hsa04926 | Relaxin signaling pathway | 73 | 0.5615385 | 12.301045 |
hsa05217 | Basal cell carcinoma | 35 | 0.5555556 | 6.022180 |
hsa05165 | Human papillomavirus infection | 177 | 0.5548589 | 28.453434 |
hsa04611 | Platelet activation | 68 | 0.5528455 | 11.084687 |
hsa04213 | Longevity regulating pathway - multiple species | 34 | 0.5483871 | 5.696059 |
hsa00052 | Galactose metabolism | 17 | 0.5483871 | 3.044223 |
hsa04064 | NF-kappa B signaling pathway | 52 | 0.5473684 | 8.407872 |
hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 37 | 0.5441176 | 6.037338 |
hsa04810 | Regulation of actin cytoskeleton | 115 | 0.5424528 | 17.541252 |
hsa04960 | Aldosterone-regulated sodium reabsorption | 20 | 0.5405405 | 3.413487 |
hsa05100 | Bacterial invasion of epithelial cells | 41 | 0.5394737 | 6.504861 |
hsa05321 | Inflammatory bowel disease (IBD) | 35 | 0.5384615 | 5.614283 |
hsa04923 | Regulation of lipolysis in adipocytes | 29 | 0.5370370 | 4.702228 |
hsa04919 | Thyroid hormone signaling pathway | 62 | 0.5344828 | 9.371831 |
hsa05418 | Fluid shear stress and atherosclerosis | 74 | 0.5323741 | 10.983445 |
hsa05167 | Kaposi’s sarcoma-associated herpesvirus infection | 99 | 0.5322581 | 14.506817 |
hsa04915 | Estrogen signaling pathway | 52 | 0.5306122 | 7.815822 |
hsa04151 | PI3K-Akt signaling pathway | 186 | 0.5299145 | 26.749722 |
hsa04657 | IL-17 signaling pathway | 49 | 0.5268817 | 7.259622 |
hsa04550 | Signaling pathways regulating pluripotency of stem cells | 73 | 0.5251799 | 10.473478 |
hsa04514 | Cell adhesion molecules (CAMs) | 76 | 0.5241379 | 10.835971 |
hsa04973 | Carbohydrate digestion and absorption | 23 | 0.5227273 | 3.580344 |
hsa04014 | Ras signaling pathway | 122 | 0.5169492 | 16.442840 |
hsa04918 | Thyroid hormone synthesis | 38 | 0.5135135 | 5.399093 |
hsa05340 | Primary immunodeficiency | 19 | 0.5135135 | 2.896689 |
hsa05014 | Amyotrophic lateral sclerosis (ALS) | 26 | 0.5098039 | 3.767458 |
hsa05134 | Legionellosis | 28 | 0.5090909 | 4.008987 |
hsa05164 | Influenza A | 88 | 0.5086705 | 11.537005 |
hsa05225 | Hepatocellular carcinoma | 85 | 0.5059524 | 11.008017 |
hsa04015 | Rap1 signaling pathway | 106 | 0.5047619 | 13.547460 |
hsa05200 | Pathways in cancer | 199 | 0.5037975 | 25.045339 |
hsa04310 | Wnt signaling pathway | 72 | 0.5034965 | 9.286722 |
hsa04010 | MAPK signaling pathway | 148 | 0.5034014 | 18.557869 |
hsa05414 | Dilated cardiomyopathy (DCM) | 45 | 0.5000000 | 5.885382 |
hsa04150 | mTOR signaling pathway | 75 | 0.4966887 | 9.305753 |
hsa05230 | Central carbon metabolism in cancer | 32 | 0.4923077 | 4.157659 |
hsa04360 | Axon guidance | 86 | 0.4914286 | 10.293134 |
hsa04330 | Notch signaling pathway | 23 | 0.4791667 | 2.893242 |
hsa00860 | Porphyrin and chlorophyll metabolism | 20 | 0.4761905 | 2.526448 |
hsa04141 | Protein processing in endoplasmic reticulum | 79 | 0.4759036 | 8.679745 |
hsa04218 | Cellular senescence | 76 | 0.4750000 | 8.338508 |
hsa05231 | Choline metabolism in cancer | 47 | 0.4747475 | 5.339530 |
hsa04750 | Inflammatory mediator regulation of TRP channels | 46 | 0.4742268 | 5.221909 |
hsa04670 | Leukocyte transendothelial migration | 53 | 0.4732143 | 5.895103 |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 34 | 0.4722222 | 3.930067 |
hsa04622 | RIG-I-like receptor signaling pathway | 33 | 0.4714286 | 3.811154 |
hsa04066 | HIF-1 signaling pathway | 47 | 0.4700000 | 5.196027 |
hsa04914 | Progesterone-mediated oocyte maturation | 46 | 0.4646465 | 4.926535 |
hsa04621 | NOD-like receptor signaling pathway | 78 | 0.4642857 | 7.995579 |
hsa05162 | Measles | 62 | 0.4626866 | 6.378664 |
hsa04211 | Longevity regulating pathway | 41 | 0.4606742 | 4.336140 |
hsa05216 | Thyroid cancer | 17 | 0.4594595 | 2.015452 |
hsa00983 | Drug metabolism - other enzymes | 21 | 0.4565217 | 2.360940 |
hsa05323 | Rheumatoid arthritis | 41 | 0.4555556 | 4.200029 |
hsa05203 | Viral carcinogenesis | 91 | 0.4527363 | 8.556977 |
hsa04072 | Phospholipase D signaling pathway | 66 | 0.4520548 | 6.310275 |
hsa05168 | Herpes simplex infection | 82 | 0.4432432 | 7.264316 |
hsa04971 | Gastric acid secretion | 33 | 0.4400000 | 3.125851 |
hsa05160 | Hepatitis C | 57 | 0.4351145 | 4.912126 |
hsa04390 | Hippo signaling pathway | 67 | 0.4350649 | 5.687284 |
hsa04930 | Type II diabetes mellitus | 20 | 0.4347826 | 1.989686 |
hsa04068 | FoxO signaling pathway | 57 | 0.4318182 | 4.795605 |
hsa04120 | Ubiquitin mediated proteolysis | 59 | 0.4306569 | 4.905588 |
hsa04931 | Insulin resistance | 46 | 0.4299065 | 3.902861 |
hsa04140 | Autophagy - animal | 55 | 0.4296875 | 4.570816 |
hsa04910 | Insulin signaling pathway | 59 | 0.4275362 | 4.792328 |
hsa04114 | Oocyte meiosis | 53 | 0.4274194 | 4.340786 |
hsa04972 | Pancreatic secretion | 41 | 0.4270833 | 3.451904 |
hsa05031 | Amphetamine addiction | 29 | 0.4264706 | 2.545970 |
hsa01524 | Platinum drug resistance | 31 | 0.4246575 | 2.657878 |
hsa04215 | Apoptosis - multiple species | 14 | 0.4242424 | 1.389848 |
hsa04970 | Salivary secretion | 38 | 0.4222222 | 3.111276 |
hsa04913 | Ovarian steroidogenesis | 21 | 0.4200000 | 1.870630 |
hsa04520 | Adherens junction | 30 | 0.4166667 | 2.439696 |
hsa04144 | Endocytosis | 101 | 0.4139344 | 7.013285 |
hsa00140 | Steroid hormone biosynthesis | 24 | 0.4137931 | 1.992166 |
hsa04024 | cAMP signaling pathway | 81 | 0.4090909 | 5.485392 |
hsa04976 | Bile secretion | 29 | 0.4084507 | 2.231221 |
hsa04217 | Necroptosis | 66 | 0.4024390 | 4.292423 |
hsa04925 | Aldosterone synthesis and secretion | 33 | 0.4024390 | 2.360830 |
hsa05410 | Hypertrophic cardiomyopathy (HCM) | 33 | 0.3975904 | 2.265982 |
hsa04725 | Cholinergic synapse | 44 | 0.3928571 | 2.750733 |
hsa04062 | Chemokine signaling pathway | 70 | 0.3783784 | 3.551047 |
hsa04728 | Dopaminergic synapse | 49 | 0.3769231 | 2.566100 |
hsa04911 | Insulin secretion | 32 | 0.3764706 | 1.818108 |
hsa04137 | Mitophagy - animal | 24 | 0.3692308 | 1.347630 |
hsa04921 | Oxytocin signaling pathway | 56 | 0.3660131 | 2.541400 |
hsa04152 | AMPK signaling pathway | 44 | 0.3636364 | 2.032510 |
hsa04630 | Jak-STAT signaling pathway | 58 | 0.3580247 | 2.372011 |
hsa04371 | Apelin signaling pathway | 49 | 0.3576642 | 2.060391 |
hsa04713 | Circadian entrainment | 34 | 0.3541667 | 1.483705 |
hsa05034 | Alcoholism | 63 | 0.3500000 | 2.284851 |
hsa04261 | Adrenergic signaling in cardiomyocytes | 50 | 0.3472222 | 1.830194 |
hsa04022 | cGMP-PKG signaling pathway | 55 | 0.3374233 | 1.708476 |
hsa04530 | Tight junction | 57 | 0.3352941 | 1.700614 |
ID | Term | Genes involved | Match ratio | -log10 p-value |
---|---|---|---|---|
446203 | Asparagine N-linked glycosylation | 117 | 1.0000000 | 64.217644 |
1630316 | Glycosaminoglycan metabolism | 116 | 1.0000000 | 63.692040 |
1474228 | Degradation of the extracellular matrix | 109 | 1.0000000 | 59.960848 |
3000178 | ECM proteoglycans | 67 | 1.0000000 | 36.319799 |
446193 | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 65 | 1.0000000 | 35.214261 |
1442490 | Collagen degradation | 62 | 1.0000000 | 33.644440 |
1650814 | Collagen biosynthesis and modifying enzymes | 59 | 1.0000000 | 31.965914 |
5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 58 | 1.0000000 | 31.411847 |
5362768 | Hh mutants that don’t undergo autocatalytic processing are degraded by ERAD | 55 | 1.0000000 | 29.769089 |
5387390 | Hh mutants abrogate ligand secretion | 55 | 1.0000000 | 29.769089 |
4641257 | degradation of AXIN | 54 | 1.0000000 | 29.214775 |
3000171 | Non-integrin membrane-ECM interactions | 53 | 1.0000000 | 28.654808 |
180534 | Vpu mediated degradation of CD4 | 51 | 1.0000000 | 27.551171 |
446219 | Synthesis of substrates in N-glycan biosythesis | 51 | 1.0000000 | 27.551171 |
1638091 | Heparan sulfate/heparin (HS-GAG) metabolism | 49 | 1.0000000 | 26.461208 |
1793185 | Chondroitin sulfate/dermatan sulfate metabolism | 49 | 1.0000000 | 26.461208 |
211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 49 | 1.0000000 | 26.461208 |
1566948 | Elastic fibre formation | 39 | 1.0000000 | 20.959810 |
1660662 | Glycosphingolipid metabolism | 38 | 1.0000000 | 20.407130 |
1251932 | PLCG1 events in ERBB2 signaling | 36 | 1.0000000 | 19.314356 |
166658 | Complement cascade | 36 | 1.0000000 | 19.314356 |
948021 | Transport to the Golgi and subsequent modification | 36 | 1.0000000 | 19.314356 |
212718 | EGFR interacts with phospholipase C-gamma | 35 | 1.0000000 | 18.761232 |
2129379 | Molecules associated with elastic fibres | 35 | 1.0000000 | 18.761232 |
1489509 | DAG and IP3 signaling | 33 | 1.0000000 | 17.660785 |
1638074 | Keratan sulfate/keratin metabolism | 33 | 1.0000000 | 17.660785 |
4085001 | Sialic acid metabolism | 32 | 1.0000000 | 17.113169 |
111996 | Ca-dependent events | 30 | 1.0000000 | 16.000917 |
3000157 | Laminin interactions | 30 | 1.0000000 | 16.000917 |
111933 | Calmodulin induced events | 28 | 1.0000000 | 14.904865 |
111997 | CaM pathway | 28 | 1.0000000 | 14.904865 |
2022854 | Keratan sulfate biosynthesis | 28 | 1.0000000 | 14.904865 |
1592389 | Activation of Matrix Metalloproteinases | 27 | 1.0000000 | 14.359009 |
2022928 | HS-GAG biosynthesis | 27 | 1.0000000 | 14.359009 |
3238698 | WNT ligand biogenesis and trafficking | 26 | 1.0000000 | 13.815213 |
3560782 | Diseases associated with glycosaminoglycan metabolism | 26 | 1.0000000 | 13.815213 |
3781865 | Diseases of glycosylation | 26 | 1.0000000 | 13.815213 |
450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 26 | 1.0000000 | 13.815213 |
1971475 | A tetrasaccharide linker sequence is required for GAG synthesis | 25 | 1.0000000 | 13.275532 |
210991 | Basigin interactions | 25 | 1.0000000 | 13.275532 |
3000170 | Syndecan interactions | 25 | 1.0000000 | 13.275532 |
1912422 | Pre-NOTCH Expression and Processing | 24 | 1.0000000 | 12.728450 |
977606 | Regulation of Complement cascade | 24 | 1.0000000 | 12.728450 |
983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 24 | 1.0000000 | 12.728450 |
201451 | Signaling by BMP | 23 | 1.0000000 | 12.172444 |
445989 | TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 22 | 1.0000000 | 11.627287 |
5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 22 | 1.0000000 | 11.627287 |
2022870 | Chondroitin sulfate biosynthesis | 21 | 1.0000000 | 11.079741 |
2024096 | HS-GAG degradation | 21 | 1.0000000 | 11.079741 |
450302 | activated TAK1 mediates p38 MAPK activation | 21 | 1.0000000 | 11.079741 |
5621575 | CD209 (DC-SIGN) signaling | 21 | 1.0000000 | 11.079741 |
198725 | Nuclear Events (kinase and transcription factor activation) | 20 | 1.0000000 | 10.532013 |
202427 | Phosphorylation of CD3 and TCR zeta chains | 20 | 1.0000000 | 10.532013 |
450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 20 | 1.0000000 | 10.532013 |
975576 | N-glycan antennae elongation in the medial/trans-Golgi | 20 | 1.0000000 | 10.532013 |
166663 | Initial triggering of complement | 19 | 1.0000000 | 9.989926 |
1912408 | Pre-NOTCH Transcription and Translation | 19 | 1.0000000 | 9.989926 |
3560783 | Defective B4GALT7 causes EDS, progeroid type | 19 | 1.0000000 | 9.989926 |
3560801 | Defective B3GAT3 causes JDSSDHD | 19 | 1.0000000 | 9.989926 |
442982 | Ras activation uopn Ca2+ infux through NMDA receptor | 19 | 1.0000000 | 9.989926 |
937041 | IKK complex recruitment mediated by RIP1 | 19 | 1.0000000 | 9.989926 |
111931 | PKA-mediated phosphorylation of CREB | 17 | 1.0000000 | 8.907790 |
198753 | ERK/MAPK targets | 17 | 1.0000000 | 8.907790 |
442729 | CREB phosphorylation through the activation of CaMKII | 17 | 1.0000000 | 8.907790 |
622312 | Inflammasomes | 17 | 1.0000000 | 8.907790 |
163615 | PKA activation | 16 | 1.0000000 | 8.365867 |
933542 | TRAF6 mediated NF-kB activation | 16 | 1.0000000 | 8.365867 |
936964 | Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 16 | 1.0000000 | 8.365867 |
2214320 | Anchoring fibril formation | 15 | 1.0000000 | 7.826704 |
3322077 | Glycogen synthesis | 15 | 1.0000000 | 7.826704 |
389357 | CD28 dependent PI3K/Akt signaling | 15 | 1.0000000 | 7.826704 |
75892 | Platelet Adhesion to exposed collagen | 15 | 1.0000000 | 7.826704 |
937072 | TRAF6 mediated induction of TAK1 complex | 15 | 1.0000000 | 7.826704 |
975577 | N-Glycan antennae elongation | 15 | 1.0000000 | 7.826704 |
2142845 | Hyaluronan metabolism | 14 | 1.0000000 | 7.296046 |
1663150 | The activation of arylsulfatases | 13 | 1.0000000 | 6.759526 |
2024101 | CS/DS degradation | 13 | 1.0000000 | 6.759526 |
532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 13 | 1.0000000 | 6.759526 |
879415 | Advanced glycosylation endproduct receptor signaling | 13 | 1.0000000 | 6.759526 |
2022857 | Keratan sulfate degradation | 12 | 1.0000000 | 6.227558 |
3656237 | Defective EXT2 causes exostoses 2 | 12 | 1.0000000 | 6.227558 |
3656253 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 12 | 1.0000000 | 6.227558 |
5607763 | CLEC7A (Dectin-1) induces NFAT activation | 12 | 1.0000000 | 6.227558 |
844456 | The NLRP3 inflammasome | 12 | 1.0000000 | 6.227558 |
157052 | NICD traffics to nucleus | 11 | 1.0000000 | 5.698052 |
166786 | Creation of C4 and C2 activators | 11 | 1.0000000 | 5.698052 |
193634 | Axonal growth inhibition (RHOA activation) | 11 | 1.0000000 | 5.698052 |
198323 | AKT phosphorylates targets in the cytosol | 11 | 1.0000000 | 5.698052 |
2022923 | Dermatan sulfate biosynthesis | 11 | 1.0000000 | 5.698052 |
2160916 | Hyaluronan uptake and degradation | 11 | 1.0000000 | 5.698052 |
350054 | Notch-HLH transcription pathway | 11 | 1.0000000 | 5.698052 |
5602498 | MyD88 deficiency (TLR2/4) | 11 | 1.0000000 | 5.698052 |
5603041 | IRAK4 deficiency (TLR2/4) | 11 | 1.0000000 | 5.698052 |
901042 | Calnexin/calreticulin cycle | 11 | 1.0000000 | 5.698052 |
1300644 | Interaction With The Zona Pellucida | 10 | 1.0000000 | 5.168105 |
168799 | Neurotoxicity of clostridium toxins | 10 | 1.0000000 | 5.168105 |
193692 | Regulated proteolysis of p75NTR | 10 | 1.0000000 | 5.168105 |
199983 | Golgi to ER Retrograde Transport | 10 | 1.0000000 | 5.168105 |
199997 | COPI Mediated Transport | 10 | 1.0000000 | 5.168105 |
209952 | Peptide hormone biosynthesis | 10 | 1.0000000 | 5.168105 |
2562578 | TRIF-mediated programmed cell death | 10 | 1.0000000 | 5.168105 |
3229121 | Glycogen storage diseases | 10 | 1.0000000 | 5.168105 |
3785653 | Myoclonic epilepsy of Lafora | 10 | 1.0000000 | 5.168105 |
450341 | Activation of the AP-1 family of transcription factors | 10 | 1.0000000 | 5.168105 |
5173214 | O-glycosylation of TSR domain-containing proteins | 10 | 1.0000000 | 5.168105 |
5621480 | Dectin-2 family | 10 | 1.0000000 | 5.168105 |
5663084 | Diseases of carbohydrate metabolism | 10 | 1.0000000 | 5.168105 |
937042 | IRAK2 mediated activation of TAK1 complex | 10 | 1.0000000 | 5.168105 |
975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 10 | 1.0000000 | 5.168105 |
1474244 | Extracellular matrix organization | 247 | 0.9919679 | 135.949757 |
216083 | Integrin cell surface interactions | 82 | 0.9879518 | 42.981639 |
937061 | TRIF-mediated TLR3/TLR4 signaling | 76 | 0.9870130 | 39.642536 |
1474290 | Collagen formation | 69 | 0.9857143 | 35.765594 |
168180 | TRAF6 Mediated Induction of proinflammatory cytokines | 55 | 0.9821429 | 28.178270 |
169911 | Regulation of Apoptosis | 49 | 0.9800000 | 24.938034 |
69229 | Ubiquitin-dependent degradation of Cyclin D1 | 49 | 0.9800000 | 24.938034 |
75815 | Ubiquitin-dependent degradation of Cyclin D | 49 | 0.9800000 | 24.938034 |
450294 | MAP kinase activation in TLR cascade | 48 | 0.9795918 | 24.390701 |
1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | 46 | 0.9787234 | 23.308723 |
2132295 | MHC class II antigen presentation | 87 | 0.9775281 | 44.283576 |
2682334 | EPH-Ephrin signaling | 82 | 0.9761905 | 41.517241 |
5621481 | C-type lectin receptors (CLRs) | 120 | 0.9756098 | 61.002947 |
2022090 | Assembly of collagen fibrils and other multimeric structures | 39 | 0.9750000 | 19.519348 |
166166 | MyD88-independent TLR3/TLR4 cascade | 76 | 0.9743590 | 38.208008 |
168164 | Toll Like Receptor 3 (TLR3) Cascade | 76 | 0.9743590 | 38.208008 |
428157 | Sphingolipid metabolism | 68 | 0.9714286 | 33.921545 |
163841 | Gamma carboxylation, hypusine formation and arylsulfatase activation | 34 | 0.9714286 | 16.830373 |
597592 | Post-translational protein modification | 300 | 0.9708738 | 156.351695 |
202733 | Cell surface interactions at the vascular wall | 96 | 0.9696970 | 47.907746 |
5607764 | CLEC7A (Dectin-1) signaling | 96 | 0.9696970 | 47.907746 |
5173105 | O-linked glycosylation | 61 | 0.9682540 | 30.115952 |
3928663 | EPHA-mediated growth cone collapse | 28 | 0.9655172 | 13.622801 |
174113 | SCF-beta-TrCP mediated degradation of Emi1 | 52 | 0.9629630 | 25.297816 |
913709 | O-linked glycosylation of mucins | 51 | 0.9622642 | 24.766837 |
187577 | SCF(Skp2)-mediated degradation of p27/p21 | 50 | 0.9615385 | 24.235364 |
69541 | Stabilization of p53 | 50 | 0.9615385 | 24.235364 |
163125 | Post-translational modification: synthesis of GPI-anchored proteins | 25 | 0.9615385 | 12.020497 |
182971 | EGFR downregulation | 25 | 0.9615385 | 12.020497 |
349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 49 | 0.9607843 | 23.699754 |
69017 | CDK-mediated phosphorylation and removal of Cdc6 | 48 | 0.9600000 | 23.160387 |
166058 | MyD88:Mal cascade initiated on plasma membrane | 71 | 0.9594595 | 34.324654 |
168179 | Toll Like Receptor TLR1:TLR2 Cascade | 71 | 0.9594595 | 34.324654 |
168188 | Toll Like Receptor TLR6:TLR2 Cascade | 71 | 0.9594595 | 34.324654 |
181438 | Toll Like Receptor 2 (TLR2) Cascade | 71 | 0.9594595 | 34.324654 |
166016 | Toll Like Receptor 4 (TLR4) Cascade | 92 | 0.9583333 | 44.454167 |
5654228 | Phospholipase C-mediated cascade; FGFR4 | 45 | 0.9574468 | 21.562961 |
166054 | Activated TLR4 signalling | 89 | 0.9569892 | 42.847228 |
3928665 | EPH-ephrin mediated repulsion of cells | 44 | 0.9565217 | 21.028438 |
1169091 | Activation of NF-kappaB in B cells | 63 | 0.9545455 | 30.026079 |
168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 42 | 0.9545455 | 19.967046 |
164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 20 | 0.9523810 | 9.376560 |
3928662 | EPHB-mediated forward signaling | 38 | 0.9500000 | 17.838410 |
5610783 | Degradation of GLI2 by the proteasome | 56 | 0.9491525 | 26.325457 |
5610785 | GLI3 is processed to GLI3R by the proteasome | 56 | 0.9491525 | 26.325457 |
69563 | p53-Dependent G1 DNA Damage Response | 52 | 0.9454545 | 24.212317 |
69580 | p53-Dependent G1/S DNA damage checkpoint | 52 | 0.9454545 | 24.212317 |
202430 | Translocation of ZAP-70 to Immunological synapse | 17 | 0.9444444 | 7.823998 |
210993 | Tie2 Signaling | 17 | 0.9444444 | 7.823998 |
167021 | PLC-gamma1 signalling | 33 | 0.9428571 | 15.196529 |
69601 | Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 49 | 0.9423077 | 22.619190 |
69610 | p53-Independent DNA Damage Response | 49 | 0.9423077 | 22.619190 |
69613 | p53-Independent G1/S DNA damage checkpoint | 49 | 0.9423077 | 22.619190 |
168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 65 | 0.9420290 | 30.026079 |
975155 | MyD88 dependent cascade initiated on endosome | 65 | 0.9420290 | 30.026079 |
975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 64 | 0.9411765 | 29.502120 |
162710 | Synthesis of glycosylphosphatidylinositol (GPI) | 16 | 0.9411765 | 7.311079 |
164378 | PKA activation in glucagon signalling | 16 | 0.9411765 | 7.311079 |
1236974 | ER-Phagosome pathway | 60 | 0.9375000 | 27.400779 |
1660661 | Sphingolipid de novo biosynthesis | 30 | 0.9375000 | 13.644334 |
2990846 | SUMOylation | 74 | 0.9367089 | 33.773307 |
202424 | Downstream TCR signaling | 44 | 0.9361702 | 19.988765 |
5358346 | Hedgehog ligand biogenesis | 58 | 0.9354839 | 26.348654 |
5610780 | Degradation of GLI1 by the proteasome | 56 | 0.9333333 | 25.297816 |
3108214 | SUMOylation of DNA damage response and repair proteins | 69 | 0.9324324 | 31.130748 |
3108232 | SUMO E3 ligases SUMOylate target proteins | 69 | 0.9324324 | 31.130748 |
442742 | CREB phosphorylation through the activation of Ras | 27 | 0.9310345 | 12.078241 |
177929 | Signaling by EGFR | 156 | 0.9285714 | 70.267083 |
168638 | NOD1/2 Signaling Pathway | 25 | 0.9259259 | 11.044427 |
168142 | Toll Like Receptor 10 (TLR10) Cascade | 62 | 0.9253731 | 27.482214 |
168176 | Toll Like Receptor 5 (TLR5) Cascade | 62 | 0.9253731 | 27.482214 |
975871 | MyD88 cascade initiated on plasma membrane | 62 | 0.9253731 | 27.482214 |
180585 | Vif-mediated degradation of APOBEC3G | 49 | 0.9245283 | 21.654086 |
983168 | Antigen processing: Ubiquitination & Proteasome degradation | 49 | 0.9245283 | 21.654086 |
389356 | CD28 co-stimulation | 24 | 0.9230769 | 10.530990 |
912526 | Interleukin receptor SHC signaling | 24 | 0.9230769 | 10.530990 |
1606322 | ZBP1(DAI) mediated induction of type I IFNs | 12 | 0.9230769 | 5.277938 |
2424491 | DAP12 signaling | 142 | 0.9220779 | 62.986356 |
5654687 | Downstream signaling of activated FGFR1 | 128 | 0.9208633 | 56.686975 |
5654696 | Downstream signaling of activated FGFR2 | 128 | 0.9208633 | 56.686975 |
5654708 | Downstream signaling of activated FGFR3 | 128 | 0.9208633 | 56.686975 |
5654716 | Downstream signaling of activated FGFR4 | 128 | 0.9208633 | 56.686975 |
1168372 | Downstream signaling events of B Cell Receptor (BCR) | 151 | 0.9207317 | 66.721570 |
5654221 | Phospholipase C-mediated cascade; FGFR2 | 46 | 0.9200000 | 20.096129 |
5654219 | Phospholipase C-mediated cascade: FGFR1 | 44 | 0.9166667 | 19.073430 |
5260271 | Diseases of Immune System | 22 | 0.9166667 | 9.509175 |
5602358 | Diseases associated with the TLR signaling cascade | 22 | 0.9166667 | 9.509175 |
977068 | Termination of O-glycan biosynthesis | 22 | 0.9166667 | 9.509175 |
193697 | p75NTR regulates axonogenesis | 11 | 0.9166667 | 4.796095 |
389359 | CD28 dependent Vav1 pathway | 11 | 0.9166667 | 4.796095 |
933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 11 | 0.9166667 | 4.796095 |
168138 | Toll Like Receptor 9 (TLR9) Cascade | 65 | 0.9154930 | 28.115904 |
438064 | Post NMDA receptor activation events | 32 | 0.9142857 | 13.772418 |
190236 | Signaling by FGFR | 138 | 0.9139073 | 60.077725 |
5654736 | Signaling by FGFR1 | 138 | 0.9139073 | 60.077725 |
5654738 | Signaling by FGFR2 | 138 | 0.9139073 | 60.077725 |
5654741 | Signaling by FGFR3 | 138 | 0.9139073 | 60.077725 |
5654743 | Signaling by FGFR4 | 138 | 0.9139073 | 60.077725 |
69615 | G1/S DNA Damage Checkpoints | 53 | 0.9137931 | 22.821117 |
5654227 | Phospholipase C-mediated cascade; FGFR3 | 41 | 0.9111111 | 17.531130 |
983189 | Kinesins | 20 | 0.9090909 | 8.495828 |
159854 | Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 10 | 0.9090909 | 4.293323 |
1810476 | RIP-mediated NFkB activation via ZBP1 | 10 | 0.9090909 | 4.293323 |
2029485 | Role of phospholipids in phagocytosis | 19 | 0.9047619 | 7.988767 |
2172127 | DAP12 interactions | 154 | 0.9005848 | 64.792376 |
109869 | RAF/MAP kinase cascade | 9 | 0.9000000 | 3.795375 |
164940 | Nef mediated downregulation of MHC class I complex cell surface expression | 9 | 0.9000000 | 3.795375 |
170660 | Adenylate cyclase activating pathway | 9 | 0.9000000 | 3.795375 |
73929 | Base-Excision Repair, AP Site Formation | 9 | 0.9000000 | 3.795375 |
4608870 | Asymmetric localization of PCP proteins | 52 | 0.8965517 | 21.485499 |
1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 17 | 0.8947368 | 7.011200 |
1643713 | Signaling by EGFR in Cancer | 17 | 0.8947368 | 7.011200 |
5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 17 | 0.8947368 | 7.011200 |
1250342 | PI3K events in ERBB4 signaling | 84 | 0.8936170 | 34.492863 |
1257604 | PIP3 activates AKT signaling | 84 | 0.8936170 | 34.492863 |
1963642 | PI3K events in ERBB2 signaling | 84 | 0.8936170 | 34.492863 |
5654689 | PI-3K cascade:FGFR1 | 84 | 0.8936170 | 34.492863 |
5654695 | PI-3K cascade:FGFR2 | 84 | 0.8936170 | 34.492863 |
5654710 | PI-3K cascade:FGFR3 | 84 | 0.8936170 | 34.492863 |
5654720 | PI-3K cascade:FGFR4 | 84 | 0.8936170 | 34.492863 |
4641258 | degradation of DVL | 50 | 0.8928571 | 20.468415 |
168898 | Toll-Like Receptors Cascades | 99 | 0.8918919 | 40.532992 |
450408 | AUF1 (hnRNP D0) destabilizes mRNA | 49 | 0.8909091 | 19.967046 |
983705 | Signaling by the B Cell Receptor (BCR) | 169 | 0.8894737 | 69.331505 |
168325 | Viral Messenger RNA Synthesis | 24 | 0.8888889 | 9.729153 |
3928664 | Ephrin signaling | 16 | 0.8888889 | 6.522487 |
180292 | GAB1 signalosome | 87 | 0.8877551 | 35.185668 |
77388 | SHC-related events | 15 | 0.8823529 | 6.036820 |
2454202 | Fc epsilon receptor (FCERI) signaling | 149 | 0.8816568 | 60.048779 |
1227986 | Signaling by ERBB2 | 134 | 0.8815789 | 53.918394 |
350562 | Regulation of ornithine decarboxylase (ODC) | 44 | 0.8800000 | 17.469742 |
2219528 | PI3K/AKT Signaling in Cancer | 71 | 0.8765432 | 27.949117 |
198203 | PI3K/AKT activation | 85 | 0.8762887 | 33.494779 |
2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 90 | 0.8737864 | 35.185668 |
1236975 | Antigen processing-Cross presentation | 67 | 0.8701299 | 25.980010 |
389948 | PD-1 signaling | 20 | 0.8695652 | 7.778065 |
112410 | SHC-mediated signalling | 13 | 0.8666667 | 5.087512 |
180336 | SHC1 events in EGFR signaling | 13 | 0.8666667 | 5.087512 |
354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | 13 | 0.8666667 | 5.087512 |
5637810 | Constitutive Signaling by EGFRvIII | 13 | 0.8666667 | 5.087512 |
5637812 | Signaling by EGFRvIII in Cancer | 13 | 0.8666667 | 5.087512 |
937039 | IRAK1 recruits IKK complex | 13 | 0.8666667 | 5.087512 |
975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 13 | 0.8666667 | 5.087512 |
2871796 | FCERI mediated MAPK activation | 32 | 0.8648649 | 12.251585 |
69656 | Cyclin A:Cdk2-associated events at S phase entry | 51 | 0.8644068 | 19.492050 |
5339562 | Uptake and actions of bacterial toxins | 19 | 0.8636364 | 7.298288 |
5654712 | FRS2-mediated FGFR4 signaling | 25 | 0.8620690 | 9.517695 |
983169 | Class I MHC mediated antigen processing & presentation | 80 | 0.8602151 | 30.263379 |
164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 24 | 0.8571429 | 9.039178 |
1963640 | GRB2 events in ERBB2 signaling | 18 | 0.8571429 | 6.817696 |
112412 | SOS-mediated signalling | 12 | 0.8571429 | 4.607703 |
179812 | GRB2 events in EGFR signaling | 12 | 0.8571429 | 4.607703 |
190322 | FGFR4 ligand binding and activation | 12 | 0.8571429 | 4.607703 |
918233 | TRAF3-dependent IRF activation pathway | 12 | 0.8571429 | 4.607703 |
186763 | Downstream signal transduction | 129 | 0.8543046 | 48.394045 |
156584 | Cytosolic sulfonation of small molecules | 17 | 0.8500000 | 6.348207 |
5654719 | SHC-mediated cascade:FGFR4 | 17 | 0.8500000 | 6.348207 |
186797 | Signaling by PDGF | 150 | 0.8474576 | 55.627328 |
442755 | Activation of NMDA receptor upon glutamate binding and postsynaptic events | 33 | 0.8461538 | 12.078354 |
209560 | NF-kB is activated and signals survival | 11 | 0.8461538 | 4.132895 |
74749 | Signal attenuation | 11 | 0.8461538 | 4.132895 |
1250347 | SHC1 events in ERBB4 signaling | 16 | 0.8421053 | 5.877098 |
187037 | NGF signalling via TRKA from the plasma membrane | 159 | 0.8412698 | 58.075619 |
5654733 | Negative regulation of FGFR4 signaling | 26 | 0.8387097 | 9.367205 |
69202 | Cyclin E associated events during G1/S transition | 51 | 0.8360656 | 18.180722 |
195253 | Degradation of beta-catenin by the destruction complex | 55 | 0.8333333 | 19.476378 |
1250196 | SHC1 events in ERBB2 signaling | 20 | 0.8333333 | 7.156574 |
210990 | PECAM1 interactions | 10 | 0.8333333 | 3.661680 |
4086400 | PCP/CE pathway | 64 | 0.8311688 | 22.540923 |
2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 49 | 0.8305085 | 17.237029 |
451927 | Interleukin-2 signaling | 34 | 0.8292683 | 11.945570 |
202403 | TCR signaling | 53 | 0.8281250 | 18.526857 |
68827 | CDT1 association with the CDC6:ORC:origin complex | 48 | 0.8275862 | 16.761339 |
170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 24 | 0.8275862 | 8.429721 |
2871837 | FCERI mediated NF-kB activation | 24 | 0.8275862 | 8.429721 |
5218920 | VEGFR2 mediated vascular permeability | 19 | 0.8260870 | 6.696691 |
438066 | Unblocking of NMDA receptor, glutamate binding and activation | 14 | 0.8235294 | 4.968850 |
70221 | Glycogen breakdown (glycogenolysis) | 14 | 0.8235294 | 4.968850 |
5632684 | Hedgehog ‘on’ state | 65 | 0.8227848 | 22.415905 |
5655291 | Signaling by FGFR4 in disease | 23 | 0.8214286 | 7.962221 |
5655324 | Signaling by FGFR4 mutants | 23 | 0.8214286 | 7.962221 |
5610787 | Hedgehog ‘off’ state | 64 | 0.8205128 | 21.940881 |
1358803 | Downregulation of ERBB2:ERBB3 signaling | 9 | 0.8181818 | 3.198123 |
389513 | CTLA4 inhibitory signaling | 9 | 0.8181818 | 3.198123 |
388841 | Costimulation by the CD28 family | 44 | 0.8148148 | 14.876930 |
5218921 | VEGFR2 mediated cell proliferation | 22 | 0.8148148 | 7.513661 |
5655253 | Signaling by FGFR2 in disease | 22 | 0.8148148 | 7.513661 |
5655304 | Signaling by FGFR2 mutants | 22 | 0.8148148 | 7.513661 |
174154 | APC/C:Cdc20 mediated degradation of Securin | 52 | 0.8125000 | 17.477927 |
5654700 | FRS-mediated FGFR2 signaling | 26 | 0.8125000 | 8.793206 |
193639 | p75NTR signals via NF-kB | 13 | 0.8125000 | 4.514789 |
975110 | TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 13 | 0.8125000 | 4.514789 |
1433557 | Signaling by SCF-KIT | 108 | 0.8120301 | 36.229413 |
2871809 | FCERI mediated Ca+2 mobilization | 25 | 0.8064516 | 8.338751 |
1280218 | Adaptive Immune System | 345 | 0.8023256 | 118.894689 |
174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 48 | 0.8000000 | 15.613515 |
5654693 | FRS-mediated FGFR1 signaling | 24 | 0.8000000 | 7.877060 |
205043 | NRIF signals cell death from the nucleus | 12 | 0.8000000 | 4.057877 |
372708 | p130Cas linkage to MAPK signaling for integrins | 12 | 0.8000000 | 4.057877 |
446107 | Type I hemidesmosome assembly | 8 | 0.8000000 | 2.746978 |
5099900 | WNT5A-dependent internalization of FZD4 | 8 | 0.8000000 | 2.746978 |
1236394 | Signaling by ERBB4 | 114 | 0.7972028 | 36.813192 |
174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 55 | 0.7971014 | 17.759710 |
5654727 | Negative regulation of FGFR2 signaling | 27 | 0.7941176 | 8.716696 |
162909 | Host Interactions of HIV factors | 100 | 0.7936508 | 32.002843 |
1295596 | Spry regulation of FGF signaling | 11 | 0.7857143 | 3.612905 |
5654699 | SHC-mediated cascade:FGFR2 | 18 | 0.7826087 | 5.726403 |
5358351 | Signaling by Hedgehog | 86 | 0.7818182 | 26.655960 |
5654726 | Negative regulation of FGFR1 signaling | 25 | 0.7812500 | 7.826704 |
446652 | Interleukin-1 signaling | 35 | 0.7777778 | 10.780060 |
5654706 | FRS-mediated FGFR3 signaling | 21 | 0.7777778 | 6.560262 |
174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 52 | 0.7761194 | 15.882495 |
165054 | Rev-mediated nuclear export of HIV RNA | 24 | 0.7741935 | 7.395571 |
180746 | Nuclear import of Rev protein | 24 | 0.7741935 | 7.395571 |
180910 | Vpr-mediated nuclear import of PICs | 24 | 0.7741935 | 7.395571 |
5655272 | Signaling by FGFR3 mutants | 17 | 0.7727273 | 5.290414 |
5655332 | Signaling by FGFR3 in disease | 17 | 0.7727273 | 5.290414 |
2029481 | FCGR activation | 10 | 0.7692308 | 3.170962 |
209543 | p75NTR recruits signalling complexes | 10 | 0.7692308 | 3.170962 |
512988 | Interleukin-3, 5 and GM-CSF signaling | 33 | 0.7674419 | 9.902746 |
375165 | NCAM signaling for neurite out-growth | 49 | 0.7656250 | 14.552191 |
179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 52 | 0.7647059 | 15.394371 |
140837 | Intrinsic Pathway of Fibrin Clot Formation | 13 | 0.7647059 | 4.032656 |
1839126 | FGFR2 mutant receptor activation | 13 | 0.7647059 | 4.032656 |
190241 | FGFR2 ligand binding and activation | 13 | 0.7647059 | 4.032656 |
2033519 | Activated point mutants of FGFR2 | 13 | 0.7647059 | 4.032656 |
445144 | Signal transduction by L1 | 16 | 0.7619048 | 4.881210 |
5654688 | SHC-mediated cascade:FGFR1 | 16 | 0.7619048 | 4.881210 |
5654732 | Negative regulation of FGFR3 signaling | 22 | 0.7586207 | 6.533600 |
3858494 | beta-catenin independent WNT signaling | 85 | 0.7522124 | 24.300461 |
68867 | Assembly of the pre-replicative complex | 48 | 0.7500000 | 13.668038 |
3301854 | Nuclear Pore Complex (NPC) Disassembly | 24 | 0.7500000 | 6.945779 |
176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 52 | 0.7428571 | 14.491980 |
202433 | Generation of second messenger molecules | 23 | 0.7419355 | 6.527195 |
166520 | Signalling by NGF | 201 | 0.7362637 | 55.889080 |
68949 | Orc1 removal from chromatin | 50 | 0.7352941 | 13.656096 |
69052 | Switching of origins to a post-replicative state | 50 | 0.7352941 | 13.656096 |
176408 | Regulation of APC/C activators between G1/S and early anaphase | 55 | 0.7333333 | 14.904865 |
112043 | PLC beta mediated events | 33 | 0.7333333 | 9.022403 |
190242 | FGFR1 ligand binding and activation | 11 | 0.7333333 | 3.177983 |
176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 52 | 0.7323944 | 14.064345 |
449147 | Signaling by Interleukins | 78 | 0.7289720 | 20.862970 |
177243 | Interactions of Rev with host cellular proteins | 24 | 0.7272727 | 6.531423 |
2197563 | NOTCH2 intracellular domain regulates transcription | 8 | 0.7272727 | 2.317137 |
174143 | APC/C-mediated degradation of cell cycle proteins | 58 | 0.7250000 | 15.337580 |
453276 | Regulation of mitotic cell cycle | 58 | 0.7250000 | 15.337580 |
71387 | Metabolism of carbohydrates | 179 | 0.7246964 | 47.833303 |
170968 | Frs2-mediated activation | 13 | 0.7222222 | 3.617524 |
2428933 | SHC-related events triggered by IGF1R | 13 | 0.7222222 | 3.617524 |
389977 | Post-chaperonin tubulin folding pathway | 13 | 0.7222222 | 3.617524 |
5654704 | SHC-mediated cascade:FGFR3 | 13 | 0.7222222 | 3.617524 |
5663202 | Diseases of signal transduction | 169 | 0.7191489 | 44.285041 |
983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 23 | 0.7187500 | 6.131959 |
112040 | G-protein mediated events | 33 | 0.7173913 | 8.619893 |
69300 | Removal of licensing factors from origins | 50 | 0.7142857 | 12.837654 |
69304 | Regulation of DNA replication | 50 | 0.7142857 | 12.837654 |
114604 | GPVI-mediated activation cascade | 20 | 0.7142857 | 5.295033 |
419037 | NCAM1 interactions | 27 | 0.7105263 | 6.972202 |
176033 | Interactions of Vpr with host cellular proteins | 24 | 0.7058824 | 6.155877 |
140534 | Ligand-dependent caspase activation | 12 | 0.7058824 | 3.207851 |
5675482 | Regulation of necroptotic cell death | 12 | 0.7058824 | 3.207851 |
167044 | Signalling to RAS | 19 | 0.7037037 | 4.918120 |
354192 | Integrin alphaIIb beta3 signaling | 19 | 0.7037037 | 4.918120 |
177504 | Retrograde neurotrophin signalling | 7 | 0.7000000 | 1.917367 |
375281 | Hormone ligand-binding receptors | 7 | 0.7000000 | 1.917367 |
430116 | GP1b-IX-V activation signalling | 7 | 0.7000000 | 1.917367 |
5627123 | RHO GTPases activate PAKs | 16 | 0.6956522 | 4.087096 |
432040 | Vasopressin regulates renal water homeostasis via Aquaporins | 18 | 0.6923077 | 4.524705 |
156988 | Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor | 9 | 0.6923077 | 2.365634 |
171007 | p38MAPK events | 9 | 0.6923077 | 2.365634 |
190375 | FGFR2c ligand binding and activation | 9 | 0.6923077 | 2.365634 |
170984 | ARMS-mediated activation | 11 | 0.6875000 | 2.814803 |
416993 | Trafficking of GluR2-containing AMPA receptors | 11 | 0.6875000 | 2.814803 |
5627117 | RHO GTPases Activate ROCKs | 11 | 0.6875000 | 2.814803 |
912631 | Regulation of signaling by CBL | 11 | 0.6875000 | 2.814803 |
3000480 | Scavenging by Class A Receptors | 13 | 0.6842105 | 3.254412 |
5213460 | RIPK1-mediated regulated necrosis | 13 | 0.6842105 | 3.254412 |
5218859 | Regulated Necrosis | 13 | 0.6842105 | 3.254412 |
437239 | Recycling pathway of L1 | 17 | 0.6800000 | 4.132895 |
140877 | Formation of Fibrin Clot (Clotting Cascade) | 25 | 0.6756757 | 5.843096 |
76009 | Platelet Aggregation (Plug Formation) | 25 | 0.6756757 | 5.843096 |
4420097 | VEGFA-VEGFR2 Pathway | 62 | 0.6739130 | 13.977217 |
450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 58 | 0.6666667 | 12.781593 |
445095 | Interaction between L1 and Ankyrins | 12 | 0.6666667 | 2.872696 |
187706 | Signalling to p38 via RIT and RIN | 10 | 0.6666667 | 2.425077 |
391160 | Signal regulatory protein (SIRP) family interactions | 10 | 0.6666667 | 2.425077 |
5625900 | RHO GTPases activate CIT | 10 | 0.6666667 | 2.425077 |
5626467 | RHO GTPases activate IQGAPs | 10 | 0.6666667 | 2.425077 |
1502540 | Signaling by Activin | 8 | 0.6666667 | 1.983078 |
1679131 | Trafficking and processing of endosomal TLR | 8 | 0.6666667 | 1.983078 |
1839130 | Signaling by activated point mutants of FGFR3 | 8 | 0.6666667 | 1.983078 |
190239 | FGFR3 ligand binding and activation | 8 | 0.6666667 | 1.983078 |
190372 | FGFR3c ligand binding and activation | 8 | 0.6666667 | 1.983078 |
2033514 | FGFR3 mutant receptor activation | 8 | 0.6666667 | 1.983078 |
198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 45 | 0.6617647 | 9.796828 |
373760 | L1CAM interactions | 53 | 0.6543210 | 11.205846 |
169893 | Prolonged ERK activation events | 13 | 0.6500000 | 2.939325 |
1980145 | Signaling by NOTCH2 | 18 | 0.6428571 | 3.885521 |
170670 | Adenylate cyclase inhibitory pathway | 9 | 0.6428571 | 2.056963 |
997269 | Inhibition of adenylate cyclase pathway | 9 | 0.6428571 | 2.056963 |
432720 | Lysosome Vesicle Biogenesis | 16 | 0.6400000 | 3.448565 |
1839122 | Signaling by activated point mutants of FGFR1 | 7 | 0.6363636 | 1.609014 |
190373 | FGFR1c ligand binding and activation | 7 | 0.6363636 | 1.609014 |
1980148 | Signaling by NOTCH3 | 7 | 0.6363636 | 1.609014 |
1980150 | Signaling by NOTCH4 | 7 | 0.6363636 | 1.609014 |
376172 | DSCAM interactions | 7 | 0.6363636 | 1.609014 |
2559585 | Oncogene Induced Senescence | 19 | 0.6333333 | 3.958463 |
2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 45 | 0.6250000 | 8.607012 |
70153 | Glucose transport | 25 | 0.6250000 | 4.960107 |
1433559 | Regulation of KIT signaling | 10 | 0.6250000 | 2.140831 |
2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 10 | 0.6250000 | 2.140831 |
399954 | Sema3A PAK dependent Axon repulsion | 10 | 0.6250000 | 2.140831 |
187687 | Signalling to ERKs | 23 | 0.6216216 | 4.536554 |
68874 | M/G1 Transition | 49 | 0.6202532 | 9.178392 |
69002 | DNA Replication Pre-Initiation | 49 | 0.6202532 | 9.178392 |
194138 | Signaling by VEGF | 62 | 0.6200000 | 11.541586 |
2586552 | Signaling by Leptin | 13 | 0.6190476 | 2.662176 |
389960 | Formation of tubulin folding intermediates by CCT/TriC | 13 | 0.6190476 | 2.662176 |
2979096 | NOTCH2 Activation and Transmission of Signal to the Nucleus | 11 | 0.6111111 | 2.225274 |
422475 | Axon guidance | 178 | 0.6095890 | 31.965914 |
180024 | DARPP-32 events | 14 | 0.6086957 | 2.747488 |
157118 | Signaling by NOTCH | 52 | 0.6046512 | 9.151896 |
936440 | Negative regulators of RIG-I/MDA5 signaling | 18 | 0.6000000 | 3.341633 |
140875 | Common Pathway of Fibrin Clot Formation | 12 | 0.6000000 | 2.316060 |
418597 | G alpha (z) signalling events | 9 | 0.6000000 | 1.798910 |
189200 | Hexose transport | 25 | 0.5952381 | 4.448666 |
2980766 | Nuclear Envelope Breakdown | 25 | 0.5952381 | 4.448666 |
111885 | Opioid Signalling | 38 | 0.5937500 | 6.503669 |
2173789 | TGF-beta receptor signaling activates SMADs | 19 | 0.5937500 | 3.431975 |
2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 13 | 0.5909091 | 2.406931 |
416572 | Sema4D induced cell migration and growth-cone collapse | 13 | 0.5909091 | 2.406931 |
5357801 | Programmed Cell Death | 90 | 0.5844156 | 14.411391 |
3371556 | Cellular response to heat stress | 42 | 0.5833333 | 6.843506 |
109581 | Apoptosis | 88 | 0.5827815 | 13.992233 |
2029482 | Regulation of actin dynamics for phagocytic cup formation | 30 | 0.5769231 | 4.886753 |
74751 | Insulin receptor signalling cascade | 50 | 0.5747126 | 7.784614 |
195721 | Signaling by Wnt | 140 | 0.5714286 | 21.213614 |
1226099 | Signaling by FGFR in disease | 24 | 0.5714286 | 3.889827 |
3371571 | HSF1-dependent transactivation | 12 | 0.5714286 | 2.084986 |
399719 | Trafficking of AMPA receptors | 17 | 0.5666667 | 2.791859 |
399721 | Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity | 17 | 0.5666667 | 2.791859 |
373753 | Nephrin interactions | 13 | 0.5652174 | 2.184002 |
392517 | Rap1 signalling | 9 | 0.5625000 | 1.571935 |
77389 | IRS-related events | 46 | 0.5609756 | 6.763503 |
2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 14 | 0.5600000 | 2.283195 |
400685 | Sema4D in semaphorin signaling | 14 | 0.5600000 | 2.283195 |
5357769 | Caspase activation via extrinsic apoptotic signalig pathway | 14 | 0.5600000 | 2.283195 |
445717 | Aquaporin-mediated transport | 19 | 0.5588235 | 2.981729 |
114608 | Platelet degranulation | 45 | 0.5555556 | 6.467588 |
3371453 | Regulation of HSF1-mediated heat shock response | 30 | 0.5555556 | 4.457823 |
432722 | Golgi Associated Vesicle Biogenesis | 15 | 0.5555556 | 2.379708 |
168928 | RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | 36 | 0.5538462 | 5.207757 |
877300 | Interferon gamma signaling | 42 | 0.5526316 | 5.981673 |
112399 | IRS-mediated signalling | 44 | 0.5500000 | 6.173760 |
4086398 | Ca2+ pathway | 22 | 0.5500000 | 3.269770 |
69239 | Synthesis of DNA | 52 | 0.5473684 | 7.127602 |
76005 | Response to elevated platelet cytosolic Ca2+ | 47 | 0.5465116 | 6.456227 |
381676 | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 12 | 0.5454545 | 1.882195 |
69206 | G1/S Transition | 56 | 0.5436893 | 7.509120 |
1251985 | Nuclear signaling by ERBB4 | 20 | 0.5405405 | 2.878902 |
2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 47 | 0.5402299 | 6.258696 |
2428924 | IGF1R signaling cascade | 47 | 0.5402299 | 6.258696 |
2173788 | Downregulation of TGF-beta receptor signaling | 14 | 0.5384615 | 2.083760 |
1169408 | ISG15 antiviral mechanism | 35 | 0.5303030 | 4.549909 |
1169410 | Antiviral mechanism by IFN-stimulated genes | 35 | 0.5303030 | 4.549909 |
69242 | S Phase | 62 | 0.5299145 | 7.714172 |
4641263 | regulation of FZD by ubiquitination | 9 | 0.5294118 | 1.370089 |
1181150 | Signaling by NODAL | 10 | 0.5263158 | 1.481533 |
2173782 | Binding and Uptake of Ligands by Scavenger Receptors | 21 | 0.5250000 | 2.795104 |
1280215 | Cytokine Signaling in Immune system | 149 | 0.5246479 | 17.815629 |
2428928 | IRS-related events triggered by IGF1R | 44 | 0.5238095 | 5.414601 |
193704 | p75 NTR receptor-mediated signalling | 45 | 0.5232558 | 5.515553 |
373755 | Semaphorin interactions | 34 | 0.5230769 | 4.272601 |
2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 24 | 0.5217391 | 3.098872 |
2644603 | Signaling by NOTCH1 in Cancer | 24 | 0.5217391 | 3.098872 |
2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 24 | 0.5217391 | 3.098872 |
2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 24 | 0.5217391 | 3.098872 |
2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 24 | 0.5217391 | 3.098872 |
69306 | DNA Replication | 52 | 0.5200000 | 6.202882 |
1234174 | Regulation of Hypoxia-inducible Factor (HIF) by oxygen | 13 | 0.5200000 | 1.801875 |
2262749 | Cellular response to hypoxia | 13 | 0.5200000 | 1.801875 |
390466 | Chaperonin-mediated protein folding | 15 | 0.5172414 | 2.004138 |
5655302 | Signaling by FGFR1 in disease | 17 | 0.5151515 | 2.210502 |
5655311 | Signaling by FGFR1 mutants | 17 | 0.5151515 | 2.210502 |
201681 | TCF dependent signaling in response to WNT | 88 | 0.5086705 | 9.593274 |
5663213 | RHO GTPases Activate WASPs and WAVEs | 15 | 0.5000000 | 1.843546 |
69231 | Cyclin D associated events in G1 | 15 | 0.5000000 | 1.843546 |
69236 | G1 Phase | 15 | 0.5000000 | 1.843546 |
389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 14 | 0.5000000 | 1.738894 |
375170 | CDO in myogenesis | 12 | 0.5000000 | 1.527672 |
525793 | Myogenesis | 12 | 0.5000000 | 1.527672 |
2467813 | Separation of Sister Chromatids | 76 | 0.4967320 | 7.753800 |
109582 | Hemostasis | 222 | 0.4933333 | 22.254041 |
109704 | PI3K Cascade | 34 | 0.4927536 | 3.612905 |
76002 | Platelet activation, signaling and aggregation | 93 | 0.4920635 | 9.140880 |
69620 | Cell Cycle Checkpoints | 60 | 0.4878049 | 5.866730 |
162906 | HIV Infection | 106 | 0.4862385 | 9.989926 |
163359 | Glucagon signaling in metabolic regulation | 16 | 0.4848485 | 1.795734 |
68882 | Mitotic Anaphase | 78 | 0.4844720 | 7.347857 |
453279 | Mitotic G1-G1/S phases | 61 | 0.4841270 | 5.820753 |
933541 | TRAF6 mediated IRF7 activation | 14 | 0.4827586 | 1.583922 |
2555396 | Mitotic Metaphase and Anaphase | 78 | 0.4814815 | 7.205141 |
389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 13 | 0.4814815 | 1.480130 |
2559580 | Oxidative Stress Induced Senescence | 42 | 0.4772727 | 3.968454 |
2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 19 | 0.4750000 | 1.957546 |
1266738 | Developmental Biology | 207 | 0.4726027 | 17.896881 |
74752 | Signaling by Insulin receptor | 52 | 0.4684685 | 4.538754 |
1980143 | Signaling by NOTCH1 | 28 | 0.4666667 | 2.581566 |
2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 13 | 0.4642857 | 1.335667 |
199992 | trans-Golgi Network Vesicle Budding | 19 | 0.4418605 | 1.575808 |
2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 19 | 0.4418605 | 1.575808 |
421837 | Clathrin derived vesicle budding | 19 | 0.4418605 | 1.575808 |
68886 | M Phase | 103 | 0.4382979 | 6.751841 |
913531 | Interferon Signaling | 77 | 0.4350282 | 5.011694 |
5653656 | Vesicle-mediated transport | 80 | 0.4347826 | 5.168105 |
170834 | Signaling by TGF-beta Receptor Complex | 31 | 0.4305556 | 2.159302 |
204998 | Cell death signalling via NRAGE, NRIF and NADE | 26 | 0.4262295 | 1.804736 |
199991 | Membrane Trafficking | 59 | 0.4041096 | 2.924486 |
70326 | Glucose metabolism | 29 | 0.4027778 | 1.597527 |
2262752 | Cellular responses to stress | 102 | 0.3984375 | 4.489953 |
1500931 | Cell-Cell communication | 49 | 0.3920000 | 2.184002 |
68875 | Mitotic Prophase | 30 | 0.3896104 | 1.433104 |
112314 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | 52 | 0.3795620 | 1.979302 |
2559583 | Cellular Senescence | 54 | 0.3776224 | 1.985510 |
5663205 | Infectious disease | 131 | 0.3638889 | 3.479518 |
69278 | Cell Cycle, Mitotic | 143 | 0.3496333 | 2.902124 |
Category | Description | GO ID | -log10 pvalue |
---|---|---|---|
beta-catenin binding | beta-catenin binding | GO:0008013 | 0.9491 |
calcium ion binding | calcium ion binding | GO:0005509 | 10.6397 |
calcium-dependent protein binding | calcium-dependent protein binding | GO:0048306 | 1.0646 |
carbohydrate binding | carbohydrate binding | GO:0030246 | 102.0306 |
CARD domain binding | CARD domain binding | GO:0050700 | 1.1464 |
CARD domain binding | PTB domain binding | GO:0051425 | 0.7277 |
cell adhesion molecule binding | cell adhesion molecule binding | GO:0050839 | 1.7932 |
chemoattractant activity | chemoattractant activity | GO:0042056 | 0.9002 |
complement binding | complement binding | GO:0001848 | 2.0527 |
complement component C1q binding | complement component C1q binding | GO:0001849 | 0.9124 |
damaged DNA binding | damaged DNA binding | GO:0003684 | 0.3332 |
enzyme binding | enzyme binding | GO:0019899 | 8.3189 |
extracellular matrix binding | extracellular matrix binding | GO:0050840 | 4.8758 |
extracellular matrix structural constituent | extracellular matrix structural constituent | GO:0005201 | 35.2968 |
extracellular matrix structural constituent | structural constituent of cytoskeleton | GO:0005200 | 5.0513 |
extracellular matrix structural constituent | structural constituent of nuclear pore | GO:0017056 | 3.0832 |
extracellular matrix structural constituent | extracellular matrix structural constituent conferring tensile strength | GO:0030020 | 1.8967 |
extracellular matrix structural constituent | extracellular matrix constituent conferring elasticity | GO:0030023 | 1.2698 |
extracellular matrix structural constituent | extracellular matrix constituent, lubricant activity | GO:0030197 | 0.3065 |
fibronectin binding | fibronectin binding | GO:0001968 | 4.8758 |
glycoprotein binding | glycoprotein binding | GO:0001948 | 16.6949 |
glycoprotein binding | heparin binding | GO:0008201 | 15.1940 |
glycoprotein binding | GDP binding | GO:0019003 | 6.7169 |
glycoprotein binding | lipopolysaccharide binding | GO:0001530 | 4.4285 |
glycoprotein binding | glycosaminoglycan binding | GO:0005539 | 3.1227 |
glycoprotein binding | chitin binding | GO:0008061 | 2.0527 |
glycoprotein binding | sialic acid binding | GO:0033691 | 2.0527 |
glycoprotein binding | retinoic acid binding | GO:0001972 | 1.9630 |
glycoprotein binding | 3’-phosphoadenosine 5’-phosphosulfate binding | GO:0050656 | 1.8967 |
glycoprotein binding | ATP binding | GO:0005524 | 1.0103 |
glycoprotein binding | glycosphingolipid binding | GO:0043208 | 0.7277 |
glycoprotein binding | galactoside binding | GO:0016936 | 0.7277 |
glycoprotein binding | phospholipid binding | GO:0005543 | 0.3725 |
growth factor binding | growth factor binding | GO:0019838 | 1.3316 |
GTP-dependent protein binding | GTP-dependent protein binding | GO:0030742 | 1.7914 |
I-SMAD binding | I-SMAD binding | GO:0070411 | 2.8379 |
identical protein binding | identical protein binding | GO:0042802 | 3.1709 |
insulin receptor substrate binding | insulin receptor substrate binding | GO:0043560 | 1.1439 |
integrin binding | integrin binding | GO:0005178 | 30.5089 |
integrin binding | collagen binding | GO:0005518 | 16.6907 |
integrin binding | growth factor activity | GO:0008083 | 11.3605 |
integrin binding | frizzled binding | GO:0005109 | 7.7104 |
integrin binding | fibroblast growth factor receptor binding | GO:0005104 | 7.4210 |
integrin binding | protein complex binding | GO:0032403 | 5.8919 |
integrin binding | transforming growth factor beta receptor binding | GO:0005160 | 3.9339 |
integrin binding | MHC class I protein binding | GO:0042288 | 3.6558 |
integrin binding | cytokine activity | GO:0005125 | 3.2034 |
integrin binding | insulin receptor binding | GO:0005158 | 2.9274 |
integrin binding | ephrin receptor binding | GO:0046875 | 2.6506 |
integrin binding | tumor necrosis factor receptor binding | GO:0005164 | 2.0951 |
integrin binding | type I transforming growth factor beta receptor binding | GO:0034713 | 1.6886 |
integrin binding | natural killer cell lectin-like receptor binding | GO:0046703 | 1.6886 |
integrin binding | collagen binding involved in cell-matrix adhesion | GO:0098639 | 1.2698 |
integrin binding | patched binding | GO:0005113 | 1.1464 |
integrin binding | IgG binding | GO:0019864 | 1.1439 |
integrin binding | activin binding | GO:0048185 | 0.9469 |
integrin binding | neurotrophin TRKA receptor binding | GO:0005168 | 0.9268 |
integrin binding | hormone activity | GO:0005179 | 0.8169 |
integrin binding | proteasome binding | GO:0070628 | 0.7943 |
integrin binding | insulin-like growth factor receptor binding | GO:0005159 | 0.5352 |
integrin binding | low-density lipoprotein particle binding | GO:0030169 | 0.5352 |
integrin binding | D1 dopamine receptor binding | GO:0031748 | 0.3730 |
integrin binding | Roundabout binding | GO:0048495 | 0.3730 |
integrin binding | acetylcholine receptor binding | GO:0033130 | 0.3730 |
integrin binding | T cell receptor binding | GO:0042608 | 0.3065 |
ion channel binding | ion channel binding | GO:0044325 | 0.4556 |
L-serine transmembrane transporter activity | L-serine transmembrane transporter activity | GO:0015194 | 0.9124 |
L-serine transmembrane transporter activity | lipoprotein transporter activity | GO:0042954 | 0.7277 |
L-serine transmembrane transporter activity | ammonium transmembrane transporter activity | GO:0008519 | 0.6991 |
L-serine transmembrane transporter activity | nucleocytoplasmic transporter activity | GO:0005487 | 0.6196 |
L-serine transmembrane transporter activity | NMDA glutamate receptor activity | GO:0004972 | 0.5079 |
L-serine transmembrane transporter activity | glycolipid transporter activity | GO:0017089 | 0.4650 |
L-serine transmembrane transporter activity | protein transporter activity | GO:0008565 | 0.3550 |
laminin binding | laminin binding | GO:0043236 | 4.3481 |
mannose binding | mannose binding | GO:0005537 | 8.5782 |
mannose binding | polysaccharide binding | GO:0030247 | 2.6745 |
mannose binding | oligosaccharide binding | GO:0070492 | 0.9268 |
myosin V binding | myosin V binding | GO:0031489 | 6.6027 |
myosin V binding | ankyrin binding | GO:0030506 | 0.8205 |
myosin V binding | vinculin binding | GO:0017166 | 0.7317 |
peptide antigen binding | peptide antigen binding | GO:0042605 | 8.9280 |
peptide antigen binding | MHC class II protein complex binding | GO:0023026 | 2.8973 |
peptide antigen binding | ER retention sequence binding | GO:0046923 | 0.4650 |
peptide antigen binding | protein antigen binding | GO:1990405 | 0.4650 |
phosphatidylinositol 3-kinase binding | phosphatidylinositol 3-kinase binding | GO:0043548 | 2.1166 |
phosphatidylinositol 3-kinase regulatory subunit binding | phosphatidylinositol 3-kinase regulatory subunit binding | GO:0036312 | 0.3730 |
platelet-derived growth factor binding | platelet-derived growth factor binding | GO:0048407 | 5.2306 |
platelet-derived growth factor binding | transforming growth factor beta binding | GO:0050431 | 4.8111 |
platelet-derived growth factor binding | C-X3-C chemokine binding | GO:0019960 | 0.4650 |
platelet-derived growth factor binding | neuregulin binding | GO:0038132 | 0.4650 |
protein binding | protein binding | GO:0005515 | 12.2145 |
protein binding, bridging | protein binding, bridging | GO:0030674 | 0.7402 |
protein C-terminus binding | protein C-terminus binding | GO:0008022 | 0.7939 |
protein domain specific binding | protein domain specific binding | GO:0019904 | 1.2640 |
protein heterodimerization activity | protein heterodimerization activity | GO:0046982 | 11.3640 |
Ras guanyl-nucleotide exchange factor activity | Ras guanyl-nucleotide exchange factor activity | GO:0005088 | 52.9071 |
Ras guanyl-nucleotide exchange factor activity | nitric-oxide synthase regulator activity | GO:0030235 | 3.1856 |
Ras guanyl-nucleotide exchange factor activity | receptor agonist activity | GO:0048018 | 2.8973 |
Ras guanyl-nucleotide exchange factor activity | endopeptidase inhibitor activity | GO:0004866 | 2.5732 |
Ras guanyl-nucleotide exchange factor activity | protein serine/threonine kinase activator activity | GO:0043539 | 1.6767 |
Ras guanyl-nucleotide exchange factor activity | enzyme activator activity | GO:0008047 | 0.9460 |
Ras guanyl-nucleotide exchange factor activity | protein phosphatase activator activity | GO:0072542 | 0.3065 |
receptor binding | receptor binding | GO:0005102 | 9.4175 |
S100 protein binding | S100 protein binding | GO:0044548 | 0.3560 |
scaffold protein binding | scaffold protein binding | GO:0097110 | 0.5877 |
signal transducer activity | signal transducer activity | GO:0004871 | 0.3588 |
SMAD binding | SMAD binding | GO:0046332 | 2.1450 |
SNAP receptor activity | SNAP receptor activity | GO:0005484 | 0.9095 |
SNARE binding | SNARE binding | GO:0000149 | 1.0061 |
TAP1 binding | TAP1 binding | GO:0046978 | 0.7277 |
transferase activity, transferring glycosyl groups | transferase activity, transferring glycosyl groups | GO:0016757 | 37.6853 |
transferase activity, transferring glycosyl groups | sulfotransferase activity | GO:0008146 | 23.7868 |
transferase activity, transferring glycosyl groups | thiol-dependent ubiquitin-specific protease activity | GO:0004843 | 22.5254 |
transferase activity, transferring glycosyl groups | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | GO:0046934 | 22.3369 |
transferase activity, transferring glycosyl groups | transferase activity, transferring hexosyl groups | GO:0016758 | 18.6488 |
transferase activity, transferring glycosyl groups | metalloendopeptidase activity | GO:0004222 | 14.9723 |
transferase activity, transferring glycosyl groups | hydrolase activity, hydrolyzing O-glycosyl compounds | GO:0004553 | 13.9723 |
transferase activity, transferring glycosyl groups | protein tyrosine kinase activity | GO:0004713 | 13.9503 |
transferase activity, transferring glycosyl groups | threonine-type endopeptidase activity | GO:0004298 | 9.2326 |
transferase activity, transferring glycosyl groups | peptidase activity | GO:0008233 | 8.5258 |
transferase activity, transferring glycosyl groups | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity | GO:0008499 | 6.6221 |
transferase activity, transferring glycosyl groups | GTPase activity | GO:0003924 | 5.9983 |
transferase activity, transferring glycosyl groups | ubiquitin conjugating enzyme activity | GO:0061631 | 5.6379 |
transferase activity, transferring glycosyl groups | sulfuric ester hydrolase activity | GO:0008484 | 5.2943 |
transferase activity, transferring glycosyl groups | ephrin receptor activity | GO:0005003 | 3.9116 |
transferase activity, transferring glycosyl groups | fucosyltransferase activity | GO:0008417 | 3.8620 |
transferase activity, transferring glycosyl groups | SUMO transferase activity | GO:0019789 | 3.7858 |
transferase activity, transferring glycosyl groups | arylsulfatase activity | GO:0004065 | 3.4127 |
transferase activity, transferring glycosyl groups | alpha-(1->3)-fucosyltransferase activity | GO:0046920 | 3.1856 |
transferase activity, transferring glycosyl groups | transferase activity | GO:0016740 | 3.1725 |
transferase activity, transferring glycosyl groups | MAP kinase tyrosine/serine/threonine phosphatase activity | GO:0017017 | 3.0184 |
transferase activity, transferring glycosyl groups | MAP kinase activity | GO:0004707 | 2.6745 |
transferase activity, transferring glycosyl groups | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | GO:0004579 | 2.6670 |
transferase activity, transferring glycosyl groups | phosphorus-oxygen lyase activity | GO:0016849 | 2.4615 |
transferase activity, transferring glycosyl groups | MAP kinase kinase activity | GO:0004708 | 2.4615 |
transferase activity, transferring glycosyl groups | microtubule motor activity | GO:0003777 | 2.3957 |
transferase activity, transferring glycosyl groups | dolichyl-phosphate-mannose-protein mannosyltransferase activity | GO:0004169 | 1.8967 |
transferase activity, transferring glycosyl groups | proteasome-activating ATPase activity | GO:0036402 | 1.8967 |
transferase activity, transferring glycosyl groups | UDP-xylosyltransferase activity | GO:0035252 | 1.8967 |
transferase activity, transferring glycosyl groups | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity | GO:0001665 | 1.8967 |
transferase activity, transferring glycosyl groups | ubiquitin protein ligase activity involved in ERAD pathway | GO:1904264 | 1.6886 |
transferase activity, transferring glycosyl groups | sphingosine N-acyltransferase activity | GO:0050291 | 1.4646 |
transferase activity, transferring glycosyl groups | sphingomyelin phosphodiesterase activity | GO:0004767 | 1.4646 |
transferase activity, transferring glycosyl groups | hydrolase activity, acting on glycosyl bonds | GO:0016798 | 1.3825 |
transferase activity, transferring glycosyl groups | signal transducer, downstream of receptor, with protein tyrosine kinase activity | GO:0004716 | 1.3825 |
transferase activity, transferring glycosyl groups | 1-phosphatidylinositol-3-phosphate 4-kinase activity | GO:0052811 | 1.2698 |
transferase activity, transferring glycosyl groups | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | GO:0016641 | 1.2698 |
transferase activity, transferring glycosyl groups | serine C-palmitoyltransferase activity | GO:0004758 | 1.2698 |
transferase activity, transferring glycosyl groups | phosphatidylinositol N-acetylglucosaminyltransferase activity | GO:0017176 | 1.2698 |
transferase activity, transferring glycosyl groups | GPI-anchor transamidase activity | GO:0003923 | 1.2698 |
transferase activity, transferring glycosyl groups | sphingosine-1-phosphate phosphatase activity | GO:0042392 | 1.2698 |
transferase activity, transferring glycosyl groups | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity | GO:0030618 | 1.2698 |
transferase activity, transferring glycosyl groups | phosphoprotein phosphatase activity | GO:0004721 | 1.0901 |
transferase activity, transferring glycosyl groups | adenylate cyclase activity | GO:0004016 | 0.9421 |
transferase activity, transferring glycosyl groups | ligase activity | GO:0016874 | 0.8792 |
transferase activity, transferring glycosyl groups | ubiquitin-ubiquitin ligase activity | GO:0034450 | 0.7943 |
transferase activity, transferring glycosyl groups | procollagen-proline 4-dioxygenase activity | GO:0004656 | 0.7277 |
transferase activity, transferring glycosyl groups | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | GO:0008454 | 0.7277 |
transferase activity, transferring glycosyl groups | ceramidase activity | GO:0017040 | 0.7277 |
transferase activity, transferring glycosyl groups | hyaluronan synthase activity | GO:0050501 | 0.7277 |
transferase activity, transferring glycosyl groups | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | GO:0050510 | 0.7277 |
transferase activity, transferring glycosyl groups | oligosaccharyl transferase activity | GO:0004576 | 0.7277 |
transferase activity, transferring glycosyl groups | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity | GO:0004583 | 0.7277 |
transferase activity, transferring glycosyl groups | protein serine/threonine/tyrosine kinase activity | GO:0004712 | 0.7203 |
transferase activity, transferring glycosyl groups | phosphatidylinositol phosphate kinase activity | GO:0016307 | 0.6991 |
transferase activity, transferring glycosyl groups | protein kinase C activity | GO:0004697 | 0.5352 |
transferase activity, transferring glycosyl groups | NF-kappaB-inducing kinase activity | GO:0004704 | 0.3065 |
ubiquitin binding | ubiquitin binding | GO:0043130 | 1.8377 |
ubiquitin protein ligase binding | ubiquitin protein ligase binding | GO:0031625 | 10.9273 |
ubiquitin protein ligase binding | protein kinase binding | GO:0019901 | 9.9661 |
ubiquitin protein ligase binding | protease binding | GO:0002020 | 7.2507 |
ubiquitin protein ligase binding | protein phosphatase binding | GO:0019903 | 4.9916 |
ubiquitin protein ligase binding | receptor tyrosine kinase binding | GO:0030971 | 2.1450 |
ubiquitin protein ligase binding | phospholipase binding | GO:0043274 | 1.6767 |
ubiquitin protein ligase binding | thioesterase binding | GO:0031996 | 1.1792 |
ubiquitin protein ligase binding | nitric-oxide synthase binding | GO:0050998 | 1.1792 |
ubiquitin protein ligase binding | protein kinase A catalytic subunit binding | GO:0034236 | 1.1792 |
ubiquitin protein ligase binding | ubiquitin-specific protease binding | GO:1990381 | 0.7943 |
ubiquitin protein ligase binding | mitogen-activated protein kinase kinase kinase binding | GO:0031435 | 0.7395 |
ubiquitin protein ligase binding | protein kinase C binding | GO:0005080 | 0.7193 |
ubiquitin protein ligase binding | ATPase binding | GO:0051117 | 0.6687 |
ubiquitin protein ligase binding | acrosin binding | GO:0032190 | 0.4650 |
ubiquitin protein ligase binding | mitogen-activated protein kinase kinase binding | GO:0031434 | 0.4405 |
ubiquitin protein ligase binding | kinase binding | GO:0019900 | 0.4201 |
virus receptor activity | virus receptor activity | GO:0001618 | 12.2981 |
virus receptor activity | receptor activity | GO:0004872 | 12.2870 |
virus receptor activity | MHC class II receptor activity | GO:0032395 | 6.5776 |
virus receptor activity | coreceptor activity | GO:0015026 | 4.5430 |
virus receptor activity | signal transducer activity, downstream of receptor | GO:0005057 | 3.7011 |
virus receptor activity | scavenger receptor activity | GO:0005044 | 2.0012 |
virus receptor activity | signaling pattern recognition receptor activity | GO:0008329 | 1.4646 |
virus receptor activity | cytokine receptor activity | GO:0004896 | 0.8154 |
virus receptor activity | thrombospondin receptor activity | GO:0070053 | 0.7277 |
virus receptor activity | axon guidance receptor activity | GO:0008046 | 0.6991 |
virus receptor activity | Wnt-activated receptor activity | GO:0042813 | 0.6196 |
virus receptor activity | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway | GO:1904929 | 0.3065 |
Wnt-protein binding | Wnt-protein binding | GO:0017147 | 1.7908 |
Category | Description | GO ID | -log10 pvalue |
---|---|---|---|
carbohydrate metabolism | carbohydrate metabolic process | GO:0005975 | 40.0241 |
cell activation | cell activation | GO:0001775 | 1.7257 |
cell proliferation | cell proliferation | GO:0008283 | 2.1381 |
cell-matrix adhesion | cell-matrix adhesion | GO:0007160 | 23.0592 |
cell-matrix adhesion | cell adhesion mediated by integrin | GO:0033627 | 7.7474 |
cell-matrix adhesion | cell-substrate adhesion | GO:0031589 | 2.3989 |
ER to Golgi vesicle-mediated transport | ER to Golgi vesicle-mediated transport | GO:0006888 | 60.1489 |
ER to Golgi vesicle-mediated transport | regulation of glucose transport | GO:0010827 | 10.5606 |
ER to Golgi vesicle-mediated transport | tRNA export from nucleus | GO:0006409 | 9.9580 |
ER to Golgi vesicle-mediated transport | platelet degranulation | GO:0002576 | 9.9159 |
ER to Golgi vesicle-mediated transport | protein transport | GO:0015031 | 4.7154 |
ER to Golgi vesicle-mediated transport | vesicle-mediated transport | GO:0016192 | 3.6755 |
ER to Golgi vesicle-mediated transport | protein localization to cell surface | GO:0034394 | 3.3371 |
ER to Golgi vesicle-mediated transport | positive regulation of phagocytosis | GO:0050766 | 3.0705 |
ER to Golgi vesicle-mediated transport | opsonization | GO:0008228 | 3.0594 |
ER to Golgi vesicle-mediated transport | receptor-mediated endocytosis | GO:0006898 | 3.0337 |
ER to Golgi vesicle-mediated transport | endocytosis | GO:0006897 | 2.7111 |
ER to Golgi vesicle-mediated transport | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | GO:0045899 | 2.4692 |
ER to Golgi vesicle-mediated transport | positive regulation of potassium ion transmembrane transporter activity | GO:1901018 | 1.7263 |
extracellular matrix organization | extracellular matrix organization | GO:0030198 | 69.1592 |
extracellular matrix organization | mitotic nuclear envelope disassembly | GO:0007077 | 6.6247 |
extracellular matrix organization | Golgi organization | GO:0007030 | 3.1137 |
extracellular matrix organization | hemidesmosome assembly | GO:0031581 | 2.2532 |
extracellular matrix organization | G2/M transition of mitotic cell cycle | GO:0000086 | 1.9633 |
extracellular matrix organization | phagosome maturation | GO:0090382 | 1.7263 |
microtubule-based process | microtubule-based process | GO:0007017 | 7.3761 |
movement of cell or subcellular component | movement of cell or subcellular component | GO:0006928 | 2.6700 |
negative regulation of apoptotic process | negative regulation of apoptotic process | GO:0043066 | 5.6830 |
negative regulation of apoptotic process | negative regulation of endothelial cell apoptotic process | GO:2000352 | 4.0451 |
negative regulation of apoptotic process | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902042 | 2.9037 |
negative regulation of apoptotic process | necroptotic process | GO:0070266 | 2.8866 |
negative regulation of apoptotic process | apoptotic signaling pathway | GO:0097190 | 2.6120 |
negative regulation of apoptotic process | positive regulation of neuron apoptotic process | GO:0043525 | 1.9153 |
protein glycosylation | protein glycosylation | GO:0006486 | 64.3467 |
protein glycosylation | protein sumoylation | GO:0016925 | 49.4255 |
protein glycosylation | collagen catabolic process | GO:0030574 | 34.2921 |
protein glycosylation | ubiquitin-dependent protein catabolic process | GO:0006511 | 33.9429 |
protein glycosylation | protein deubiquitination | GO:0016579 | 27.3478 |
protein glycosylation | glycosphingolipid metabolic process | GO:0006687 | 24.0185 |
protein glycosylation | regulation of cellular amino acid metabolic process | GO:0006521 | 23.6815 |
protein glycosylation | glycosaminoglycan biosynthetic process | GO:0006024 | 21.9230 |
protein glycosylation | protein polyubiquitination | GO:0000209 | 17.5192 |
protein glycosylation | peptidyl-tyrosine phosphorylation | GO:0018108 | 17.2847 |
protein glycosylation | proteolysis | GO:0006508 | 15.9959 |
protein glycosylation | phosphatidylinositol phosphorylation | GO:0046854 | 15.5691 |
protein glycosylation | positive regulation of NF-kappaB transcription factor activity | GO:0051092 | 14.8709 |
protein glycosylation | regulation of mRNA stability | GO:0043488 | 13.9093 |
protein glycosylation | platelet activation | GO:0030168 | 13.2238 |
protein glycosylation | oligosaccharide metabolic process | GO:0009311 | 13.1518 |
protein glycosylation | flavonoid glucuronidation | GO:0052696 | 12.6957 |
protein glycosylation | positive regulation of gene expression | GO:0010628 | 10.4137 |
protein glycosylation | sialylation | GO:0097503 | 9.6787 |
protein glycosylation | cellular protein modification process | GO:0006464 | 7.8081 |
protein glycosylation | dolichol-linked oligosaccharide biosynthetic process | GO:0006488 | 7.7474 |
protein glycosylation | positive regulation of cell proliferation | GO:0008284 | 7.4475 |
protein glycosylation | post-translational protein modification | GO:0043687 | 7.1290 |
protein glycosylation | protein K48-linked ubiquitination | GO:0070936 | 5.8734 |
protein glycosylation | positive regulation of fibroblast proliferation | GO:0048146 | 5.6917 |
protein glycosylation | glycogen biosynthetic process | GO:0005978 | 5.4554 |
protein glycosylation | protein stabilization | GO:0050821 | 5.1783 |
protein glycosylation | regulation of protein stability | GO:0031647 | 5.1733 |
protein glycosylation | 3’-phosphoadenosine 5’-phosphosulfate metabolic process | GO:0050427 | 5.0465 |
protein glycosylation | sulfation | GO:0051923 | 4.9929 |
protein glycosylation | oligosaccharide catabolic process | GO:0009313 | 4.9929 |
protein glycosylation | positive regulation of epithelial cell proliferation | GO:0050679 | 4.5781 |
protein glycosylation | renal water homeostasis | GO:0003091 | 4.4890 |
protein glycosylation | endoplasmic reticulum mannose trimming | GO:1904380 | 4.3183 |
protein glycosylation | L-fucose catabolic process | GO:0042355 | 4.3183 |
protein glycosylation | peptidyl-serine phosphorylation | GO:0018105 | 4.2946 |
protein glycosylation | positive regulation of DNA replication | GO:0045740 | 4.2884 |
protein glycosylation | positive regulation of pri-miRNA transcription from RNA polymerase II promoter | GO:1902895 | 3.1070 |
protein glycosylation | protein deglycosylation | GO:0006517 | 3.0594 |
protein glycosylation | positive regulation of protein binding | GO:0032092 | 2.8863 |
protein glycosylation | positive regulation of cell growth | GO:0030307 | 2.8662 |
protein glycosylation | activation of adenylate cyclase activity | GO:0007190 | 2.8438 |
protein glycosylation | N-acetylglucosamine metabolic process | GO:0006044 | 2.7971 |
protein glycosylation | positive regulation of phosphatidylinositol 3-kinase activity | GO:0043552 | 2.6749 |
protein glycosylation | Notch receptor processing | GO:0007220 | 2.6717 |
protein glycosylation | peptidyl-glutamic acid carboxylation | GO:0017187 | 2.6218 |
protein glycosylation | membrane protein ectodomain proteolysis | GO:0006509 | 2.6110 |
protein glycosylation | positive regulation of smooth muscle cell proliferation | GO:0048661 | 2.5693 |
protein glycosylation | positive regulation of nitric oxide biosynthetic process | GO:0045429 | 2.3996 |
protein glycosylation | lipid glycosylation | GO:0030259 | 2.3571 |
protein glycosylation | posttranscriptional gene silencing by RNA | GO:0035194 | 2.3571 |
protein glycosylation | mannose metabolic process | GO:0006013 | 2.3571 |
protein glycosylation | fucose metabolic process | GO:0006004 | 2.3571 |
protein glycosylation | negative regulation of cell proliferation | GO:0008285 | 2.2816 |
protein glycosylation | hormone biosynthetic process | GO:0042446 | 2.2532 |
protein glycosylation | defense response | GO:0006952 | 2.2141 |
protein glycosylation | fibrinolysis | GO:0042730 | 2.1490 |
protein glycosylation | protein K11-linked deubiquitination | GO:0035871 | 2.0509 |
protein glycosylation | global genome nucleotide-excision repair | GO:0070911 | 1.9454 |
protein glycosylation | myeloid dendritic cell differentiation | GO:0043011 | 1.9147 |
protein glycosylation | depyrimidination | GO:0045008 | 1.8732 |
protein glycosylation | histone H2B ubiquitination | GO:0033523 | 1.8732 |
protein glycosylation | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | GO:0017183 | 1.8732 |
protein glycosylation | protein K63-linked ubiquitination | GO:0070534 | 1.7443 |
protein glycosylation | glycoprotein metabolic process | GO:0009100 | 1.7257 |
response to calcium ion | response to calcium ion | GO:0051592 | 3.2880 |
response to calcium ion | response to drug | GO:0042493 | 2.1281 |
response to estrogen | response to estrogen | GO:0043627 | 4.3314 |
skeletal system development | skeletal system development | GO:0001501 | 5.9117 |
skeletal system development | cell fate commitment | GO:0045165 | 5.4249 |
skeletal system development | lung development | GO:0030324 | 2.8894 |
skeletal system development | ureteric bud development | GO:0001657 | 2.6216 |
skeletal system development | ossification | GO:0001503 | 2.4932 |
skeletal system development | learning or memory | GO:0007611 | 1.8791 |
skeletal system development | palate development | GO:0060021 | 1.7470 |
stimulatory C-type lectin receptor signaling pathway | stimulatory C-type lectin receptor signaling pathway | GO:0002223 | 69.5226 |
stimulatory C-type lectin receptor signaling pathway | antigen processing and presentation of exogenous peptide antigen via MHC class II | GO:0019886 | 60.1536 |
stimulatory C-type lectin receptor signaling pathway | leukocyte migration | GO:0050900 | 56.9727 |
stimulatory C-type lectin receptor signaling pathway | ephrin receptor signaling pathway | GO:0048013 | 40.5276 |
stimulatory C-type lectin receptor signaling pathway | NIK/NF-kappaB signaling | GO:0038061 | 39.1318 |
stimulatory C-type lectin receptor signaling pathway | regulation of phosphatidylinositol 3-kinase signaling | GO:0014066 | 31.1589 |
stimulatory C-type lectin receptor signaling pathway | Wnt signaling pathway, planar cell polarity pathway | GO:0060071 | 30.6222 |
stimulatory C-type lectin receptor signaling pathway | T cell costimulation | GO:0031295 | 24.0650 |
stimulatory C-type lectin receptor signaling pathway | tumor necrosis factor-mediated signaling pathway | GO:0033209 | 21.5788 |
stimulatory C-type lectin receptor signaling pathway | activation of MAPK activity | GO:0000187 | 20.7444 |
stimulatory C-type lectin receptor signaling pathway | antigen processing and presentation | GO:0019882 | 19.8665 |
stimulatory C-type lectin receptor signaling pathway | integrin-mediated signaling pathway | GO:0007229 | 17.3417 |
stimulatory C-type lectin receptor signaling pathway | inflammatory response | GO:0006954 | 16.1013 |
stimulatory C-type lectin receptor signaling pathway | regulation of complement activation | GO:0030449 | 15.0874 |
stimulatory C-type lectin receptor signaling pathway | signal transduction | GO:0007165 | 14.8515 |
stimulatory C-type lectin receptor signaling pathway | transforming growth factor beta receptor signaling pathway | GO:0007179 | 13.9132 |
stimulatory C-type lectin receptor signaling pathway | I-kappaB kinase/NF-kappaB signaling | GO:0007249 | 12.5430 |
stimulatory C-type lectin receptor signaling pathway | axon guidance | GO:0007411 | 12.3849 |
stimulatory C-type lectin receptor signaling pathway | negative regulation of epidermal growth factor receptor signaling pathway | GO:0042059 | 11.2965 |
stimulatory C-type lectin receptor signaling pathway | regulation of defense response to virus by virus | GO:0050690 | 10.9370 |
stimulatory C-type lectin receptor signaling pathway | regulation of cellular response to heat | GO:1900034 | 10.5872 |
stimulatory C-type lectin receptor signaling pathway | angiogenesis | GO:0001525 | 10.4832 |
stimulatory C-type lectin receptor signaling pathway | endodermal cell differentiation | GO:0035987 | 10.2895 |
stimulatory C-type lectin receptor signaling pathway | immune response | GO:0006955 | 10.0252 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of GTPase activity | GO:0043547 | 9.9344 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of cell migration | GO:0030335 | 9.7829 |
stimulatory C-type lectin receptor signaling pathway | small GTPase mediated signal transduction | GO:0007264 | 9.6469 |
stimulatory C-type lectin receptor signaling pathway | regulation of immune response | GO:0050776 | 9.6190 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of I-kappaB kinase/NF-kappaB signaling | GO:0043123 | 9.4529 |
stimulatory C-type lectin receptor signaling pathway | cell-cell signaling | GO:0007267 | 8.4215 |
stimulatory C-type lectin receptor signaling pathway | activation of protein kinase A activity | GO:0034199 | 8.3167 |
stimulatory C-type lectin receptor signaling pathway | transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 8.1957 |
stimulatory C-type lectin receptor signaling pathway | interferon-gamma-mediated signaling pathway | GO:0060333 | 8.0429 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of tumor necrosis factor production | GO:0032760 | 7.3607 |
stimulatory C-type lectin receptor signaling pathway | vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 6.5640 |
stimulatory C-type lectin receptor signaling pathway | cellular response to mechanical stimulus | GO:0071260 | 6.1350 |
stimulatory C-type lectin receptor signaling pathway | adaptive immune response | GO:0002250 | 5.9617 |
stimulatory C-type lectin receptor signaling pathway | response to lipopolysaccharide | GO:0032496 | 5.9142 |
stimulatory C-type lectin receptor signaling pathway | leukocyte cell-cell adhesion | GO:0007159 | 5.8128 |
stimulatory C-type lectin receptor signaling pathway | negative regulation of Ras protein signal transduction | GO:0046580 | 5.8128 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of interleukin-6 production | GO:0032755 | 5.6480 |
stimulatory C-type lectin receptor signaling pathway | defense response to Gram-positive bacterium | GO:0050830 | 5.5286 |
stimulatory C-type lectin receptor signaling pathway | fibroblast growth factor receptor signaling pathway | GO:0008543 | 5.4585 |
stimulatory C-type lectin receptor signaling pathway | JNK cascade | GO:0007254 | 5.4400 |
stimulatory C-type lectin receptor signaling pathway | cell surface receptor signaling pathway | GO:0007166 | 5.3514 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of protein kinase B signaling | GO:0051897 | 5.1633 |
stimulatory C-type lectin receptor signaling pathway | cellular response to organic cyclic compound | GO:0071407 | 4.7478 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of interferon-gamma production | GO:0032729 | 4.7464 |
stimulatory C-type lectin receptor signaling pathway | blood coagulation, intrinsic pathway | GO:0007597 | 4.7060 |
stimulatory C-type lectin receptor signaling pathway | microtubule-based movement | GO:0007018 | 4.5743 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of B cell proliferation | GO:0030890 | 4.2680 |
stimulatory C-type lectin receptor signaling pathway | Ras protein signal transduction | GO:0007265 | 4.1268 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of osteoblast differentiation | GO:0045669 | 4.0481 |
stimulatory C-type lectin receptor signaling pathway | complement activation, alternative pathway | GO:0006957 | 3.8124 |
stimulatory C-type lectin receptor signaling pathway | negative regulation of type I interferon production | GO:0032480 | 3.5358 |
stimulatory C-type lectin receptor signaling pathway | response to hypoxia | GO:0001666 | 3.4183 |
stimulatory C-type lectin receptor signaling pathway | natural killer cell activation | GO:0030101 | 3.1070 |
stimulatory C-type lectin receptor signaling pathway | negative regulation of glucuronosyltransferase activity | GO:1904224 | 2.9845 |
stimulatory C-type lectin receptor signaling pathway | Notch signaling pathway | GO:0007219 | 2.9607 |
stimulatory C-type lectin receptor signaling pathway | aorta development | GO:0035904 | 2.8866 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of peptidyl-threonine phosphorylation | GO:0010800 | 2.8437 |
stimulatory C-type lectin receptor signaling pathway | leukocyte tethering or rolling | GO:0050901 | 2.7971 |
stimulatory C-type lectin receptor signaling pathway | cellular defense response | GO:0006968 | 2.7640 |
stimulatory C-type lectin receptor signaling pathway | epithelial to mesenchymal transition | GO:0001837 | 2.7248 |
stimulatory C-type lectin receptor signaling pathway | regulation of inflammatory response | GO:0050727 | 2.6496 |
stimulatory C-type lectin receptor signaling pathway | cartilage condensation | GO:0001502 | 2.6110 |
stimulatory C-type lectin receptor signaling pathway | heterotypic cell-cell adhesion | GO:0034113 | 2.6110 |
stimulatory C-type lectin receptor signaling pathway | response to estradiol | GO:0032355 | 2.5847 |
stimulatory C-type lectin receptor signaling pathway | cellular response to lipoteichoic acid | GO:0071223 | 2.4692 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of interleukin-8 production | GO:0032757 | 2.4137 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of interleukin-4 production | GO:0032753 | 2.3785 |
stimulatory C-type lectin receptor signaling pathway | antigen processing and presentation of endogenous peptide antigen via MHC class I | GO:0019885 | 2.3571 |
stimulatory C-type lectin receptor signaling pathway | T-helper 1 type immune response | GO:0042088 | 2.2532 |
stimulatory C-type lectin receptor signaling pathway | activation of NF-kappaB-inducing kinase activity | GO:0007250 | 2.1425 |
stimulatory C-type lectin receptor signaling pathway | cellular response to platelet-derived growth factor stimulus | GO:0036120 | 2.1425 |
stimulatory C-type lectin receptor signaling pathway | intracellular signal transduction | GO:0035556 | 2.0201 |
stimulatory C-type lectin receptor signaling pathway | cellular response to insulin stimulus | GO:0032869 | 2.0148 |
stimulatory C-type lectin receptor signaling pathway | protein autophosphorylation | GO:0046777 | 2.0013 |
stimulatory C-type lectin receptor signaling pathway | positive regulation of vascular endothelial growth factor receptor signaling pathway | GO:0030949 | 1.9118 |
stimulatory C-type lectin receptor signaling pathway | cellular response to forskolin | GO:1904322 | 1.8732 |
stimulatory C-type lectin receptor signaling pathway | cellular response to interleukin-1 | GO:0071347 | 1.8298 |
stimulatory C-type lectin receptor signaling pathway | endochondral ossification | GO:0001958 | 1.8155 |
stimulatory C-type lectin receptor signaling pathway | common-partner SMAD protein phosphorylation | GO:0007182 | 1.7263 |
stimulatory C-type lectin receptor signaling pathway | toll-like receptor 2 signaling pathway | GO:0034134 | 1.7263 |
stimulatory C-type lectin receptor signaling pathway | collagen-activated tyrosine kinase receptor signaling pathway | GO:0038063 | 1.7263 |
stimulatory C-type lectin receptor signaling pathway | response to muramyl dipeptide | GO:0032495 | 1.7257 |
sulfur compound metabolism | sulfur compound metabolic process | GO:0006790 | 4.5488 |
viral process | viral process | GO:0016032 | 12.7400 |
viral process | intracellular transport of virus | GO:0075733 | 8.5947 |
viral process | binding of sperm to zona pellucida | GO:0007339 | 2.5693 |
viral process | virion assembly | GO:0019068 | 2.2532 |
viral process | proteolysis in other organism | GO:0035897 | 1.7263 |
Category | Description | GO ID | -log10 pvalue |
---|---|---|---|
anchored component of membrane | plasma membrane | GO:0005886 | 48.3446 |
anchored component of membrane | anchored component of membrane | GO:0031225 | 43.3279 |
anchored component of membrane | integral component of plasma membrane | GO:0005887 | 24.4233 |
anchored component of membrane | external side of plasma membrane | GO:0009897 | 22.0086 |
anchored component of membrane | integrin complex | GO:0008305 | 17.5502 |
anchored component of membrane | integral component of membrane | GO:0016021 | 12.1286 |
anchored component of membrane | anchored component of plasma membrane | GO:0046658 | 10.7469 |
anchored component of membrane | integral component of lumenal side of endoplasmic reticulum membrane | GO:0071556 | 9.1060 |
anchored component of membrane | MHC class II protein complex | GO:0042613 | 8.0163 |
anchored component of membrane | intrinsic component of the cytoplasmic side of the plasma membrane | GO:0031235 | 4.5792 |
anchored component of membrane | apical plasma membrane | GO:0016324 | 3.6616 |
anchored component of membrane | membrane attack complex | GO:0005579 | 2.8520 |
anchored component of membrane | ruffle membrane | GO:0032587 | 2.6791 |
anchored component of membrane | sarcolemma | GO:0042383 | 2.4197 |
anchored component of membrane | SNARE complex | GO:0031201 | 2.3037 |
anchored component of membrane | Derlin-1 retrotranslocation complex | GO:0036513 | 2.2351 |
anchored component of membrane | sarcoglycan complex | GO:0016012 | 2.2065 |
anchored component of membrane | basolateral plasma membrane | GO:0016323 | 1.9621 |
anchored component of membrane | immunological synapse | GO:0001772 | 1.7711 |
anchored component of membrane | gamma-secretase complex | GO:0070765 | 1.5773 |
anchored component of membrane | alpha-beta T cell receptor complex | GO:0042105 | 1.5773 |
anchored component of membrane | lipopolysaccharide receptor complex | GO:0046696 | 1.2173 |
anchored component of membrane | invadopodium membrane | GO:0071438 | 1.2173 |
anchored component of membrane | synaptobrevin 2-SNAP-25-syntaxin-1a complex | GO:0070044 | 0.9787 |
anchored component of membrane | CD40 receptor complex | GO:0035631 | 0.8320 |
anchored component of membrane | pore complex | GO:0046930 | 0.5976 |
anchored component of membrane | VCP-NPL4-UFD1 AAA ATPase complex | GO:0034098 | 0.5976 |
anchored component of membrane | basal plasma membrane | GO:0009925 | 0.5933 |
anchored component of membrane | B cell receptor complex | GO:0019815 | 0.4505 |
anchored component of membrane | UDP-N-acetylglucosamine transferase complex | GO:0043541 | 0.4505 |
anchored component of membrane | inhibin-betaglycan-ActRII complex | GO:0034673 | 0.4505 |
anchored component of membrane | alphav-beta3 integrin-vitronectin complex | GO:0071062 | 0.4505 |
anchored component of membrane | microvillus membrane | GO:0031528 | 0.4254 |
anchored component of membrane | NMDA selective glutamate receptor complex | GO:0017146 | 0.3752 |
anchored component of membrane | death-inducing signaling complex | GO:0031264 | 0.3738 |
apical part of cell | apical part of cell | GO:0045177 | 0.3531 |
brush border | brush border | GO:0005903 | 1.0078 |
cell surface | cell surface | GO:0009986 | 49.1013 |
cis-Golgi network | cis-Golgi network | GO:0005801 | 5.0791 |
collagen trimer | collagen trimer | GO:0005581 | 25.2760 |
collagen trimer | proteasome complex | GO:0000502 | 23.6629 |
collagen trimer | receptor complex | GO:0043235 | 8.0198 |
collagen trimer | Ino80 complex | GO:0031011 | 5.7332 |
collagen trimer | protein complex | GO:0043234 | 4.6249 |
collagen trimer | PRC1 complex | GO:0035102 | 3.3729 |
collagen trimer | nucleosome | GO:0000786 | 3.1212 |
collagen trimer | Smc5-Smc6 complex | GO:0030915 | 2.8520 |
collagen trimer | cAMP-dependent protein kinase complex | GO:0005952 | 2.8520 |
collagen trimer | BRCA1-A complex | GO:0070531 | 2.8520 |
collagen trimer | nuclear pore | GO:0005643 | 2.8475 |
collagen trimer | kinetochore | GO:0000776 | 2.3984 |
collagen trimer | SMAD protein complex | GO:0071141 | 2.3698 |
collagen trimer | Cdc73/Paf1 complex | GO:0016593 | 1.7695 |
collagen trimer | nuclear pore outer ring | GO:0031080 | 1.7064 |
collagen trimer | PcG protein complex | GO:0031519 | 1.7046 |
collagen trimer | micro-ribonucleoprotein complex | GO:0035068 | 1.2173 |
collagen trimer | Rab-protein geranylgeranyltransferase complex | GO:0005968 | 0.9787 |
collagen trimer | calcineurin complex | GO:0005955 | 0.9787 |
collagen trimer | ripoptosome | GO:0097342 | 0.9511 |
collagen trimer | phosphatidylinositol 3-kinase complex | GO:0005942 | 0.9322 |
collagen trimer | sodium:potassium-exchanging ATPase complex | GO:0005890 | 0.8320 |
collagen trimer | nuclear envelope | GO:0005635 | 0.7966 |
collagen trimer | HULC complex | GO:0033503 | 0.6961 |
collagen trimer | BRISC complex | GO:0070552 | 0.6961 |
collagen trimer | I-kappaB/NF-kappaB complex | GO:0033256 | 0.6961 |
collagen trimer | AIM2 inflammasome complex | GO:0097169 | 0.5082 |
collagen trimer | IkappaB kinase complex | GO:0008385 | 0.4766 |
collagen trimer | Hrd1p ubiquitin ligase complex | GO:0000836 | 0.4505 |
collagen trimer | nuclear pore inner ring | GO:0044611 | 0.4505 |
collagen trimer | MAML1-RBP-Jkappa- ICN1 complex | GO:0002193 | 0.4505 |
collagen trimer | dolichol-phosphate-mannose synthase complex | GO:0033185 | 0.4505 |
collagen trimer | XPC complex | GO:0071942 | 0.4505 |
collagen trimer | Wnt signalosome | GO:1990909 | 0.3752 |
collagen trimer | RISC-loading complex | GO:0070578 | 0.3738 |
endoplasmic reticulum-Golgi intermediate compartment | endoplasmic reticulum-Golgi intermediate compartment | GO:0005793 | 8.4911 |
ER-mitochondrion membrane contact site | ER-mitochondrion membrane contact site | GO:0044233 | 0.7526 |
extracellular region | extracellular region | GO:0005576 | 68.5055 |
focal adhesion | focal adhesion | GO:0005925 | 14.9870 |
focal adhesion | cell-cell junction | GO:0005911 | 4.5181 |
focal adhesion | intercellular canaliculus | GO:0046581 | 0.3738 |
Golgi membrane | Golgi membrane | GO:0000139 | 131.5538 |
Golgi membrane | endoplasmic reticulum lumen | GO:0005788 | 51.1314 |
Golgi membrane | Golgi lumen | GO:0005796 | 36.7731 |
Golgi membrane | Golgi apparatus | GO:0005794 | 35.9153 |
Golgi membrane | cytosol | GO:0005829 | 34.1852 |
Golgi membrane | endoplasmic reticulum membrane | GO:0005789 | 33.4449 |
Golgi membrane | endoplasmic reticulum | GO:0005783 | 29.6514 |
Golgi membrane | endocytic vesicle membrane | GO:0030666 | 25.1968 |
Golgi membrane | ER to Golgi transport vesicle membrane | GO:0012507 | 24.7050 |
Golgi membrane | Golgi cisterna membrane | GO:0032580 | 21.6324 |
Golgi membrane | membrane raft | GO:0045121 | 18.9052 |
Golgi membrane | endoplasmic reticulum-Golgi intermediate compartment membrane | GO:0033116 | 18.3266 |
Golgi membrane | integral component of Golgi membrane | GO:0030173 | 11.8690 |
Golgi membrane | platelet alpha granule lumen | GO:0031093 | 10.2107 |
Golgi membrane | endosome membrane | GO:0010008 | 9.4238 |
Golgi membrane | melanosome | GO:0042470 | 8.6172 |
Golgi membrane | transport vesicle | GO:0030133 | 6.7419 |
Golgi membrane | endoplasmic reticulum quality control compartment | GO:0044322 | 4.4225 |
Golgi membrane | endolysosome membrane | GO:0036020 | 3.7631 |
Golgi membrane | perinuclear region of cytoplasm | GO:0048471 | 2.6725 |
Golgi membrane | oligosaccharyltransferase complex | GO:0008250 | 2.5663 |
Golgi membrane | endoplasmic reticulum exit site | GO:0070971 | 2.4709 |
Golgi membrane | Golgi transport complex | GO:0017119 | 2.4709 |
Golgi membrane | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex | GO:0000506 | 2.3698 |
Golgi membrane | endocytic vesicle | GO:0030139 | 1.7886 |
Golgi membrane | serine C-palmitoyltransferase complex | GO:0017059 | 1.5773 |
Golgi membrane | GPI-anchor transamidase complex | GO:0042765 | 1.5773 |
Golgi membrane | endosome | GO:0005768 | 1.5372 |
Golgi membrane | secretory granule | GO:0030141 | 1.2875 |
Golgi membrane | platelet dense tubular network membrane | GO:0031095 | 1.2131 |
Golgi membrane | sarcoplasmic reticulum | GO:0016529 | 0.9536 |
Golgi membrane | platelet alpha granule | GO:0031091 | 0.9322 |
Golgi membrane | acrosomal vesicle | GO:0001669 | 0.8439 |
Golgi membrane | zymogen granule membrane | GO:0042589 | 0.8320 |
Golgi membrane | endoplasmic reticulum chaperone complex | GO:0034663 | 0.8320 |
Golgi membrane | annulate lamellae | GO:0005642 | 0.6961 |
Golgi membrane | smooth endoplasmic reticulum | GO:0005790 | 0.5604 |
Golgi membrane | ESCRT-0 complex | GO:0033565 | 0.4505 |
Golgi membrane | TAP complex | GO:0042825 | 0.4505 |
Golgi membrane | insulin-responsive compartment | GO:0032593 | 0.3738 |
intracellular | intracellular | GO:0005622 | 2.4688 |
lysosomal lumen | lysosomal lumen | GO:0043202 | 38.2047 |
lysosomal lumen | PML body | GO:0016605 | 0.7927 |
lysosomal lumen | STAGA complex | GO:0030914 | 0.4810 |
macromolecular complex | macromolecular complex | GO:0032991 | 0.4505 |
membrane | membrane | GO:0016020 | 46.0024 |
myelin sheath | myelin sheath | GO:0043209 | 1.6925 |
neuromuscular junction | neuromuscular junction | GO:0031594 | 2.0900 |
neuromuscular junction | postsynaptic density | GO:0014069 | 0.9970 |
neuronal cell body | neuronal cell body | GO:0043025 | 3.1966 |
neuronal cell body | axonal growth cone | GO:0044295 | 1.4126 |
neuronal cell body | axon | GO:0030424 | 1.1066 |
neuronal cell body | neuron projection terminus | GO:0044306 | 0.5814 |
neuronal cell body | node of Ranvier | GO:0033268 | 0.3952 |
organelle membrane contact site | organelle membrane contact site | GO:0044232 | 0.4505 |
other organism cell | other organism cell | GO:0044216 | 0.9787 |
proteinaceous extracellular matrix | proteinaceous extracellular matrix | GO:0005578 | 92.2503 |
proteinaceous extracellular matrix | extracellular exosome | GO:0070062 | 84.1428 |
proteinaceous extracellular matrix | extracellular space | GO:0005615 | 60.5567 |
proteinaceous extracellular matrix | extracellular matrix | GO:0031012 | 50.1339 |
proteinaceous extracellular matrix | blood microparticle | GO:0072562 | 3.6697 |
proteinaceous extracellular matrix | collagen type IV trimer | GO:0005587 | 2.2065 |
proteinaceous extracellular matrix | fibrinogen complex | GO:0005577 | 1.2131 |
proteinaceous extracellular matrix | elastic fiber | GO:0071953 | 0.9787 |
proteinaceous extracellular matrix | collagen type VI trimer | GO:0005589 | 0.4505 |
proteinaceous extracellular matrix | collagen type IX trimer | GO:0005594 | 0.4505 |
proteinaceous extracellular matrix | laminin-10 complex | GO:0043259 | 0.4505 |
spindle microtubule | spindle microtubule | GO:0005876 | 2.9273 |
spindle microtubule | dynactin complex | GO:0005869 | 2.3698 |
spindle microtubule | spectrin | GO:0008091 | 1.9931 |
spindle microtubule | Arp2/3 protein complex | GO:0005885 | 1.9508 |
spindle microtubule | spectrin-associated cytoskeleton | GO:0014731 | 1.4598 |
spindle microtubule | microtubule | GO:0005874 | 1.2731 |
spindle microtubule | myosin II complex | GO:0016460 | 0.9511 |
spindle microtubule | costamere | GO:0043034 | 0.7919 |
spindle microtubule | chromosome passenger complex | GO:0032133 | 0.6961 |
spindle microtubule | kinesin II complex | GO:0016939 | 0.4505 |
uropod | uropod | GO:0001931 | 1.4603 |
uropod | pseudopodium | GO:0031143 | 1.0252 |
uropod | ciliary base | GO:0097546 | 0.4923 |
uropod | ciliary rootlet | GO:0035253 | 0.4766 |
vesicle | vesicle | GO:0031982 | 5.9259 |
vesicle | intracellular membrane-bounded organelle | GO:0043231 | 4.5240 |